N-CSR 1 d459324dncsr.htm BLACKROCK FUNDS III BlackRock Funds III

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT

INVESTMENT COMPANIES

Investment Company Act file number: 811-07332

 

Name of Fund:   BlackRock Funds III
       BlackRock LifePath® Index 2025 Fund
       BlackRock LifePath® Index 2030 Fund
       BlackRock LifePath® Index 2035 Fund
       BlackRock LifePath® Index 2040 Fund
       BlackRock LifePath® Index 2045 Fund
       BlackRock LifePath® Index 2050 Fund
       BlackRock LifePath® Index 2055 Fund
       BlackRock LifePath® Index 2060 Fund
       BlackRock LifePath® Index 2065 Fund
       BlackRock LifePath® Index Retirement Fund

 

Fund Address:   100 Bellevue Parkway, Wilmington, DE 19809

Name and address of agent for service: John M. Perlowski, Chief Executive Officer, BlackRock Funds III, 50 Hudson Yards, New York, NY 10001

Registrant’s telephone number, including area code: (800) 537-4942

Date of fiscal year end: 12/31/2022

Date of reporting period: 12/31/2022


Item 1 – Report to Stockholders

(a) The Report to Shareholders is attached herewith.


 

LOGO

  DECEMBER 31, 2022

 

 

   

  

2022 Annual Report

 

 

BlackRock Funds III

 

·  

BlackRock LifePath® Index Retirement Fund

·  

BlackRock LifePath® Index 2025 Fund

·  

BlackRock LifePath® Index 2030 Fund

·  

BlackRock LifePath® Index 2035 Fund

·  

BlackRock LifePath® Index 2040 Fund

·  

BlackRock LifePath® Index 2045 Fund

·  

BlackRock LifePath® Index 2050 Fund

·  

BlackRock LifePath® Index 2055 Fund

·  

BlackRock LifePath® Index 2060 Fund

·  

BlackRock LifePath® Index 2065 Fund

 

 

 

 

Not FDIC Insured • May Lose Value • No Bank Guarantee

 


The Markets in Review

Dear Shareholder,

Significant economic headwinds emerged during the 12-month reporting period ended December 31, 2022, as investors navigated changing economic conditions and volatile markets. The U.S. economy shrank in the first half of 2022 before returning to modest growth in the third quarter, marking a shift to a more challenging post-reopening economic environment. Changes in consumer spending patterns and a tight labor market led to elevated inflation, which reached a 40-year high before beginning to moderate. Moreover, while the foremost effect of Russia’s invasion of Ukraine has been a severe humanitarian crisis, the ongoing war continued to present challenges for both investors and policymakers.

Equity prices fell as interest rates rose, particularly during the first half of the reporting period. Both large- and small-capitalization U.S. stocks fell, although equities began to recover in the second half of the year as inflation eased and economic growth resumed. Emerging market stocks and international equities from developed markets declined overall, pressured by rising interest rates and a strengthening U.S. dollar.

The 10-year U.S. Treasury yield rose notably during the reporting period, driving its price down, as investors reacted to fluctuating inflation data and attempted to anticipate its impact on future interest rate changes. The corporate bond market also faced inflationary headwinds, and heightened uncertainty led to higher corporate bond spreads (the difference in yield between U.S. Treasuries and similarly-dated corporate bonds).

The U.S. Federal Reserve (the “Fed”), acknowledging that inflation has been more persistent than expected, raised interest rates seven times. Furthermore, the Fed wound down its bond-buying programs and is accelerating the reduction of its balance sheet. While the Fed suggested that additional rate hikes were likely, it also gave indications that the pace of increases would slow if inflation continued to subside.

The pandemic’s restructuring of the economy brought an ongoing mismatch between supply and demand, contributing to the current inflationary regime. While growth slowed in 2022, we believe that taming inflation requires a more dramatic economic decline to bring demand back to a level more in line with the economy’s capacity. The Fed has been raising interest rates at the fastest pace in decades, and seems set to overtighten in its effort to get inflation back to target. With this in mind, we believe the possibility of a U.S. recession in the near-term is high, but this prospect has not yet been fully priced in by markets. Investors should expect a period of higher volatility as markets adjust to the new economic reality and policymakers attempt to adapt to rapidly changing conditions.

In this environment, while we favor an overweight to equities in the long-term, the market’s concerns over excessive rate hikes from central banks moderate our outlook. Rising input costs and a deteriorating economic backdrop are likely to challenge corporate earnings, so we are underweight equities overall in the near term. However, we see better opportunities in credit, where valuations are attractive and higher yields provide income opportunities. We believe that global investment-grade corporates, global inflation-linked bonds, and U.S. mortgage-backed securities offer strong opportunities for a six- to twelve-month horizon.

Overall, our view is that investors need to think globally, position themselves to be prepared for a decarbonizing economy, and be nimble as market conditions change. We encourage you to talk with your financial advisor and visit blackrock.com for further insight about investing in today’s markets.

Sincerely,

 

LOGO

Rob Kapito

President, BlackRock Advisors, LLC

LOGO

Rob Kapito

President, BlackRock Advisors, LLC

 

Total Returns as of December 31, 2022
       6-Month       12-Month  
   

U.S. large cap equities
(S&P 500® Index)

  2.31%   (18.11)%
   

U.S. small cap equities
(Russell 2000® Index)

  3.91      (20.44)   
   

International equities
(MSCI Europe, Australasia, Far East Index)

  6.36      (14.45)   
   

Emerging market equities
(MSCI Emerging Markets Index)

  (2.99)      (20.09)   
   

3-month Treasury bills
(ICE BofA 3-Month U.S. Treasury Bill Index)

  1.32      1.47  
   

U.S. Treasury securities
(ICE BofA 10-Year U.S. Treasury Index)

  (5.58)      (16.28)   
   

U.S. investment grade bonds

(Bloomberg U.S. Aggregate Bond Index)

  (2.97)      (13.01)   
   

Tax-exempt municipal bonds

(Bloomberg Municipal Bond Index)

  0.50      (8.53)  
   

U.S. high yield bonds
(Bloomberg U.S. Corporate High Yield 2% Issuer Capped Index)

  3.50      (11.18)    

Past performance is not an indication of future results. Index performance is shown for illustrative purposes only. You cannot invest directly in an index.

 

 

 

 

2  

T H I S   P A G E   I S   N O T   P A R T   O F   Y O U R   F U N D   R E P O R T


Table of Contents

 

      Page  

The Markets in Review

     2  

Annual Report:

  

Fund Summary

     4  

About Fund Performance

     26  

Disclosure of Expenses

     26  

Derivative Financial Instruments

     28  

Financial Statements:

  

Schedules of Investments

     29  

Statements of Assets and Liabilities

     49  

Statements of Operations

     55  

Statements of Changes in Net Assets

     58  

Financial Highlights

     63  

Notes to Financial Statements

     103  

Report of Independent Registered Public Accounting Firm

     118  

Important Tax Information

     119  

Statement Regarding Liquidity Risk Management Program

     121  

Trustee and Officer Information

     122  

Additional Information

     126  

Glossary of Terms Used in this Report

     128  

 

 

 

LOGO

 

 

  3


Fund Summary    as of December 31, 2022    BlackRock LifePath® Index Funds

 

Portfolio Management Commentary

How did each Fund perform?

The BlackRock LifePath® Index Retirement Fund along with the BlackRock LifePath® Index Funds with target dates of 2025, 2030, 2035, 2040, 2045, 2050, 2055, 2060 and 2065 are referred to as the “LifePath Index Funds” or the “Funds”.

For the 12-month period ended December 31, 2022, with respect to the BlackRock LifePath Index Retirement Fund and the Lifepath Index Funds with vintages of 2025, 2030 and 2035, all of the Funds’ share classes underperformed their respective custom benchmarks.

For the LifePath Index Fund with the vintage of 2040, the Fund’s Class K Shares performed in line with its custom benchmark, while the Fund’s Institutional, Investor A and Investor P Shares underperformed.

For the LifePath Index Funds with vintages of 2045 and 2050, the Funds’ Institutional and Class K Shares performed in line with their respective custom benchmark, while the Funds’ Investor A and Investor P Shares underperformed.

For the LifePath Index Funds with vintages of 2055 and 2060, the Funds’ Class K Shares outperformed their respective custom benchmark, while the Funds’ Institutional Shares performed in line with their respective custom benchmark, and Investor A and Investor P Shares underperformed.

For the LifePath Index Fund with the vintage of 2065, the Fund’s Institutional and Class K Shares outperformed its custom benchmark, while the Fund’s Investor A and Investor P Shares underperformed.

What factors influenced performance?

The global equity and fixed-income markets both lost ground in 2022. Financial assets were hurt by central banks’ decision to combat surging inflation by winding down their quantitative easing policies and raising interest rates aggressively. The rapid increase in rates, in turn, fueled worries about a potential global recession and weaker corporate earnings in 2023. Growth stocks were especially weak performers, while the value style held up much better in relative terms due in part to the strength in the energy sector and outperformance for more defensive market segments. Bonds suffered meaningful weakness, with both rate- and credit-sensitive investments experiencing losses.

In this environment, none of the Funds’ holdings finished with positive absolute returns. iShares TIPS Bond ETF was the smallest detractor in the shorter-dated Funds. In the longer-dated vintages, which have higher allocations to equities and equity-like assets, iShares MSCI Total International Stock ETF detracted the least.

Holdings in BlackRock Small Cap Index Fund and two of the five subcomponents of the Bloomberg U.S. Aggregate Bond Index (long-term U.S. government bonds and long-term investment-grade corporates) were the primary detractors from performance, particularly in the short-dated vintages. Among the Funds’ longer-dated vintages, iShares Developed Real Estate Fund and BlackRock Russell 1000® Index Fund were the main detractors.

Describe recent portfolio activity.

Each LifePath Index Fund has its own time horizon, which affects its acceptable level of risk and, in turn, the strategic allocation of its holdings across asset classes. On a quarterly basis, the strategic allocation of each LifePath Index Fund is systematically adjusted to reflect the shareholders’ remaining investment time horizon. During the period, the LifePath Index Funds were rebalanced in accordance with their updated strategic allocations.

Describe portfolio positioning at period end.

Each of the LifePath Index Funds was invested according to its respective strategic allocation benchmark within tolerance limits.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

 

 

4  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary    as of December 31, 2022 (continued)    BlackRock LifePath® Index Funds

 

Glide Path Evolution

Under normal circumstances, the asset allocation of each LifePath Index Fund will change over time according to a predetermined “glide path” as each LifePath Index Fund approaches its respective target date. The glide path represents the shifting of asset classes over time. Each LifePath Index Fund’s asset allocations become more conservative prior to retirement as time elapses. This reflects the need for reduced investment risks as retirement approaches and the need for lower volatility of each LifePath Index Fund, which may be a primary source of income after retirement. As each LifePath Index Fund approaches its target date, its asset allocation will shift so that each LifePath Index Fund invests a greater percentage of its assets in fixed-income index funds. The asset allocation targets are established by the portfolio managers. The investment team, including the portfolio managers, meets regularly to assess market conditions, review the asset allocation targets of each LifePath Index Fund, and determine whether any changes are required to enable each LifePath Index Fund to achieve its investment objective. Because the BlackRock LifePath® Index Retirement Fund is in its most conservative phase, its allocation generally does not become more conservative over time, although its allocation may change to maintain its risk profile.

Although the asset allocation targets listed for the glide path are general, long-term targets, BlackRock Fund Advisors (“BFA” or the “Manager”) may periodically adjust the proportion of equity index funds and fixed-income index funds in each LifePath Index Fund, based on an assessment of the current market conditions, the potential contribution of each asset class to the expected risk and return characteristics of each LifePath Index Fund, reallocations of each LifePath Index Fund’s composition to reflect intra-year movement along the glide path and other factors. In general, such adjustments will be limited; however, BFA may determine that a greater degree of variation is warranted to protect a LifePath Index Fund or achieve its investment objective.

 

 

F U N D   S U M M A R Y

  5


LifePath Index Fund Summary    as of December 31, 2022    BlackRock LifePath® Index Retirement Fund

 

Investment Objective

BlackRock LifePath® Index Retirement Fund’s (“LifePath Index Retirement Fund” or the “LifePath Index Fund”) investment objective is to seek to provide for retirement outcomes based on quantitatively measured risk. In pursuit of this objective, LifePath Index Retirement Fund will be broadly diversified across global asset classes.

GROWTH OF $10,000 INVESTMENT

LOGO

 

  (a)

Assuming maximum sales charges, if any, transaction costs and other operating expenses, including investment advisory fees and administration fees, if any. Institutional and Investor A Shares do not have a sales charge.

 

 

  (b)

The LifePath Index Retirement Fund compares its performance to that of a customized weighted index (the “LifePath Index Retirement Fund Custom Benchmark”). Prior to May 31, 2022, the LifePath Index Retirement Fund Custom Benchmark was comprised of the Bloomberg U.S. Aggregate Bond Index, Bloomberg U.S. Treasury Inflation Protected Securities (TIPS) Index (Series-L), FTSE EPRA Nareit Developed Index, MSCI ACWI ex USA IMI Index, Russell 1000® Index and Russell 2000® Index. Effective May 31, 2022, the LifePath Index Retirement Fund Custom Benchmark was changed to remove Bloomberg U.S. Aggregate Bond Index and to add Bloomberg U.S. Long Credit Bond Index, Bloomberg U.S. Intermediate Credit Bond Index, Bloomberg U.S. Long Government Bond Index, Bloomberg U.S. Intermediate Government Bond Index and Bloomberg U.S. Securitized: MBS, ABS and CMBS Index. The investment adviser believes that the updated LifePath Index Retirement Fund Custom Benchmark is more representative of the sectors in which the LifePath Index Retirement Fund invests. The investment adviser adjusts the weightings of the indexes in the LifePath Index Retirement Fund Custom Benchmark periodically based upon its evaluation and adjustment of the LifePath Index Retirement Fund’s asset allocation strategy. The weightings are presented annually but they are adjusted quarterly.

 

The LifePath Index Fund’s custom benchmark consists of the following:

 

Period

  Bloomberg
U.S. Aggregate
Bond Index
    Bloomberg
U.S. Intermediate
Credit
Bond
Index
    Bloomberg
U.S. Intermediate
Government
Bond
Index
    Bloomberg
U.S. Long
Credit
Bond
Index
    Bloomberg
U.S. Long
Government
Bond
Index
    Bloomberg
U.S. Securitized:
MBS, ABS
and
CMBS
Index
    Bloomberg
U.S. Treasury
Inflation
Protected
Securities
(TIPS) Index
(Series-L)
    FTSE
EPRA Nareit
Developed
Index
    MSCI
ACWI ex USA
IMI Index
    Russell
1000
®
Index
    Russell
2000
®
Index
 
01/01/13 to 12/31/13     40.9     N/A       N/A       N/A       N/A       N/A       6.6     3.1     16.0     29.7     3.7
01/01/14 to 12/31/14     42.1       N/A       N/A       N/A       N/A       N/A       6.8       3.0       16.0       28.4       3.7  
01/01/15 to 12/31/15     40.4       N/A       N/A       N/A       N/A       N/A       6.7       3.3       16.9       29.3       3.4  
01/01/16 to 12/31/16     51.2       N/A       N/A       N/A       N/A       N/A       8.8       0.6       13.3       22.3       3.8  
01/01/17 to 12/31/17     51.2       N/A       N/A       N/A       N/A       N/A       8.8       0.5       13.3       21.8       4.4  
01/01/18 to 12/31/18     51.2       N/A       N/A       N/A       N/A       N/A       8.8       0.5       13.7       21.8       4.0  
01/01/19 to 12/31/19     52.0       N/A       N/A       N/A       N/A       N/A       8.0       2.2       12.3       22.1       3.4  
01/01/20 to 12/31/20     52.0       N/A       N/A       N/A       N/A       N/A       8.0       2.2       12.9       21.6       3.3  
01/01/21 to 12/31/21     52.0       N/A       N/A       N/A       N/A       N/A       8.0       2.2       13.3       20.9       3.6  
01/01/22 to 12/31/22     13.1       5.4     14.3     2.5     4.9     11.7     8.0       2.2       13.5       21.3       3.1  

See “About Fund Performance” for descriptions of the indexes.

 

 

6  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


LifePath Index Fund Summary    as of December 31, 2022 (continued)    BlackRock LifePath® Index Retirement Fund

 

Performance

 

     Average Annual Total Returns(a)(b)  
     1 Year      5 Years      10 Years  
      Without
Sales
Charge
     With
Sales
Charge
     Without
Sales
Charge
     With
Sales
Charge
     Without
Sales
Charge
     With
Sales
Charge
 

Institutional

     (15.31 )%       N/A        2.55      N/A        4.19      N/A  

Investor A

     (15.48      N/A        2.30        N/A        3.93        N/A  

Investor P

     (15.49      (19.93 )%       2.31        1.21      3.94        3.38

Class K

     (15.20      N/A        2.62        N/A        4.24        N/A  

LifePath Index Retirement Fund Custom Benchmark

     (15.05      N/A        2.68        N/A        4.35        N/A  

Bloomberg U.S. Aggregate Bond Index

     (13.01      N/A        0.02        N/A        1.06        N/A  

Bloomberg U.S. Intermediate Credit Bond Index

     (9.10      N/A        1.08        N/A        1.76        N/A  

Bloomberg U.S. Intermediate Government Bond Index

     (7.73      N/A        0.46        N/A        0.69        N/A  

Bloomberg U.S. Long Credit Bond Index

     (25.29      N/A        (0.77      N/A        2.13        N/A  

Bloomberg U.S. Long Government Bond Index

     (29.19      N/A        (2.19      N/A        0.61        N/A  

Bloomberg U.S. Securitized: MBS, ABS and CMBS Index

     (11.67      N/A        (0.43      N/A        0.80        N/A  

Bloomberg U.S. TIPS Index (Series-L)

     (11.85      N/A        2.11        N/A        1.12        N/A  

FTSE EPRA Nareit Developed Index

     (25.09      N/A        (0.23      N/A        2.99        N/A  

MSCI ACWI ex USA IMI Index

     (16.58      N/A        0.85        N/A        3.98        N/A  

Russell 1000® Index

     (19.13      N/A        9.13        N/A        12.37        N/A  

Russell 2000® Index

     (20.44      N/A        4.13        N/A        9.01        N/A  

 

  (a)

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 

 

  (b)

LifePath Index Retirement Fund normally invests its assets in underlying funds according to an asset allocation strategy designed for investors who are currently withdrawing, or plan in the near future to begin withdrawing, a substantial portion of their investment.

 

N/A — Not applicable as the share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

PORTFOLIO ALLOCATION

   
Asset Type   Percent of
Net Assets
 

Fixed-Income Funds

    60.0

Equity Funds

    39.9  

Money Market Funds

    0.1  

Liabilities in Excess of Other Assets

    (— )(a) 

TEN LARGEST HOLDINGS

   
Security   Percent of
Net Assets
 

Large Cap Index Master Portfolio

    20.7

iShares U.S. Intermediate Government Bond Index Fund

    19.2  

iShares U.S. Securitized Bond Index Fund

    15.6  

iShares Core MSCI Total International Stock ETF

    13.9  

iShares TIPS Bond ETF

    8.0  

iShares U.S. Intermediate Credit Bond Index Fund

    7.3  

iShares U.S. Long Government Bond Index Fund

    6.6  

iShares U.S. Long Credit Bond Index Fund

    3.3  

Master Small Cap Index Series

    3.1  

iShares Developed Real Estate Index Fund, Class K

    2.2  
 
(a) 

Rounds to more than (0.1)% of net assets.

 

 

U N D   S U M M  A R Y

  7


LifePath Index Fund Summary    as of December 31, 2022    BlackRock LifePath® Index 2025 Fund

 

Investment Objective

BlackRock LifePath® Index 2025 Fund’s (“LifePath Index 2025 Fund” or the “LifePath Index Fund”) investment objective is to seek to provide for retirement outcomes based on quantitatively measured risk. In pursuit of this objective, LifePath Index 2025 Fund will be broadly diversified across global asset classes, with asset allocations becoming more conservative over time.

GROWTH OF $10,000 INVESTMENT

 

LOGO

 

  (a)

Assuming maximum sales charges, if any, transaction costs and other operating expenses, including investment advisory fees and administration fees, if any. Institutional and Investor A Shares do not have a sales charge.

 

 

  (b)

The LifePath Index 2025 Fund compares its performance to that of a customized weighted index (the “LifePath Index 2025 Fund Custom Benchmark”). Prior to May 31, 2022, the LifePath Index 2025 Fund Custom Benchmark was comprised of the Bloomberg U.S. Aggregate Bond Index, Bloomberg U.S. Treasury Inflation Protected Securities (TIPS) Index (Series-L), FTSE EPRA Nareit Developed Index, MSCI ACWI ex USA IMI Index, Russell 1000® Index and Russell 2000® Index. Effective May 31, 2022, the LifePath Index 2025 Fund Custom Benchmark was changed to remove Bloomberg U.S. Aggregate Bond Index and to add Bloomberg U.S. Long Credit Bond Index, Bloomberg U.S. Intermediate Credit Bond Index, Bloomberg U.S. Long Government Bond Index, Bloomberg U.S. Intermediate Government Bond Index and Bloomberg U.S. Securitized: MBS, ABS and CMBS Index. The investment adviser believes that the updated LifePath Index 2025 Fund Custom Benchmark is more representative of the sectors in which the LifePath Index 2025 Fund invests. The investment adviser adjusts the weightings of the indexes in the LifePath Index 2025 Fund Custom Benchmark periodically based upon its evaluation and adjustment of the LifePath Index 2025 Fund’s asset allocation strategy. The weightings are presented annually but they are adjusted quarterly.

 

The LifePath Index Fund’s custom benchmark consists of the following:

 

Period

  Bloomberg
U.S. Aggregate
Bond Index
    Bloomberg
U.S. Intermediate
Credit
Bond
Index
    Bloomberg
U.S. Intermediate
Government
Bond
Index
    Bloomberg
U.S. Long
Credit
Bond
Index
    Bloomberg
U.S. Long
Government
Bond
Index
    Bloomberg
U.S. Securitized:
MBS, ABS
and
CMBS
Index
    Bloomberg
U.S. Treasury
Inflation
Protected
Securities
(TIPS) Index
(Series-L)
    FTSE
EPRA Nareit
Developed
Index
    MSCI
ACWI ex USA
IMI Index
    Russell
1000
®
Index
    Russell
2000
®
Index
 
01/01/13 to 12/31/13     33.7     N/A       N/A       N/A       N/A       N/A       5.3     4.8     18.3     34.6     3.3
01/01/14 to 12/31/14     34.5       N/A       N/A       N/A       N/A       N/A       5.4       4.9       18.5       33.4       3.3  
01/01/15 to 12/31/15     30.9       N/A       N/A       N/A       N/A       N/A       5.0       5.9       20.1       35.1       3.0  
01/01/16 to 12/31/16     32.4       N/A       N/A       N/A       N/A       N/A       5.3       5.8       19.8       33.8       2.9  
01/01/17 to 12/31/17     35.0       N/A       N/A       N/A       N/A       N/A       5.7       5.3       19.3       31.6       3.1  
01/01/18 to 12/31/18     36.5       N/A       N/A       N/A       N/A       N/A       5.9       4.5       19.3       30.7       3.1  
01/01/19 to 12/31/19     38.1       N/A       N/A       N/A       N/A       N/A       7.1       2.5       19.5       29.7       3.1  
01/01/20 to 12/31/20     40.9       N/A       N/A       N/A       N/A       N/A       7.3       2.4       18.5       28.0       2.9  
01/01/21 to 12/31/21     43.3       N/A       N/A       N/A       N/A       N/A       7.5       2.2       17.6       26.2       3.2  
01/01/22 to 12/31/22     11.3       5.1     10.9     2.9     5.1     10.4     7.6       2.1       16.4       25.3       2.9  

See “About Fund Performance” for descriptions of the indexes.

 

 

8  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


LifePath Index Fund Summary    as of December 31, 2022 (continued)    BlackRock LifePath® Index 2025 Fund

 

Performance

 

    Average Annual Total Returns(a)(b)  
    1 Year           5 Years           10 Years  
     Without
Sales
Charge
    With
Sales
Charge
           Without
Sales
Charge
    With
Sales
Charge
           Without
Sales
Charge
    With
Sales
Charge
 

Institutional

    (15.81 )%      N/A         3.12     N/A         5.52     N/A  

Investor A

    (16.01     N/A         2.86       N/A         5.25       N/A  

Investor P

    (16.03     (20.44 )%        2.86       1.75       5.26       4.69

Class K

    (15.77     N/A         3.17       N/A         5.57       N/A  

LifePath Index 2025 Fund Custom Benchmark

    (15.62     N/A         3.21       N/A         5.65       N/A  

Bloomberg U.S. Aggregate Bond Index

    (13.01     N/A         0.02       N/A         1.06       N/A  

Bloomberg U.S. Intermediate Credit Bond Index

    (9.10     N/A         1.08       N/A         1.76       N/A  

Bloomberg U.S. Intermediate Government Bond Index

    (7.73     N/A         0.46       N/A         0.69       N/A  

Bloomberg U.S. Long Credit Bond Index

    (25.29     N/A         (0.77     N/A         2.13       N/A  

Bloomberg U.S. Long Government Bond Index

    (29.19     N/A         (2.19     N/A         0.61       N/A  

Bloomberg U.S. Securitized: MBS, ABS and CMBS Index

    (11.67     N/A         (0.43     N/A         0.80       N/A  

Bloomberg U.S. TIPS Index (Series-L)

    (11.85     N/A         2.11       N/A         1.12       N/A  

FTSE EPRA Nareit Developed Index

    (25.09     N/A         (0.23     N/A         2.99       N/A  

MSCI ACWI ex USA IMI Index

    (16.58     N/A         0.85       N/A         3.98       N/A  

Russell 1000® Index

    (19.13     N/A         9.13       N/A         12.37       N/A  

Russell 2000® Index

    (20.44     N/A               4.13       N/A               9.01       N/A  

 

  (a)

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 

 

  (b)

LifePath Index 2025 Fund normally invests its assets in underlying funds according to an asset allocation strategy designed for investors planning to retire or begin withdrawing assets around the year 2025.

 

N/A — Not applicable as the share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

PORTFOLIO ALLOCATION

Asset Type   Percent of
Net Assets
 

Fixed-Income Funds

    54.2

Equity Funds

    45.8  

Money Market Funds

    0.8  

Liabilities in Excess of Other Assets

    (0.8

TEN LARGEST HOLDINGS

Security   Percent of
Net Assets
 

Large Cap Index Master Portfolio

    24.5

iShares Core MSCI Total International Stock ETF

    16.3  

iShares U.S. Intermediate Government Bond Index Fund

    14.8  

iShares U.S. Securitized Bond Index Fund

    14.0  

iShares TIPS Bond ETF

    7.7  

iShares U.S. Long Government Bond Index Fund

    6.9  

iShares U.S. Intermediate Credit Bond Index Fund

    6.9  

iShares U.S. Long Credit Bond Index Fund

    3.9  

Master Small Cap Index Series

    2.9  

iShares Developed Real Estate Index Fund, Class K

    2.1  
 

 

 

U N D   S U M M  A R Y

  9


LifePath Index Fund Summary    as of December 31, 2022    BlackRock LifePath® Index 2030 Fund

 

Investment Objective

BlackRock LifePath® Index 2030 Fund’s (“LifePath Index 2030 Fund” or the “LifePath Index Fund”) investment objective is to seek to provide for retirement outcomes based on quantitatively measured risk. In pursuit of this objective, LifePath Index 2030 Fund will be broadly diversified across global asset classes, with asset allocations becoming more conservative over time.

GROWTH OF $10,000 INVESTMENT

 

 

LOGO

 

  (a)

Assuming maximum sales charges, if any, transaction costs and other operating expenses, including investment advisory fees and administration fees, if any. Institutional and Investor A Shares do not have a sales charge.

 

 

  (b)

The LifePath Index 2030 Fund compares its performance to that of a customized weighted index (the “LifePath Index 2030 Fund Custom Benchmark”). Prior to May 31, 2022, the LifePath Index 2030 Fund Custom Benchmark was comprised of the Bloomberg U.S. Aggregate Bond Index, Bloomberg U.S. Treasury Inflation Protected Securities (TIPS) Index (Series-L), FTSE EPRA Nareit Developed Index, MSCI ACWI ex USA IMI Index, Russell 1000® Index and Russell 2000® Index. Effective May 31, 2022, the LifePath Index 2030 Fund Custom Benchmark was changed to remove Bloomberg U.S. Aggregate Bond Index and to add Bloomberg U.S. Long Credit Bond Index, Bloomberg U.S. Intermediate Credit Bond Index, Bloomberg U.S. Long Government Bond Index, Bloomberg U.S. Intermediate Government Bond Index and Bloomberg U.S. Securitized: MBS, ABS and CMBS Index. The investment adviser believes that the updated LifePath Index 2030 Fund Custom Benchmark is more representative of the sectors in which the LifePath Index 2030 Fund invests. The investment adviser adjusts the weightings of the indexes in the LifePath Index 2030 Fund Custom Benchmark periodically based upon its evaluation and adjustment of the LifePath Index 2030 Fund’s asset allocation strategy. The weightings are presented annually but they are adjusted quarterly.

 

The LifePath Index Fund’s custom benchmark consists of the following:

 

Period

  Bloomberg
U.S. Aggregate
Bond Index
    Bloomberg
U.S. Intermediate
Credit
Bond
Index
    Bloomberg
U.S. Intermediate
Government
Bond
Index
    Bloomberg
U.S. Long
Credit
Bond
Index
    Bloomberg
U.S. Long
Government
Bond
Index
    Bloomberg
U.S. Securitized:
MBS, ABS
and
CMBS
Index
    Bloomberg
U.S. Treasury
Inflation
Protected
Securities
(TIPS) Index
(Series-L)
    FTSE
EPRA Nareit
Developed
Index
    MSCI
ACWI ex USA
IMI Index
    Russell
1000
®
Index
    Russell
2000
®
Index
 
01/01/13 to 12/31/13     27.6     N/A       N/A       N/A       N/A       N/A       4.0     6.2     20.3     38.9     3.0
01/01/14 to 12/31/14     27.7       N/A       N/A       N/A       N/A       N/A       4.1       6.6       20.9       37.8       2.9  
01/01/15 to 12/31/15     21.8       N/A       N/A       N/A       N/A       N/A       3.4       8.3       23.1       40.8       2.6  
01/01/16 to 12/31/16     23.4       N/A       N/A       N/A       N/A       N/A       3.6       8.3       22.9       39.3       2.5  
01/01/17 to 12/31/17     25.9       N/A       N/A       N/A       N/A       N/A       4.0       8.1       22.5       37.1       2.4  
01/01/18 to 12/31/18     27.2       N/A       N/A       N/A       N/A       N/A       4.2       7.5       22.5       36.1       2.5  
01/01/19 to 12/31/19     26.9       N/A       N/A       N/A       N/A       N/A       6.1       3.1       25.2       36.0       2.7  
01/01/20 to 12/31/20     29.9       N/A       N/A       N/A       N/A       N/A       6.2       3.0       23.9       34.5       2.5  
01/01/21 to 12/31/21     32.1       N/A       N/A       N/A       N/A       N/A       6.5       2.9       22.9       33.1       2.5  
01/01/22 to 12/31/22     8.5       3.7     6.7     3.6     4.0     7.8     6.7       2.7       21.1       32.9       2.3  

See “About Fund Performance” for descriptions of the indexes.

 

 

10  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


LifePath Index Fund Summary    as of December 31, 2022 (continued)    BlackRock LifePath® Index 2030 Fund

 

Performance

 

     Average Annual Total Returns(a)(b)  
     1 Year      5 Years      10 Years  
      Without
Sales
Charge
     With
Sales
Charge
     Without
Sales
Charge
     With
Sales
Charge
     Without
Sales
Charge
     With
Sales
Charge
 

Institutional

     (16.49 )%       N/A        3.72      N/A        6.23      N/A  

Investor A

     (16.71      N/A        3.46        N/A        5.97        N/A  

Investor P

     (16.68      (21.05 )%       3.48        2.37      5.97        5.40

Class K

     (16.41      N/A        3.78        N/A        6.29        N/A  

LifePath Index 2030 Fund Custom Benchmark

     (16.32      N/A        3.80        N/A        6.36        N/A  

Bloomberg U.S. Aggregate Bond Index

     (13.01      N/A        0.02        N/A        1.06        N/A  

Bloomberg U.S. Intermediate Credit Bond Index

     (9.10      N/A        1.08        N/A        1.76        N/A  

Bloomberg U.S. Intermediate Government Bond Index

     (7.73      N/A        0.46        N/A        0.69        N/A  

Bloomberg U.S. Long Credit Bond Index

     (25.29      N/A        (0.77      N/A        2.13        N/A  

Bloomberg U.S. Long Government Bond Index

     (29.19      N/A        (2.19      N/A        0.61        N/A  

Bloomberg U.S. Securitized: MBS, ABS and CMBS Index

     (11.67      N/A        (0.43      N/A        0.80        N/A  

Bloomberg U.S. TIPS Index (Series-L)

     (11.85      N/A        2.11        N/A        1.12        N/A  

FTSE EPRA Nareit Developed Index

     (25.09      N/A        (0.23      N/A        2.99        N/A  

MSCI ACWI ex USA IMI Index

     (16.58      N/A        0.85        N/A        3.98        N/A  

Russell 1000® Index

     (19.13      N/A        9.13        N/A        12.37        N/A  

Russell 2000® Index

     (20.44      N/A        4.13        N/A        9.01        N/A  

 

  (a)

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 

 

  (b)

LifePath Index 2030 Fund normally invests its assets in underlying funds according to an asset allocation strategy designed for investors planning to retire or begin withdrawing assets around the year 2030.

 

N/A — Not applicable as the share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

PORTFOLIO ALLOCATION

Asset Type   Percent of
Net Assets
 

Equity Funds

    58.3

Fixed-Income Funds

    41.7  

Money Market Funds

    (a) 

Liabilities in Excess of Other Assets

    (— )(b) 

TEN LARGEST HOLDINGS

Security   Percent of
Net Assets
 

Large Cap Index Master Portfolio

    32.5

iShares Core MSCI Total International Stock ETF

    20.8  

iShares U.S. Securitized Bond Index Fund

    10.5  

iShares U.S. Intermediate Government Bond Index Fund

    9.2  

iShares TIPS Bond ETF

    6.8  

iShares U.S. Long Government Bond Index Fund

    5.3  

iShares U.S. Intermediate Credit Bond Index Fund

    5.1  

iShares U.S. Long Credit Bond Index Fund

    4.8  

iShares Developed Real Estate Index Fund, Class K

    2.7  

Master Small Cap Index Series

    2.3  
 
(a)

Rounds to less than 0.1% of net assets.

(b)

Rounds to more than (0.1)% of net assets.

 

 

U N D   S U M M  A R Y

  11


LifePath Index Fund Summary    as of December 31, 2022    BlackRock LifePath® Index 2035 Fund

 

Investment Objective

BlackRock LifePath® Index 2035 Fund’s (“LifePath Index 2035 Fund” or the “LifePath Index Fund”) investment objective is to seek to provide for retirement outcomes based on quantitatively measured risk. In pursuit of this objective, LifePath Index 2035 Fund will be broadly diversified across global asset classes, with asset allocations becoming more conservative over time.

GROWTH OF $10,000 INVESTMENT

 

LOGO

 

(a)

Assuming maximum sales charges, if any, transaction costs and other operating expenses, including investment advisory fees and administration fees, if any. Institutional and Investor A Shares do not have a sales charge.

 

(b)

The LifePath Index 2035 Fund compares its performance to that of a customized weighted index (the “LifePath Index 2035 Fund Custom Benchmark”). Prior to May 31, 2022, the LifePath Index 2035 Fund Custom Benchmark was comprised of the Bloomberg U.S. Aggregate Bond Index, Bloomberg U.S. Treasury Inflation Protected Securities (TIPS) Index (Series-L), FTSE EPRA Nareit Developed Index, MSCI ACWI ex USA IMI Index, Russell 1000® Index and Russell 2000® Index. Effective May 31, 2022, the LifePath Index 2035 Fund Custom Benchmark was changed to remove Bloomberg U.S. Aggregate Bond Index and to add Bloomberg U.S. Long Credit Bond Index, Bloomberg U.S. Intermediate Credit Bond Index, Bloomberg U.S. Long Government Bond Index, Bloomberg U.S. Intermediate Government Bond Index and Bloomberg U.S. Securitized: MBS, ABS and CMBS Index. The investment adviser believes that the updated LifePath Index 2035 Fund Custom Benchmark is more representative of the sectors in which the LifePath Index 2035 Fund invests. The investment adviser adjusts the weightings of the indexes in the LifePath Index 2035 Fund Custom Benchmark periodically based upon its evaluation and adjustment of the LifePath Index 2035 Fund’s asset allocation strategy. The weightings are presented annually but they are adjusted quarterly.

The LifePath Index Fund’s custom benchmark consists of the following:

 

Period

  Bloomberg
U.S. Aggregate
Bond Index
   

Bloomberg
U.S. Intermediate
Credit
Bond

Index

    Bloomberg
U.S. Intermediate
Government
Bond
Index
    Bloomberg
U.S. Long
Credit
Bond
Index
    Bloomberg
U.S. Long
Government
Bond
Index
    Bloomberg
U.S. Securitized:
MBS, ABS
and
CMBS
Index
    Bloomberg
U.S. Treasury
Inflation
Protected
Securities
(TIPS) Index
(Series-L)
    FTSE
EPRA Nareit
Developed
Index
    MSCI
ACWI ex USA
IMI Index
    Russell
1000
®
Index
    Russell
2000
®
Index
 
01/01/13 to 12/31/13     22.1     N/A       N/A       N/A       N/A       N/A       2.9     7.5     22.2     42.7     2.6
01/01/14 to 12/31/14     21.6       N/A       N/A       N/A       N/A       N/A       2.9       8.1       23.0       41.8       2.6  
01/01/15 to 12/31/15     13.2       N/A       N/A       N/A       N/A       N/A       1.9       10.6       26.0       46.0       2.3  
01/01/16 to 12/31/16     14.7       N/A       N/A       N/A       N/A       N/A       2.2       10.7       25.7       44.6       2.1  
01/01/17 to 12/31/17     17.1       N/A       N/A       N/A       N/A       N/A       2.5       10.8       25.5       42.4       1.7  
01/01/18 to 12/31/18     18.4       N/A       N/A       N/A       N/A       N/A       2.7       10.3       25.5       41.3       1.8  
01/01/19 to 12/31/19     17.1       N/A       N/A       N/A       N/A       N/A       4.6       3.7       30.4       41.8       2.4  
01/01/20 to 12/31/20     19.7       N/A       N/A       N/A       N/A       N/A       4.9       3.6       29.1       40.6       2.1  
01/01/21 to 12/31/21     21.8       N/A       N/A       N/A       N/A       N/A       5.2       3.5       28.0       39.6       1.9  
01/01/22 to 12/31/22     5.9       2.6     3.6     3.4     2.9     5.4     5.5       3.3       25.5       40.0       1.9  

See “About Fund Performance” for descriptions of the indexes.

 

 

12  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


LifePath Index Fund Summary    as of December 31, 2022 (continued)    BlackRock LifePath® Index 2035 Fund

 

Performance

 

   

Average Annual Total Returns(a)(b)

 
 

 

 

 
    1 Year     5 Years     10 Years  
 

 

 

 
     

Without
Sales
Charge
 
 
 
   

With
Sales
Charge
 
 
 
   

Without
Sales
Charge
 
 
 
   

With
Sales
Charge
 
 
 
   

Without
Sales
Charge
 
 
 
   

With
Sales
Charge
 
 
 

Institutional

    (17.06 )%      N/A       4.31     N/A       6.91     N/A  

Investor A

    (17.27     N/A       4.06       N/A       6.64       N/A  

Investor P

    (17.34     (21.68 )%      4.04       2.93     6.65       6.07

Class K

    (17.07     N/A       4.35       N/A       6.96       N/A  

LifePath Index 2035 Fund Custom Benchmark

    (16.98     N/A       4.36       N/A       7.03       N/A  

Bloomberg U.S. Aggregate Bond Index

    (13.01     N/A       0.02       N/A       1.06       N/A  

Bloomberg U.S. Intermediate Credit Bond Index

    (9.10     N/A       1.08       N/A       1.76       N/A  

Bloomberg U.S. Intermediate Government Bond Index

    (7.73     N/A       0.46       N/A       0.69       N/A  

Bloomberg U.S. Long Credit Bond Index

    (25.29     N/A       (0.77     N/A       2.13       N/A  

Bloomberg U.S. Long Government Bond Index

    (29.19     N/A       (2.19     N/A       0.61       N/A  

Bloomberg U.S. Securitized: MBS, ABS and CMBS Index

    (11.67     N/A       (0.43     N/A       0.80       N/A  

Bloomberg U.S. TIPS Index (Series-L)

    (11.85     N/A       2.11       N/A       1.12       N/A  

FTSE EPRA Nareit Developed Index

    (25.09     N/A       (0.23     N/A       2.99       N/A  

MSCI ACWI ex USA IMI Index

    (16.58     N/A       0.85       N/A       3.98       N/A  

Russell 1000® Index

    (19.13     N/A       9.13       N/A       12.37       N/A  

Russell 2000® Index

    (20.44     N/A       4.13       N/A       9.01       N/A  

 

  (a)

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 

 

  (b)

LifePath Index 2035 Fund normally invests its assets in underlying funds according to an asset allocation strategy designed for investors planning to retire or begin withdrawing assets around the year 2035.

 

N/A — Not applicable as the share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

PORTFOLIO ALLOCATION

   
Asset Type   Percent of
Net Assets
 

Equity Funds

    70.0

Fixed-Income Funds

    30.0  

Money Market Funds

    0.1  

Liabilities in Excess of Other Assets

    (0.1

TEN LARGEST HOLDINGS

   
Security   Percent of
Net Assets
 

Large Cap Index Master Portfolio

    39.8

iShares Core MSCI Total International Stock ETF

    25.0  

iShares U.S. Securitized Bond Index Fund

    7.4  

iShares TIPS Bond ETF

    5.6  

iShares U.S. Intermediate Government Bond Index Fund

    5.0  

iShares U.S. Long Credit Bond Index Fund

    4.6  

iShares U.S. Long Government Bond Index Fund

    3.9  

iShares U.S. Intermediate Credit Bond Index Fund

    3.5  

iShares Developed Real Estate Index Fund, Class K

    3.4  

Master Small Cap Index Series

    1.8  
 

 

 

U N D   S U M M  A R Y

  13


LifePath Index Fund Summary    as of December 31, 2022    BlackRock LifePath® Index 2040 Fund

 

Investment Objective

BlackRock LifePath® Index 2040 Fund’s (“LifePath Index 2040 Fund” or the “LifePath Index Fund”) investment objective is to seek to provide for retirement outcomes based on quantitatively measured risk. In pursuit of this objective, LifePath Index 2040 Fund will be broadly diversified across global asset classes, with asset allocations becoming more conservative over time.

GROWTH OF $10,000 INVESTMENT

 

 

LOGO

 

  (a)

Assuming maximum sales charges, if any, transaction costs and other operating expenses, including investment advisory fees and administration fees, if any. Institutional and Investor A Shares do not have a sales charge.

 

 

  (b)

The LifePath Index 2040 Fund compares its performance to that of a customized weighted index (the “LifePath Index 2040 Fund Custom Benchmark”). Prior to May 31, 2022, the LifePath Index 2040 Fund Custom Benchmark was comprised of the Bloomberg U.S. Aggregate Bond Index, Bloomberg U.S. Treasury Inflation Protected Securities (TIPS) Index (Series-L), FTSE EPRA Nareit Developed Index, MSCI ACWI ex USA IMI Index, Russell 1000® Index and Russell 2000® Index. Effective May 31, 2022, the LifePath Index 2040 Fund Custom Benchmark was changed to remove Bloomberg U.S. Aggregate Bond Index and to add Bloomberg U.S. Long Credit Bond Index, Bloomberg U.S. Intermediate Credit Bond Index, Bloomberg U.S. Long Government Bond Index, Bloomberg U.S. Intermediate Government Bond Index and Bloomberg U.S. Securitized: MBS, ABS and CMBS Index. The investment adviser believes that the updated LifePath Index 2040 Fund Custom Benchmark is more representative of the sectors in which the LifePath Index 2040 Fund invests. The investment adviser adjusts the weightings of the indexes in the LifePath Index 2040 Fund Custom Benchmark periodically based upon its evaluation and adjustment of the LifePath Index 2040 Fund’s asset allocation strategy. The weightings are presented annually but they are adjusted quarterly.

 

The LifePath Index Fund’s custom benchmark consists of the following:

 

Period

  Bloomberg
U.S. Aggregate
Bond Index
    Bloomberg
U.S. Intermediate
Credit
Bond
Index
    Bloomberg
U.S. Intermediate
Government
Bond
Index
    Bloomberg
U.S. Long
Credit
Bond
Index
    Bloomberg
U.S. Long
Government
Bond
Index
    Bloomberg
U.S. Securitized:
MBS, ABS
and
CMBS
Index
    Bloomberg
U.S. Treasury
Inflation
Protected
Securities
(TIPS) Index
(Series-L)
    FTSE
EPRA Nareit
Developed
Index
    MSCI
ACWI ex USA
IMI Index
    Russell
1000
®
Index
    Russell
2000
®
Index
 
01/01/13 to 12/31/13     17.1     N/A       N/A       N/A       N/A       N/A       1.7     8.7     23.9     46.2     2.4
01/01/14 to 12/31/14     16.3       N/A       N/A       N/A       N/A       N/A       1.6       9.5       24.9       45.3       2.4  
01/01/15 to 12/31/15     5.6       N/A       N/A       N/A       N/A       N/A       0.7       12.9       28.6       50.1       2.1  
01/01/16 to 12/31/16     6.9       N/A       N/A       N/A       N/A       N/A       0.9       12.9       28.5       48.9       1.9  
01/01/17 to 12/31/17     9.2       N/A       N/A       N/A       N/A       N/A       1.2       13.2       28.2       47.1       1.1  
01/01/18 to 12/31/18     10.3       N/A       N/A       N/A       N/A       N/A       1.4       12.8       28.3       45.9       1.3  
01/01/19 to 12/31/19     8.4       N/A       N/A       N/A       N/A       N/A       3.0       4.2       35.2       47.0       2.2  
01/01/20 to 12/31/20     10.8       N/A       N/A       N/A       N/A       N/A       3.2       4.1       33.9       46.2       1.8  
01/01/21 to 12/31/21     12.6       N/A       N/A       N/A       N/A       N/A       3.6       4.0       32.7       45.7       1.4  
01/01/22 to 12/31/22     3.5       1.2     1.2     3.3     1.8     3.3     4.0       3.9       29.7       46.7       1.4  

See “About Fund Performance” for descriptions of the indexes.

 

 

14  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


LifePath Index Fund Summary    as of December 31, 2022 (continued)    BlackRock LifePath® Index 2040 Fund

 

Performance

 

     Average Annual Total Returns(a)(b)  
  

 

 

 
     1 Year     5 Years     10 Years  
     

 

 

 
      


Without
Sales
Charge
 
 
 
 
   


With
Sales
Charge
 
 
 
 
   

Without
Sales
Charge
 
 
 
   

With
Sales
Charge
 
 
 
   

Without
Sales
Charge
 
 
 
   

With
Sales
Charge
 
 
 

Institutional

     (17.70 )%      N/A       4.79     N/A       7.50     N/A  

Investor A

     (17.90     N/A       4.53       N/A       7.24       N/A  

Investor P

     (17.91     (22.22 )%      4.53       3.41     7.24       6.67

Class K

     (17.65     N/A       4.84       N/A       7.56       N/A  

LifePath Index 2040 Fund Custom Benchmark

     (17.62     N/A       4.83       N/A       7.61       N/A  

Bloomberg U.S. Aggregate Bond Index

     (13.01     N/A       0.02       N/A       1.06       N/A  

Bloomberg U.S. Intermediate Credit Bond Index

     (9.10     N/A       1.08       N/A       1.76       N/A  

Bloomberg U.S. Intermediate Government Bond Index

     (7.73     N/A       0.46       N/A       0.69       N/A  

Bloomberg U.S. Long Credit Bond Index

     (25.29     N/A       (0.77     N/A       2.13       N/A  

Bloomberg U.S. Long Government Bond Index

     (29.19     N/A       (2.19     N/A       0.61       N/A  

Bloomberg U.S. Securitized: MBS, ABS and CMBS Index

     (11.67     N/A       (0.43     N/A       0.80       N/A  

Bloomberg U.S. TIPS Index (Series-L)

     (11.85     N/A       2.11       N/A       1.12       N/A  

FTSE EPRA Nareit Developed Index

     (25.09     N/A       (0.23     N/A       2.99       N/A  

MSCI ACWI ex USA IMI Index

     (16.58     N/A       0.85       N/A       3.98       N/A  

Russell 1000® Index

     (19.13     N/A       9.13       N/A       12.37       N/A  

Russell 2000® Index

     (20.44     N/A       4.13       N/A       9.01       N/A  

 

  (a)

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 

 

  (b)

LifePath Index 2040 Fund normally invests its assets in underlying funds according to an asset allocation strategy designed for investors planning to retire or begin withdrawing assets around the year 2040.

 

N/A — Not applicable as the share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

PORTFOLIO ALLOCATION

   
Asset Type   Percent of
Net Assets
 

Equity Funds

    81.1

Fixed-Income Funds

    18.9  

Money Market Funds

    0.1  

Liabilities in Excess of Other Assets

    (0.1

TEN LARGEST HOLDINGS

   
Security   Percent of
Net Assets
 

Large Cap Index Master Portfolio

    46.8

iShares Core MSCI Total International Stock ETF

    29.0  

iShares U.S. Long Credit Bond Index Fund

    4.5  

iShares U.S. Securitized Bond Index Fund

    4.5  

iShares TIPS Bond ETF

    4.1  

iShares Developed Real Estate Index Fund, Class K

    3.9  

iShares U.S. Long Government Bond Index Fund

    2.4  

iShares U.S. Intermediate Government Bond Index Fund

    1.7  

iShares U.S. Intermediate Credit Bond Index Fund

    1.7  

Master Small Cap Index Series

    1.4  
 

 

 

U N D   S U M M  A R Y

  15


LifePath Index Fund Summary    as of December 31, 2022    BlackRock LifePath® Index 2045 Fund

 

Investment Objective

BlackRock LifePath® Index 2045 Fund’s (“LifePath Index 2045 Fund” or the “LifePath Index Fund”) investment objective is to seek to provide for retirement outcomes based on quantitatively measured risk. In pursuit of this objective, LifePath Index 2045 Fund will be broadly diversified across global asset classes, with asset allocations becoming more conservative over time.

GROWTH OF $10,000 INVESTMENT

 

LOGO

 

  (a)

Assuming maximum sales charges, if any, transaction costs and other operating expenses, including investment advisory fees and administration fees, if any. Institutional and Investor A Shares do not have a sales charge.

 

 

  (b)

The LifePath Index 2045 Fund compares its performance to that of a customized weighted index (the “LifePath Index 2045 Fund Custom Benchmark”). Prior to May 31, 2022, the LifePath Index 2045 Fund Custom Benchmark was comprised of the Bloomberg U.S. Aggregate Bond Index, Bloomberg U.S. Treasury Inflation Protected Securities (TIPS) Index (Series-L), FTSE EPRA Nareit Developed Index, MSCI ACWI ex USA IMI Index, Russell 1000® Index and Russell 2000® Index. Effective May 31, 2022, the LifePath Index 2045 Fund Custom Benchmark was changed to remove Bloomberg U.S. Aggregate Bond Index and to add Bloomberg U.S. Long Credit Bond Index, Bloomberg U.S. Intermediate Credit Bond Index, Bloomberg U.S. Long Government Bond Index, Bloomberg U.S. Intermediate Government Bond Index and Bloomberg U.S. Securitized: MBS, ABS and CMBS Index. The investment adviser believes that the updated LifePath Index 2045 Fund Custom Benchmark is more representative of the sectors in which the LifePath Index 2045 Fund invests. The investment adviser adjusts the weightings of the indexes in the LifePath Index 2045 Fund Custom Benchmark periodically based upon its evaluation and adjustment of the LifePath Index 2045 Fund’s asset allocation strategy. The weightings are presented annually but they are adjusted quarterly.

 

The LifePath Index Fund’s custom benchmark consists of the following:

 

Period

  Bloomberg
U.S. Aggregate
Bond Index
    Bloomberg
U.S. Intermediate
Credit
Bond
Index
    Bloomberg
U.S. Intermediate
Government
Bond
Index
    Bloomberg
U.S. Long
Credit
Bond
Index
    Bloomberg
U.S. Long
Government
Bond
Index
    Bloomberg
U.S. Securitized:
MBS, ABS
and
CMBS
Index
    Bloomberg
U.S. Treasury
Inflation
Protected
Securities
(TIPS) Index
(Series-L)
    FTSE
EPRA Nareit
Developed
Index
    MSCI
ACWI ex USA
IMI Index
    Russell
1000
®
Index
    Russell
2000
®
Index
 
01/01/13 to 12/31/13     13.2     N/A       N/A       N/A       N/A       N/A       N/A       9.8     25.4     49.5     2.1
01/01/14 to 12/31/14     12.6       N/A       N/A       N/A       N/A       N/A       N/A       10.7       26.4       48.1       2.2  
01/01/15 to 12/31/15     1.8       N/A       N/A       N/A       N/A       N/A       0.2     14.2       30.0       51.7       2.1  
01/01/16 to 12/31/16     2.3       N/A       N/A       N/A       N/A       N/A       0.2       14.6       30.2       50.8       1.9  
01/01/17 to 12/31/17     3.4       N/A       N/A       N/A       N/A       N/A       0.3       15.3       30.5       49.6       0.9  
01/01/18 to 12/31/18     4.0       N/A       N/A       N/A       N/A       N/A       0.4       15.0       30.7       48.8       1.1  
01/01/19 to 12/31/19     3.0       N/A       N/A       N/A       N/A       N/A       1.4       4.6       38.5       50.5       2.0  
01/01/20 to 12/31/20     4.3       N/A       N/A       N/A       N/A       N/A       1.6       4.5       37.6       50.5       1.5  
01/01/21 to 12/31/21     5.3       N/A       N/A       N/A       N/A       N/A       1.9       4.5       36.6       50.6       1.1  
01/01/22 to 12/31/22     1.6       0.0     0.0     3.0     0.4     1.5     2.2       4.4       33.3       52.5       1.1  

See “About Fund Performance” for descriptions of the indexes.

 

 

16  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


LifePath Index Fund Summary    as of December 31, 2022 (continued)    BlackRock LifePath® Index 2045 Fund

 

Performance

 

     Average Annual Total Returns(a)(b)  
     1 Year      5 Years      10 Years  
      Without
Sales
Charge
     With
Sales
Charge
     Without
Sales
Charge
     With
Sales
Charge
     Without
Sales
Charge
     With
Sales
Charge
 

Institutional

     (18.10 )%       N/A        5.22      N/A        8.00      N/A  

Investor A

     (18.31      N/A        4.94        N/A        7.73        N/A  

Investor P

     (18.33      (22.62 )%       4.94        3.81      7.72        7.14

Class K

     (18.05      N/A        5.27        N/A        8.05        N/A  

LifePath Index 2045 Fund Custom Benchmark

     (18.09      N/A        5.20        N/A        8.07        N/A  

Bloomberg U.S. Aggregate Bond Index

     (13.01      N/A        0.02        N/A        1.06        N/A  

Bloomberg U.S. Intermediate Credit Bond Index

     (9.10      N/A        1.08        N/A        1.76        N/A  

Bloomberg U.S. Intermediate Government Bond Index

     (7.73      N/A        0.46        N/A        0.69        N/A  

Bloomberg U.S. Long Credit Bond Index

     (25.29      N/A        (0.77      N/A        2.13        N/A  

Bloomberg U.S. Long Government Bond Index

     (29.19      N/A        (2.19      N/A        0.61        N/A  

Bloomberg U.S. Securitized: MBS, ABS and CMBS Index

     (11.67      N/A        (0.43      N/A        0.80        N/A  

Bloomberg U.S. TIPS Index (Series-L)

     (11.85      N/A        2.11        N/A        1.12        N/A  

FTSE EPRA Nareit Developed Index

     (25.09      N/A        (0.23      N/A        2.99        N/A  

MSCI ACWI ex USA IMI Index

     (16.58      N/A        0.85        N/A        3.98        N/A  

Russell 1000® Index

     (19.13      N/A        9.13        N/A        12.37        N/A  

Russell 2000® Index

     (20.44      N/A        4.13        N/A        9.01        N/A  

 

  (a)

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 

 

  (b)

LifePath Index 2045 Fund normally invests its assets in underlying funds according to an asset allocation strategy designed for investors planning to retire or begin withdrawing assets around the year 2045.

 

N/A — Not applicable as the share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

PORTFOLIO ALLOCATION

Asset Type   Percent of
Net Assets
 

Equity Funds

    91.1

Fixed-Income Funds

    8.9  

Money Market Funds

    0.5  

Liabilities in Excess of Other Assets

    (0.5

TEN LARGEST HOLDINGS

Security   Percent of
Net Assets
 

Large Cap Index Master Portfolio

    53.0

iShares Core MSCI Total International Stock ETF

    32.6  

iShares Developed Real Estate Index Fund, Class K

    4.4  

iShares U.S. Long Credit Bond Index Fund

    4.0  

iShares TIPS Bond ETF

    2.4  

iShares U.S. Securitized Bond Index Fund

    2.0  

Master Small Cap Index Series

    1.1  

iShares U.S. Long Government Bond Index Fund

    0.5  

BlackRock Cash Funds: Institutional, SL Agency Shares

    0.4  

BlackRock Cash Funds: Treasury, SL Agency Shares

    0.1  
 

 

 

U N D   S U M M  A R Y

  17


LifePath Index Fund Summary    as of December 31, 2022    BlackRock LifePath® Index 2050 Fund

 

Investment Objective

BlackRock LifePath® Index 2050 Fund’s (“LifePath Index 2050 Fund” or the “LifePath Index Fund”) investment objective is to seek to provide for retirement outcomes based on quantitatively measured risk. In pursuit of this objective, LifePath Index 2050 Fund will be broadly diversified across global asset classes, with asset allocations becoming more conservative over time.

GROWTH OF $10,000 INVESTMENT

 

LOGO

 

  (a)

Assuming maximum sales charges, if any, transaction costs and other operating expenses, including investment advisory fees and administration fees, if any. Institutional and Investor A Shares do not have a sales charge.

 

 

  (b)

The LifePath Index 2050 Fund compares its performance to that of a customized weighted index (the “LifePath Index 2050 Fund Custom Benchmark”). Prior to May 31, 2022, the LifePath Index 2050 Fund Custom Benchmark was comprised of the Bloomberg U.S. Aggregate Bond Index, Bloomberg U.S. Treasury Inflation Protected Securities (TIPS) Index (Series-L), FTSE EPRA Nareit Developed Index, MSCI ACWI ex USA IMI Index, Russell 1000® Index and Russell 2000® Index. Effective May 31, 2022, the LifePath Index 2050 Fund Custom Benchmark was changed to remove Bloomberg U.S. Aggregate Bond Index and to add Bloomberg U.S. Long Credit Bond Index, Bloomberg U.S. Intermediate Credit Bond Index, Bloomberg U.S. Long Government Bond Index, Bloomberg U.S. Intermediate Government Bond Index and Bloomberg U.S. Securitized: MBS, ABS and CMBS Index. The investment adviser believes that the updated LifePath Index 2050 Fund Custom Benchmark is more representative of the sectors in which the LifePath Index 2050 Fund invests. The investment adviser adjusts the weightings of the indexes in the LifePath Index 2050 Fund Custom Benchmark periodically based upon its evaluation and adjustment of the LifePath Index 2050 Fund’s asset allocation strategy. The weightings are presented annually but they are adjusted quarterly.

 

The LifePath Index Fund’s custom benchmark consists of the following:

 

Period   Bloomberg
U.S. Aggregate
Bond Index
   

Bloomberg
U.S. Intermediate
Credit

Bond

Index

   

Bloomberg
U.S. Intermediate
Government
Bond

Index

    Bloomberg
U.S. Long
Credit
Bond
Index
   

Bloomberg
U.S. Long
Government
Bond

Index

   

Bloomberg
U.S. Securitized:
MBS, ABS

and

CMBS

Index

    Bloomberg
U.S. Treasury
Inflation
Protected
Securities
(TIPS) Index
(Series-L)
    FTSE
EPRA Nareit
Developed
Index
    MSCI
ACWI ex USA
IMI Index
    Russell
1000
®
Index
    Russell
2000
®
Index
 

01/01/13 to

12/31/13

    7.9     N/A       N/A       N/A       N/A       N/A       N/A       10.8     26.9     52.5     1.9

01/01/14 to

12/31/14

    8.3       N/A       N/A       N/A       N/A       N/A       N/A       11.7       27.7       50.4       1.9  

01/01/15 to

12/31/15

    1.0       N/A       N/A       N/A       N/A       N/A       N/A       14.5       30.3       52.1       2.1  

01/01/16 to

12/31/16

    1.0       N/A       N/A       N/A       N/A       N/A       N/A       15.0       30.9       51.2       1.9  

01/01/17 to

12/31/17

    1.0       N/A       N/A       N/A       N/A       N/A       N/A       16.2       31.5       50.4       0.9  

01/01/18 to

12/31/18

    1.2       N/A       N/A       N/A       N/A       N/A       N/A       16.0       31.7       50.1       1.0  

01/01/19 to

12/31/19

    1.0       N/A       N/A       N/A       N/A       N/A       0.4     4.8       39.9       52.0       1.9  

01/01/20 to

12/31/20

    1.3       N/A       N/A       N/A       N/A       N/A       0.5       4.7       39.5       52.7       1.3  

01/01/21 to

12/31/21

    1.6       N/A       N/A       N/A       N/A       N/A       0.6       4.7       38.8       53.3       1.0  

01/01/22 to

12/31/22

    0.6       0.0     0.0     1.4     0.0     0.0     0.8       4.7       35.6       55.9       1.0  

See “About Fund Performance” for descriptions of the indexes.

 

 

18  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


LifePath Index Fund Summary    as of December 31, 2022 (continued)    BlackRock LifePath® Index 2050 Fund

 

Performance

 

    Average Annual Total Returns(a)(b)  
    1 Year     5 Years     10 Years  
     Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
 

Institutional

    (18.32 )%      N/A       5.41     N/A       8.28     N/A  

Investor A

    (18.54     N/A       5.13       N/A       8.01       N/A  

Investor P

    (18.51     (22.79 )%      5.14       4.02     8.01       7.43

Class K

    (18.33     N/A       5.45       N/A       8.32       N/A  

LifePath Index 2050 Fund Custom Benchmark

    (18.35     N/A       5.40       N/A       8.36       N/A  

Bloomberg U.S. Aggregate Bond Index

    (13.01     N/A       0.02       N/A       1.06       N/A  

Bloomberg U.S. Intermediate Credit Bond Index

    (9.10     N/A       1.08       N/A       1.76       N/A  

Bloomberg U.S. Intermediate Government Bond Index

    (7.73     N/A       0.46       N/A       0.69       N/A  

Bloomberg U.S. Long Credit Bond Index

    (25.29     N/A       (0.77     N/A       2.13       N/A  

Bloomberg U.S. Long Government Bond Index

    (29.19     N/A       (2.19     N/A       0.61       N/A  

Bloomberg U.S. Securitized: MBS, ABS and CMBS Index

    (11.67     N/A       (0.43     N/A       0.80       N/A  

Bloomberg U.S. TIPS Index (Series-L)

    (11.85     N/A       2.11       N/A       1.12       N/A  

FTSE EPRA Nareit Developed Index

    (25.09     N/A       (0.23     N/A       2.99       N/A  

MSCI ACWI ex USA IMI Index

    (16.58     N/A       0.85       N/A       3.98       N/A  

Russell 1000® Index

    (19.13     N/A       9.13       N/A       12.37       N/A  

Russell 2000® Index

    (20.44     N/A       4.13       N/A       9.01       N/A  

 

  (a)

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 

 

  (b)

LifePath Index 2050 Fund normally invests its assets in underlying funds according to an asset allocation strategy designed for investors planning to retire or begin withdrawing assets around the year 2050.

 

N/A — Not applicable as the share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

PORTFOLIO ALLOCATION

Asset Type   Percent of
Net Assets
 

Equity Funds

    97.3

Fixed-Income Funds

    2.7  

Money Market Funds

    0.9  

Liabilities in Excess of Other Assets

    (0.9

TEN LARGEST HOLDINGS

Security   Percent of
Net Assets
 

Large Cap Index Master Portfolio

    56.6

iShares Core MSCI Total International Stock ETF

    34.9  

iShares Developed Real Estate Index Fund, Class K

    4.7  

iShares U.S. Long Credit Bond Index Fund

    1.9  

Master Small Cap Index Series

    1.1  

BlackRock Cash Funds: Institutional, SL Agency Shares

    0.8  

iShares TIPS Bond ETF

    0.8  

BlackRock Cash Funds: Treasury, SL Agency Shares

    0.1  

iShares U.S. Long Government Bond Index Fund

    (a) 
 

 

(a) 

Rounds to less than 0.1% of net assets.

 

 

U N D   S U M M  A R Y

  19


LifePath Index Fund Summary    as of December 31, 2022    BlackRock LifePath® Index 2055 Fund

 

Investment Objective

BlackRock LifePath® Index 2055 Fund’s (“LifePath Index 2055 Fund” or the “LifePath Index Fund”) investment objective is to seek to provide for retirement outcomes based on quantitatively measured risk. In pursuit of this objective, LifePath Index 2055 Fund will be broadly diversified across global asset classes, with asset allocations becoming more conservative over time.

GROWTH OF $10,000 INVESTMENT

 

LOGO

 

  (a)

Assuming maximum sales charges, if any, transaction costs and other operating expenses, including investment advisory fees and administration fees, if any. Institutional and Investor A Shares do not have a sales charge.

 

 

  (b)

The LifePath Index 2055 Fund compares its performance to that of a customized weighted index (the “LifePath Index 2055 Fund Custom Benchmark”). Prior to May 31, 2022, the LifePath Index 2055 Fund Custom Benchmark was comprised of the Bloomberg U.S. Aggregate Bond Index, Bloomberg U.S. Treasury Inflation Protected Securities (TIPS) Index (Series-L), FTSE EPRA Nareit Developed Index, MSCI ACWI ex USA IMI Index, Russell 1000® Index and Russell 2000® Index. Effective May 31, 2022, the LifePath Index 2055 Fund Custom Benchmark was changed to remove Bloomberg U.S. Aggregate Bond Index and to add Bloomberg U.S. Long Credit Bond Index, Bloomberg U.S. Intermediate Credit Bond Index, Bloomberg U.S. Long Government Bond Index, Bloomberg U.S. Intermediate Government Bond Index and Bloomberg U.S. Securitized: MBS, ABS and CMBS Index. The investment adviser believes that the updated LifePath Index 2055 Fund Custom Benchmark is more representative of the sectors in which the LifePath Index 2055 Fund invests. The investment adviser adjusts the weightings of the indexes in the LifePath Index 2055 Fund Custom Benchmark periodically based upon its evaluation and adjustment of the LifePath Index 2055 Fund’s asset allocation strategy. The weightings are presented annually but they are adjusted quarterly.

 

The LifePath Index Fund’s custom benchmark consists of the following:

 

Period   Bloomberg
U.S. Aggregate
Bond Index
   

Bloomberg
U.S. Intermediate
Credit

Bond

Index

   

Bloomberg
U.S. Intermediate
Government
Bond

Index

   

Bloomberg
U.S. Long

Credit

Bond

Index

   

Bloomberg
U.S. Long

Government

Bond

Index

    Bloomberg
U.S. Securitized:
MBS, ABS
and
CMBS
Index
    Bloomberg
U.S. Treasury
Inflation
Protected
Securities
(TIPS) Index
(Series-L)
    FTSE
EPRA Nareit
Developed
Index
    MSCI
ACWI ex USA
IMI Index
    Russell
1000
®
Index
    Russell
2000
®
Index
 

01/01/13 to

12/31/13

    2.7     N/A       N/A       N/A       N/A       N/A       N/A       12.2     28.4     54.8     1.9

01/01/14 to

12/31/14

    4.2       N/A       N/A       N/A       N/A       N/A       N/A       12.8       29.0       52.1       1.9  

01/01/15 to

12/31/15

    1.0       N/A       N/A       N/A       N/A       N/A       N/A       14.5       30.3       52.1       2.1  

01/01/16 to

12/31/16

    1.0       N/A       N/A       N/A       N/A       N/A       N/A       15.0       30.9       51.2       1.9  

01/01/17 to

12/31/17

    1.0       N/A       N/A       N/A       N/A       N/A       N/A       16.2       31.5       50.4       0.9  

01/01/18 to

12/31/18

    1.0       N/A       N/A       N/A       N/A       N/A       N/A       16.1       31.8       50.1       1.0  

01/01/19 to

12/31/19

    0.9       N/A       N/A       N/A       N/A       N/A       0.1     4.8       40.2       52.0       2.0  

01/01/20 to

12/31/20

    0.8       N/A       N/A       N/A       N/A       N/A       0.2       4.8       39.9       52.9       1.4  

01/01/21 to

12/31/21

    0.9       N/A       N/A       N/A       N/A       N/A       0.2       4.8       39.3       53.8       1.0  

01/01/22 to

12/31/22

    0.3       0.0     0.0     0.6     0.0     0.0     0.2       4.8       36.3       56.8       1.0  

See “About Fund Performance” for descriptions of the indexes.

 

 

20  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


LifePath Index Fund Summary    as of December 31, 2022 (continued)    BlackRock LifePath® Index 2055 Fund

 

Performance

 

     Average Annual Total Returns(a)(b)  
     1 Year      5 Years      10 Years  
      Without
Sales
Charge
     With
Sales
Charge
     Without
Sales
Charge
     With
Sales
Charge
     Without
Sales
Charge
     With
Sales
Charge
 

Institutional

     (18.38 )%       N/A        5.43      N/A        8.43      N/A  

Investor A

     (18.59      N/A        5.17        N/A        8.16        N/A  

Investor P

     (18.55      (22.83 )%       5.17        4.04      8.17        7.58

Class K

     (18.33      N/A        5.48        N/A        8.49        N/A  

LifePath Index 2055 Fund Custom Benchmark

     (18.40      N/A        5.44        N/A        8.51        N/A  

Bloomberg U.S. Aggregate Bond Index

     (13.01      N/A        0.02        N/A        1.06        N/A  

Bloomberg U.S. Intermediate Credit Bond Index

     (9.10      N/A        1.08        N/A        1.76        N/A  

Bloomberg U.S. Intermediate Government Bond Index

     (7.73      N/A        0.46        N/A        0.69        N/A  

Bloomberg U.S. Long Credit Bond Index

     (25.29      N/A        (0.77      N/A        2.13        N/A  

Bloomberg U.S. Long Government Bond Index

     (29.19      N/A        (2.19      N/A        0.61        N/A  

Bloomberg U.S. Securitized: MBS, ABS and CMBS Index

     (11.67      N/A        (0.43      N/A        0.80        N/A  

Bloomberg U.S. TIPS Index (Series-L)

     (11.85      N/A        2.11        N/A        1.12        N/A  

FTSE EPRA Nareit Developed Index

     (25.09      N/A        (0.23      N/A        2.99        N/A  

MSCI ACWI ex USA IMI Index

     (16.58      N/A        0.85        N/A        3.98        N/A  

Russell 1000® Index

     (19.13      N/A        9.13        N/A        12.37        N/A  

Russell 2000® Index

     (20.44      N/A        4.13        N/A        9.01        N/A  

 

  (a)

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 

 

  (b)

LifePath Index 2055 Fund normally invests its assets in underlying funds according to an asset allocation strategy designed for investors planning to retire or begin withdrawing assets around the year 2055.

 

N/A — Not applicable as the share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

 

PORTFOLIO ALLOCATION

Asset Type   Percent of
Net Assets
 

Equity Funds

    98.9

Money Market Funds

    8.3  

Fixed-Income Funds

    1.0  

Liabilities in Excess of Other Assets

    (8.2

TEN LARGEST HOLDINGS

Security   Percent of
Net Assets
 

Large Cap Index Master Portfolio

    57.6

iShares Core MSCI Total International Stock ETF

    35.5  

BlackRock Cash Funds: Institutional, SL Agency Shares

    8.2  

iShares Developed Real Estate Index Fund, Class K

    4.8  

Master Small Cap Index Series

    1.0  

iShares U.S. Long Credit Bond Index Fund

    0.8  

iShares TIPS Bond ETF

    0.2  

BlackRock Cash Funds: Treasury, SL Agency Shares

    0.1  
 

 

 

U N D   S U M M  A R Y

  21


LifePath Index Fund Summary    as of December 31, 2022    BlackRock LifePath® Index 2060 Fund

 

Investment Objective

BlackRock LifePath® Index 2060 Fund’s (“LifePath Index 2060 Fund” or the “LifePath Index Fund”) investment objective is to seek to provide for retirement outcomes based on quantitatively measured risk. In pursuit of this objective, LifePath Index 2060 Fund will be broadly diversified across global asset classes, with asset allocations becoming more conservative over time.

GROWTH OF $10,000 INVESTMENT

 

LOGO

The LifePath Index Fund commenced operations on February 29, 2016.

 

  (a)

Assuming maximum sales charges, if any, transaction costs and other operating expenses, including investment advisory fees and administration fees, if any. Institutional and Investor A Shares do not have a sales charge.

 

 

  (b)

The LifePath Index 2060 Fund compares its performance to that of a customized weighted index (the “LifePath Index 2060 Fund Custom Benchmark”). Prior to May 31, 2022, the LifePath Index 2060 Fund Custom Benchmark was comprised of the Bloomberg U.S. Aggregate Bond Index, Bloomberg U.S. Treasury Inflation Protected Securities (TIPS) Index (Series-L), FTSE EPRA Nareit Developed Index, MSCI ACWI ex USA IMI Index, Russell 1000® Index and Russell 2000® Index. Effective May 31, 2022, the LifePath Index 2060 Fund Custom Benchmark was changed to remove Bloomberg U.S. Aggregate Bond Index and to add Bloomberg U.S. Long Credit Bond Index, Bloomberg U.S. Intermediate Credit Bond Index, Bloomberg U.S. Long Government Bond Index, Bloomberg U.S. Intermediate Government Bond Index and Bloomberg U.S. Securitized: MBS, ABS and CMBS Index. The investment adviser believes that the updated LifePath Index 2060 Fund Custom Benchmark is more representative of the sectors in which the LifePath Index 2060 Fund invests. The investment adviser adjusts the weightings of the indexes in the LifePath Index 2060 Fund Custom Benchmark periodically based upon its evaluation and adjustment of the LifePath Index 2060 Fund’s asset allocation strategy. The weightings are presented annually but they are adjusted quarterly.

 

The LifePath Index Fund’s custom benchmark consists of the following:

 

Period(a)   Bloomberg
U.S. Aggregate
Bond Index
    Bloomberg
U.S. Intermediate
Credit
Bond
Index
    Bloomberg
U.S. Intermediate
Government
Bond
Index
    Bloomberg
U.S. Long
Credit
Bond
Index
    Bloomberg
U.S. Long
Government
Bond
Index
    Bloomberg
U.S. Securitized:
MBS, ABS
and
CMBS
Index
    Bloomberg
U.S. Treasury
Inflation
Protected
Securities
(TIPS) Index
(Series-L)
    FTSE
EPRA Nareit
Developed
Index
    MSCI
ACWI ex USA
IMI Index
    Russell
1000
®
Index
    Russell
2000
®
Index
 

02/29/16 to

12/31/16

    1.0     N/A       N/A       N/A       N/A       N/A       N/A       15.0     30.9     51.2     1.9

01/01/17 to

12/31/17

    1.0       N/A       N/A       N/A       N/A       N/A       N/A       16.2       31.5       50.4       0.9  

01/01/18 to

12/31/18

    1.0       N/A       N/A       N/A       N/A       N/A       N/A       16.1       31.8       50.1       1.0  

01/01/19 to

12/31/19

    0.9       N/A       N/A       N/A       N/A       N/A       0.1     4.8       40.2       52.0       2.0  

01/01/20 to

12/31/20

    0.9       N/A       N/A       N/A       N/A       N/A       0.1       4.8       39.9       52.9       1.4  

01/01/21 to

12/31/21

    0.9       N/A       N/A       N/A       N/A       N/A       0.1       4.8       39.3       53.9       1.0  

01/01/22 to

12/31/22

    0.4       0.0     0.0     0.7     0.0     0.0     0.1       4.8       36.3       56.7       1.0  

 

(a)

The LifePath Index Fund commenced operations on February 29, 2016.

 

 

See “About Fund Performance” for descriptions of the indexes.

 

 

22  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


LifePath Index Fund Summary    as of December 31, 2022 (continued)    BlackRock LifePath® Index 2060 Fund

 

Performance

 

     Average Annual Total Returns(a)(b)  
     1 Year      5 Years      Since
Inception(c)
 
      Without
Sales
Charge
     With
Sales
Charge
     Without
Sales
Charge
     With
Sales
Charge
     Without
Sales
Charge
     With
Sales
Charge
 

Institutional

     (18.42 )%       N/A        5.44      N/A        9.21      N/A  

Investor A

     (18.58      N/A        5.18        N/A        8.93        N/A  

Investor P

     (18.57      (22.85 )%       5.20        4.07      8.95        8.10

Class K

     (18.32      N/A        5.48        N/A        9.26        N/A  

LifePath Index 2060 Fund Custom Benchmark

     (18.40      N/A        5.43        N/A        9.21        N/A  

Bloomberg U.S. Aggregate Bond Index

     (13.01      N/A        0.02        N/A        0.61        N/A  

Bloomberg U.S. Intermediate Credit Bond Index

     (9.10      N/A        1.08        N/A        1.70        N/A  

Bloomberg U.S. Intermediate Government Bond Index

     (7.73      N/A        0.46        N/A        0.35        N/A  

Bloomberg U.S. Long Credit Bond Index

     (25.29      N/A        (0.77      N/A        2.29        N/A  

Bloomberg U.S. Long Government Bond Index

     (29.19      N/A        (2.19      N/A        (1.34      N/A  

Bloomberg U.S. Securitized: MBS, ABS and CMBS Index

     (11.67      N/A        (0.43      N/A        0.06        N/A  

Bloomberg U.S. TIPS Index (Series-L)

     (11.85      N/A        2.11        N/A        2.28        N/A  

FTSE EPRA Nareit Developed Index

     (25.09      N/A        (0.23      N/A        2.46        N/A  

MSCI ACWI ex USA IMI Index

     (16.58      N/A        0.85        N/A        6.21        N/A  

Russell 1000® Index

     (19.13      N/A        9.13        N/A        12.47        N/A  

Russell 2000® Index

     (20.44      N/A        4.13        N/A        9.56        N/A  

 

  (a)

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 

 

  (b)

LifePath Index 2060 Fund normally invests its assets in underlying funds according to an asset allocation strategy designed for investors planning to retire or begin withdrawing assets around the year 2060.

 

 

  (c)

The LifePath Index Fund commenced operations on February 29, 2016.

 

N/A — Not applicable as the share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

 

PORTFOLIO ALLOCATION

Asset Type   Percent of
Net Assets
 

Equity Funds

    99.0

Fixed-Income Funds

    1.0  

Money Market Funds

    0.1  

Liabilities in Excess of Other Assets

    (0.1

TEN LARGEST HOLDINGS

Security   Percent of
Net Assets
 

Large Cap Index Master Portfolio

    57.6

iShares Core MSCI Total International Stock ETF

    35.6  

iShares Developed Real Estate Index Fund, Class K

    4.8  

Master Small Cap Index Series

    1.0  

iShares U.S. Long Credit Bond Index Fund

    0.9  

iShares TIPS Bond ETF

    0.1  

BlackRock Cash Funds: Institutional, SL Agency Shares

    0.1  

BlackRock Cash Funds: Treasury, SL Agency Shares

    (a) 
 
(a) 

Rounds to less than 0.1% of net assets.

 

 

U N D   S U M M  A R Y

  23


LifePath Index Fund Summary    as of December 31, 2022    BlackRock LifePath® Index 2065 Fund

 

Investment Objective

BlackRock LifePath® Index 2065 Fund’s (“LifePath Index 2065 Fund” or the “LifePath Index Fund”) investment objective is to seek to provide for retirement outcomes based on quantitatively measured risk. In pursuit of this objective, LifePath Index 2065 Fund will be broadly diversified across global asset classes, with asset allocations becoming more conservative over time.

GROWTH OF $10,000 INVESTMENT

 

LOGO

The LifePath Index Fund commenced operations on October 30, 2019.

 

  (a)

Assuming maximum sales charges, if any, transaction costs and other operating expenses, including investment advisory fees and administration fees, if any. Institutional and Investor A Shares do not have a sales charge.

 

 

  (b)

The LifePath Index 2065 Fund compares its performance to that of a customized weighted index (the “LifePath Index 2065 Fund Custom Benchmark”). Prior to May 31, 2022, the LifePath Index 2065 Fund Custom Benchmark was comprised of the Bloomberg U.S. Aggregate Bond Index, Bloomberg U.S. Treasury Inflation Protected Securities (TIPS) Index (Series-L), FTSE EPRA Nareit Developed Index, MSCI ACWI ex USA IMI Index, Russell 1000® Index and Russell 2000® Index. Effective May 31, 2022, the LifePath Index 2065 Fund Custom Benchmark was changed to remove Bloomberg U.S. Aggregate Bond Index and to add Bloomberg U.S. Long Credit Bond Index, Bloomberg U.S. Intermediate Credit Bond Index, Bloomberg U.S. Long Government Bond Index, Bloomberg U.S. Intermediate Government Bond Index and Bloomberg U.S. Securitized: MBS, ABS and CMBS Index. The investment adviser believes that the updated LifePath Index 2065 Fund Custom Benchmark is more representative of the sectors in which the LifePath Index 2065 Fund invests. The investment adviser adjusts the weightings of the indexes in the LifePath Index 2065 Fund Custom Benchmark periodically based upon its evaluation and adjustment of the LifePath Index 2065 Fund’s asset allocation strategy. The weightings are presented annually but they are adjusted quarterly.

 

The LifePath Index Fund’s custom benchmark consists of the following:

 

Period(a)   Bloomberg
U.S. Aggregate
Bond Index
   

Bloomberg
U.S. Intermediate
Credit

Bond

Index

   

Bloomberg
U.S. Intermediate
Government

Bond

Index

    Bloomberg
U.S. Long
Credit
Bond
Index
    Bloomberg
U.S. Long
Government
Bond
Index
   

Bloomberg
U.S. Securitized:
MBS, ABS

and

CMBS

Index

    Bloomberg
U.S. Treasury
Inflation
Protected
Securities
(TIPS) Index
(Series-L)
    FTSE
EPRA Nareit
Developed
Index
    MSCI
ACWI ex USA
IMI Index
    Russell
1000
®
Index
    Russell
2000
®
Index
 

10/30/19 to

12/31/19

    1.0     N/A       N/A       N/A       N/A       N/A       0.0     4.8     40.2     52.0     2.0

01/01/20 to

12/31/20

    1.0       N/A       N/A       N/A       N/A       N/A       0.0       4.8       39.9       52.9       1.4  

01/01/21 to

12/31/21

    1.1       N/A       N/A       N/A       N/A       N/A       0.0       4.8       39.3       53.8       1.0  

01/01/22 to

12/31/22

    0.4       0.0     0.0     0.7     0.0     0.0     0.0       4.8       36.3       56.8       1.0  

 

(a)

The LifePath Index Fund commenced operations on October 30, 2019.

 
 

See “About Fund Performance” for descriptions of the indexes.

 

 

 

24  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


LifePath Index Fund Summary    as of December 31, 2022 (continued)    BlackRock LifePath® Index 2065 Fund

 

Performance

 

     Average Annual Total Returns(a)(b)  
     1 Year      Since
Inception(c)
 
      Without
Sales
Charge
     With
Sales
Charge
     Without
Sales
Charge
     With
Sales
Charge
 

Institutional

     (18.30 )%       N/A        5.46      N/A  

Investor A

     (18.56      N/A        5.19        N/A  

Investor P

     (18.51      (22.79 )%       5.21        3.45

Class K

     (18.32      N/A        5.50        N/A  

LifePath Index 2065 Fund Custom Benchmark

     (18.41      N/A        5.36        N/A  

Bloomberg U.S. Aggregate Bond Index

     (13.01      N/A        (2.45      N/A  

Bloomberg U.S. Intermediate Credit Bond Index

     (9.10      N/A        (0.93      N/A  

Bloomberg U.S. Intermediate Government Bond Index

     (7.73      N/A        (1.27      N/A  

Bloomberg U.S. Long Credit Bond Index

     (25.29      N/A        (4.96      N/A  

Bloomberg U.S. Long Government Bond Index

     (29.19      N/A        (7.48      N/A  

Bloomberg U.S. Securitized: MBS, ABS and CMBS Index

     (11.67      N/A        (2.75      N/A  

Bloomberg U.S. TIPS Index (Series-L)

     (11.85      N/A        1.49        N/A  

FTSE EPRA Nareit Developed Index

     (25.09      N/A        (4.84      N/A  

MSCI ACWI ex USA IMI Index

     (16.58      N/A        1.91        N/A  

Russell 1000® Index

     (19.13      N/A        9.07        N/A  

Russell 2000® Index

     (20.44      N/A        4.98        N/A  

 

  (a)

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees.

 

 

  (b)

LifePath Index 2065 Fund normally invests its assets in underlying funds according to an asset allocation strategy designed for investors planning to retire or begin withdrawing assets around the year 2065.

 

 

  (c)

The LifePath Index Fund commenced operations on October 30, 2019.

 

N/A — Not applicable as the share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

 

PORTFOLIO ALLOCATION

Asset Type   Percent of
Net Assets
 

Equity Funds

    99.0

Fixed-Income Funds

    1.0  

Money Market Funds

    0.4  

Liabilities in Excess of Other Assets

    (0.4

TEN LARGEST HOLDINGS

Security   Percent of
Net Assets
 

Large Cap Index Master Portfolio

    57.6

iShares Core MSCI Total International Stock ETF

    35.6  

iShares Developed Real Estate Index Fund, Class K

    4.8  

iShares U.S. Long Credit Bond Index Fund

    1.0  

Master Small Cap Index Series

    1.0  

BlackRock Cash Funds: Treasury, SL Agency Shares

    0.4  
 

 

 

U N D   S U M M  A R Y

  25


About Fund Performance

 

Institutional and Class K Shares are not subject to any sales charge. These shares bear no ongoing distribution or service fees and are available only to certain eligible investors.

Investor A Shares are not subject to any sales charge and bear no ongoing distribution fee. These shares are subject to an ongoing service fee of 0.25% per year. These shares are generally available through financial intermediaries.

Investor P Shares are subject to a maximum initial sales charge (front-end load) of 5.25% and a service fee of 0.25% per year (but no distribution fee). Certain redemptions of these shares may be subject to a contingent deferred sales charge (“CDSC”) where no initial sales charge was paid at the time of purchase. These shares are only available to investors purchasing shares through registered representatives of an insurance company’s broker-dealer that has entered into an agreement with the LifePath Index Funds’ distributor to offer such shares. Except with respect to LifePath Index 2065 Fund, Investor P Shares performance shown prior to the Investor P Shares inception date of August 6, 2018 is that of Institutional Shares (which have no distribution or service fees) and was restated to reflect Investor P Shares fees.

Past performance is not an indication of future results. Financial markets have experienced extreme volatility and trading in many instruments has been disrupted. These circumstances may continue for an extended period of time and may continue to affect adversely the value and liquidity of each LifePath Index Fund’s investments. As a result, current performance may be lower or higher than the performance data quoted. Refer to blackrock.com to obtain performance data current to the most recent month-end. Performance results do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. Figures shown in the performance tables assume reinvestment of all distributions, if any, at net asset value (“NAV”) on the ex-dividend date or payable date, as applicable. Investment return and principal value of shares will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Distributions paid to each class of shares will vary because of the different levels of service, distribution and transfer agency fees applicable to each class, which are deducted from the income available to be paid to shareholders.

BlackRock Fund Advisors (“BFA” or the “Manager”) and BlackRock Advisors, LLC (“BAL” or the “Administrator”), each LifePath Index Fund’s Manager and Administrator respectively, have contractually agreed to waive and/or reimburse a portion of each LifePath Index Fund’s expenses. Without such waivers and/or reimbursements, each LifePath Index Fund’s performance would have been lower. With respect to each LifePath Index Fund’s contractual waivers, if any, the Manager and the Administrator are under no obligation to continue waiving and/or reimbursing their fees after the applicable termination date of such agreement. See the Notes to Financial Statements for additional information on waivers and/or reimbursements.

The LifePath Index Funds’ custom benchmarks are hypothetical representations of the performance of the respective LifePath Index Fund’s asset classes according to their weightings as of the most recent quarter-end. The weightings of the various indexes that are included in the LifePath Index Funds’ custom benchmarks are adjusted quarterly to reflect the LifePath Index Funds’ changing asset allocations over time. As of December 31, 2022, the following indexes are used to calculate the LifePath Index Funds’ custom benchmarks: Bloomberg U.S. Intermediate Credit Bond Index, Bloomberg U.S. Intermediate Government Bond Index, Bloomberg U.S. Long Credit Bond Index, Bloomberg U.S. Long Government Bond Index, Bloomberg U.S. Securitized: MBS, ABS and CMBS Index, Bloomberg U.S. Treasury Inflation Protected Securities (TIPS) Index (Series-L), FTSE EPRA Nareit Developed Index, MSCI ACWI ex USA IMI Index, Russell 1000® Index and Russell 2000® Index. Effective May 31, 2022, Bloomberg U.S. Aggregate Bond Index was removed from the LifePath Index Funds’ custom benchmark.

The Bloomberg U.S. Aggregate Bond Index is a broad-based flagship benchmark that measures the investment grade, U.S. dollar-denominated, fixed-rate taxable bond market. The Bloomberg U.S. Intermediate Credit Bond Index measures the investment grade, US dollar-denominated, fixed-rate, taxable corporate and government-related bond markets with a maturity greater than 1 year and less than 10 years. The Bloomberg U.S. Intermediate Government Bond Index includes US dollar-denominated, fixed-rate, nominal US Treasuries and US agency debentures with a maturity greater 1 year and less than 10 years. The Bloomberg U.S. Long Credit Bond Index measures the investment grade, US dollar-denominated, fixed-rate, taxable corporate and government-related bond markets with a maturity greater than 10 years. The Bloomberg U.S. Long Government Bond Index includes US dollar-denominated, fixed-rate, nominal US Treasuries and US agency debentures with a maturity greater than 10 years. The Bloomberg U.S. Securitized: MBS, ABS and CMBS Index measures the performance of residential mortgage backed securities issued by Government Sponsored Enterprises, asset backed securities and commercial mortgage backed securities. The Bloomberg U.S. Treasury Inflation Protected Securities (TIPS) Index (Series-L) is an unmanaged index that measures the performance of the inflation-protected public obligations of the U.S. Treasury. The FTSE EPRA Nareit Developed Index is a global market capitalization weighted index composed of listed real estate securities from developed market countries in North America, Europe, and Asia. The MSCI ACWI ex USA IMI Index is a free float-adjusted market capitalization weighted index that measures the equity market performance of the developed (excluding the U.S.) and emerging investable market universe. The Russell 1000® Index is an index that measures the performance of the large-cap segment of the U.S. equity universe. It is a subset of the Russell 3000® Index and includes approximately 1,000 of the largest securities based on a combination of their market capitalization and current index membership. The Index represents approximately 93% of the U.S. market. The Russell 2000® Index is an index that measures the performance of the small-cap segment of the U.S. equity universe. It is a subset of the Russell 3000® Index representing approximately 10% of the total market capitalization of that index. It includes approximately 2,000 of the smallest securities based on a combination of their market cap and current index membership.

Disclosure of Expenses

Shareholders of each LifePath Index Fund may incur the following charges: (a) transactional expenses, such as sales charges; and (b) operating expenses, including investment advisory fees, administration fees, service and distribution fees, including 12b-1 fees, acquired fund fees and expenses, and other fund expenses. The expense

 

 

26  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Disclosure of Expenses  (continued)

 

examples shown (which are based on a hypothetical investment of $1,000 invested at the beginning of the period and held through the end of the period) are intended to assist shareholders both in calculating expenses based on an investment in each LifePath Index Fund and in comparing these expenses with similar costs of investing in other mutual funds.

The expense examples provide information about actual account values and actual expenses. Annualized expense ratios reflect contractual and voluntary fee waivers, if any. In order to estimate the expenses a shareholder paid during the period covered by this report, shareholders can divide their account value by $1,000 and then multiply the result by the number corresponding to their LifePath Index Fund and share class under the heading entitled “Expenses Paid During the Period.”

The expense examples also provide information about hypothetical account values and hypothetical expenses based on a LifePath Index Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses. In order to assist shareholders in comparing the ongoing expenses of investing in these LifePath Index Funds and other funds, compare the 5% hypothetical examples with the 5% hypothetical examples that appear in shareholder reports of other funds.

The expenses shown in the expense examples are intended to highlight shareholders’ ongoing costs only and do not reflect transactional expenses, such as sales charges, if any. Therefore, the hypothetical examples are useful in comparing ongoing expenses only and will not help shareholders determine the relative total expenses of owning different funds. If these transactional expenses were included, shareholder expenses would have been higher.

Expense Example

 

    Actual            Hypothetical 5% Return         
     Beginning
Account Value
(07/01/22)
     Ending
Account Value
(12/31/22)
     Expenses
Paid During
the Period (a)
            Beginning
Account Value
(07/01/22)
     Ending
Account Value
(12/31/22)
     Expenses
Paid During
the Period (a)
     Annualized
Expense
Ratio
 

LifePath Index Retirement Fund

                     

Institutional

    $ 1,000.00        $    987.60        $ 0.55                 $ 1,000.00        $ 1,024.65        $ 0.56        0.11

Investor A

    1,000.00        986.30        1.80          1,000.00        1,023.39        1.84        0.36  

Investor P

    1,000.00        987.00        1.80          1,000.00        1,023.39        1.84        0.36  

Class K

    1,000.00        988.70        0.30          1,000.00        1,024.90        0.31        0.06  

LifePath Index 2025 Fund

                     

Institutional

    1,000.00        990.30        0.55          1,000.00        1,024.65        0.56        0.11  

Investor A

    1,000.00        988.90        1.80          1,000.00        1,023.39        1.84        0.36  

Investor P

    1,000.00        988.90        1.80          1,000.00        1,023.39        1.84        0.36  

Class K

    1,000.00        990.60        0.30          1,000.00        1,024.90        0.31        0.06  

LifePath Index 2030 Fund

                     

Institutional

    1,000.00        996.40        0.50          1,000.00        1,024.70        0.51        0.10  

Investor A

    1,000.00        995.00        1.76          1,000.00        1,023.44        1.79        0.35  

Investor P

    1,000.00        995.70        1.76          1,000.00        1,023.44        1.79        0.35  

Class K

    1,000.00        996.70        0.30          1,000.00        1,024.90        0.31        0.06  

LifePath Index 2035 Fund

                     

Institutional

    1,000.00        1,002.60        0.50          1,000.00        1,024.70        0.51        0.10  

Investor A

    1,000.00        1,001.20        1.77          1,000.00        1,023.44        1.79        0.35  

Investor P

    1,000.00        1,001.30        1.77          1,000.00        1,023.44        1.79        0.35  

Class K

    1,000.00        1,002.90        0.25          1,000.00        1,024.95        0.26        0.05  

LifePath Index 2040 Fund

                     

Institutional

    1,000.00        1,008.00        0.51          1,000.00        1,024.70        0.51        0.10  

Investor A

    1,000.00        1,006.70        1.77          1,000.00        1,023.44        1.79        0.35  

Investor P

    1,000.00        1,007.30        1.77          1,000.00        1,023.44        1.79        0.35  

Class K

    1,000.00        1,008.30        0.25          1,000.00        1,024.95        0.26        0.05  

LifePath Index 2045 Fund

                     

Institutional

    1,000.00        1,014.50        0.51          1,000.00        1,024.70        0.51        0.10  

Investor A

    1,000.00        1,013.20        1.78          1,000.00        1,023.44        1.79        0.35  

Investor P

    1,000.00        1,012.70        1.78          1,000.00        1,023.44        1.79        0.35  

Class K

    1,000.00        1,014.20        0.25          1,000.00        1,024.95        0.26        0.05  

LifePath Index 2050 Fund

                     

Institutional

    1,000.00        1,017.80        0.51          1,000.00        1,024.70        0.51        0.10  

Investor A

    1,000.00        1,015.90        1.78          1,000.00        1,023.44        1.79        0.35  

Investor P

    1,000.00        1,016.50        1.78          1,000.00        1,023.44        1.79        0.35  

Class K

    1,000.00        1,017.50        0.25          1,000.00        1,024.95        0.26        0.05  

LifePath Index 2055 Fund

                     

Institutional

    1,000.00        1,018.30        0.51          1,000.00        1,024.70        0.51        0.10  

Investor A

    1,000.00        1,016.90        1.78          1,000.00        1,023.44        1.79        0.35  

Investor P

    1,000.00        1,017.00        1.78          1,000.00        1,023.44        1.79        0.35  

Class K

    1,000.00        1,018.50        0.25          1,000.00        1,024.95        0.26        0.05  

LifePath Index 2060 Fund

                     

Institutional

    1,000.00        1,017.90        0.51          1,000.00        1,024.70        0.51        0.10  

Investor A

    1,000.00        1,017.20        1.78          1,000.00        1,023.44        1.79        0.35  

Investor P

    1,000.00        1,017.30        1.78          1,000.00        1,023.44        1.79        0.35  

Class K

    1,000.00        1,018.80        0.25          1,000.00        1,024.95        0.26        0.05  

LifePath Index 2065 Fund

                     

Institutional

    1,000.00        1,019.00        0.51          1,000.00        1,024.70        0.51        0.10  

Investor A

    1,000.00        1,016.90        1.78          1,000.00        1,023.44        1.79        0.35  

Investor P

    1,000.00        1,017.70        1.78          1,000.00        1,023.44        1.79        0.35  

Class K

    1,000.00        1,018.30        0.25                1,000.00        1,024.95        0.26        0.05  

 

(a)

For each class of the LifePath Index Funds, expenses are equal to the annualized expense ratio for the class, multiplied by the average account value over the period, multiplied by 184/365 (to reflect the one-half year period shown).

 

 

D I S C L O S U R E   O F   E X P E N S E S

  27


Derivative Financial Instruments

 

The LifePath Index Funds may invest in various derivative financial instruments. These instruments are used to obtain exposure to a security, commodity, index, market, and/or other assets without owning or taking physical custody of securities, commodities and/or other referenced assets or to manage market, equity, credit, interest rate, foreign currency exchange rate, commodity and/or other risks. Derivative financial instruments may give rise to a form of economic leverage and involve risks, including the imperfect correlation between the value of a derivative financial instrument and the underlying asset, possible default of the counterparty to the transaction or illiquidity of the instrument. Pursuant to Rule 18f-4 under the 1940 Act, among other things, the LifePath Index Funds must either use derivative financial instruments with embedded leverage in a limited manner or comply with an outer limit on fund leverage risk based on value-at-risk. The LifePath Index Funds’ successful use of a derivative financial instrument depends on the investment adviser’s ability to predict pertinent market movements accurately, which cannot be assured. The use of these instruments may result in losses greater than if they had not been used, may limit the amount of appreciation a LifePath Index Fund can realize on an investment and/or may result in lower distributions paid to shareholders. The LifePath Index Funds’ investments in these instruments, if any, are discussed in detail in the Notes to Financial Statements.

 

 

28  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

December 31, 2022

  

BlackRock LifePath® Index Retirement Fund

(Percentages shown are based on Net Assets)

 

Security   Shares/
Investment Value
    Value  

Investment Companies(a)

   
Equity Funds — 39.9%            

iShares Core MSCI Total International Stock ETF

    17,207,367     $ 995,962,402  

iShares Developed Real Estate Index Fund, Class K

    17,673,280       157,292,190  

Large Cap Index Master Portfolio

  $     1,489,719,648       1,489,719,648  

Master Small Cap Index Series

  $ 222,346,539       222,346,539  
   

 

 

 
      2,865,320,779  
Fixed-Income Funds — 60.0%            

iShares TIPS Bond ETF

    5,398,267       574,591,540  

iShares U.S. Intermediate Credit Bond Index Fund

    54,466,094       525,053,143  

iShares U.S. Intermediate Government Bond Index Fund

    143,223,431       1,376,377,175  

iShares U.S. Long Credit Bond Index Fund

    26,241,939       237,751,964  

iShares U.S. Long Government Bond Index Fund

    55,649,606       473,021,649  

iShares U.S. Securitized Bond Index Fund

    119,453,749       1,119,281,630  
   

 

 

 
      4,306,077,101  
Security  

 

Shares

    Value  
Money Market Funds — 0.1%            

BlackRock Cash Funds: Treasury, SL Agency Shares, 4.12%(b)

    7,510,487     $ 7,510,487  
   

 

 

 

Total Investments — 100.0%
(Cost: $6,763,945,011)

      7,178,908,367  

Liabilities in Excess of Other Assets — 0.0%

      (1,769,399
   

 

 

 

Net Assets — 100.0%

    $  7,177,138,968  
   

 

 

 

 

(a) 

Affiliate of the Fund.

(b) 

Annualized 7-day yield as of period end.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the LifePath Index Fund during the year ended December 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

    Affiliated Issuer   Value at
12/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
    Shares/
Investment Value
Held at
12/31/22
    Income     Capital Gain
Distributions
from
Underlying
Funds
          

    

 

BlackRock Cash Funds: Institutional, SL Agency Shares(a)

  $ 26,873,200     $     $ (26,860,906 )(b)    $ (12,294 )   $     $           $ 75,575 (c)     $    
 

BlackRock Cash Funds: Treasury, SL Agency Shares

    11,699,096             (4,188,609 )(b)                   7,510,487       7,510,487       124,811          
 

iShares Core MSCI Total International Stock ETF

    1,214,530,327       172,484,216       (177,349,172     (9,056,516     (204,646,453     995,962,402       17,207,367       24,666,056          
 

iShares Developed Real Estate Index Fund, Class K

    217,122,940       18,429,187       (26,276,647     (397,295     (51,585,995     157,292,190       17,673,280       1,962,250          
 

iShares TIPS Bond ETF

    719,104,331       49,627,914       (70,917,716     (5,266,842     (117,956,147     574,591,540       5,398,267       39,617,569          
 

iShares U.S. Intermediate Credit Bond Index Fund

          838,973,525       (295,358,300     699,859       (19,261,941     525,053,143       54,466,094       9,859,207          
 

iShares U.S. Intermediate Government Bond Index Fund

          1,571,836,362       (136,575,191     (5,025,400     (53,858,596     1,376,377,175       143,223,431       15,064,442          
 

iShares U.S. Long Credit Bond Index Fund

          386,269,621       (122,638,582     (1,855,904     (24,023,171     237,751,964       26,241,939       7,953,669          
 

iShares U.S. Long Government Bond Index Fund

          591,573,258       (43,691,940     (3,447,339     (71,412,330     473,021,649       55,649,606       9,290,096          

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  29


Schedule of Investments  (continued)

December 31, 2022

  

BlackRock LifePath® Index Retirement Fund

 

                   
       Affiliated Issuer   Value at
12/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
    Shares/
Investment Value
Held at
12/31/22
    Income     Capital Gain
Distributions
from
Underlying
Funds
          
 

iShares U.S. Securitized Bond Index Fund

  $     $  1,310,293,637     $ (113,277,755   $ (5,299,822   $ (72,434,430   $ 1,119,281,630       119,453,749     $ 20,731,278     $    
 

Large Cap Index Master Portfolio

    1,900,622,024       522,151,130 (b)(d)            (20,962,189     (912,091,317     1,489,719,648     $ 1,489,719,648       25,979,144          
 

Master Small Cap Index Series

    325,024,898       42,823,353 (b)(d)             5,022,618       (150,524,330     222,346,539     $ 222,346,539       3,545,372          
 

U.S. Total Bond Index Master Portfolio(a)

    4,711,516,553             (4,868,016,408 )(b)(d)      (29,421,880     185,921,735           $       36,002,881          
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   
          $  (75,023,004   $  (1,491,872,975   $  7,178,908,367       $  194,872,350     $    
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

 

  (a)

As of period end, the entity is no longer held.

 
  (b)

Represents net amount purchased (sold).

 
  (c)

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 
  (d)

Inclusive of income and expense allocated from the Master Portfolio.

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the LifePath Index Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the LifePath Index Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the LifePath Index Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Assets

                 

Investments

                 

Investment Companies

                 

Equity Funds

   $ 1,153,254,592        $        $        $ 1,153,254,592  

Fixed-Income Funds

     4,306,077,101                            4,306,077,101  

Money Market Funds

     7,510,487                            7,510,487  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $  5,466,842,180        $                 —        $                 —          5,466,842,180  
  

 

 

      

 

 

      

 

 

      

 

 

 

Investments Valued at NAV(a)

                    1,712,066,187  
                 

 

 

 
                  $  7,178,908,367  
                 

 

 

 

 

  (a) 

Certain investments of the Fund were fair valued using NAV as a practical expedient or its equivalent as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

See notes to financial statements.

 

 

30  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

December 31, 2022

  

BlackRock LifePath® Index 2025 Fund

(Percentages shown are based on Net Assets)

 

Security   Shares/
Investment Value
    Value  

Investment Companies(a)

   
Equity Funds — 45.8%            

iShares Core MSCI Total International Stock ETF(b)

    16,741,013     $ 968,969,832  

iShares Developed Real Estate Index Fund, Class K

    14,299,871       127,268,854  

Large Cap Index Master Portfolio

  $     1,462,658,023         1,462,658,023  

Master Small Cap Index Series

  $ 172,036,530       172,036,530  
   

 

 

 
      2,730,933,239  
Fixed-Income Funds — 54.2%            

iShares TIPS Bond ETF(b)

    4,318,673       459,679,554  

iShares U.S. Intermediate Credit Bond Index Fund

    42,442,073       409,141,580  

iShares U.S. Intermediate Government Bond Index Fund

    92,115,451       885,229,488  

iShares U.S. Long Credit Bond Index Fund

    25,339,880       229,579,317  

iShares U.S. Long Government Bond Index Fund

    48,335,859       410,854,806  

iShares U.S. Securitized Bond Index Fund

    88,989,669       833,833,202  
   

 

 

 
      3,228,317,947  
Security  

 

Shares

    Value  
Money Market Funds — 0.8%            

BlackRock Cash Funds: Institutional, SL Agency Shares, 4.53%(c)(d)

    35,899,214     $ 35,909,984  

BlackRock Cash Funds: Treasury, SL Agency Shares, 4.12%(c)

    11,942,609       11,942,609  
   

 

 

 
      47,852,593  
   

 

 

 

Total Investments — 100.8%
(Cost: $5,721,586,114)

 

    6,007,103,779  

Liabilities in Excess of Other Assets — (0.8)%

 

    (45,842,650
   

 

 

 

Net Assets — 100.0%

 

  $   5,961,261,129  
   

 

 

 

 

(a)

Affiliate of the Fund.

(b)

All or a portion of this security is on loan.

(c)

Annualized 7-day yield as of period end.

(d)

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the LifePath Index Fund during the year ended December 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

                   
    Affiliated Issuer   Value at
12/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
    Shares/
Investment Value
Held at
12/31/22
    Income     Capital Gain
Distributions
from
Underlying
Funds
       

    

 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 13,133,999     $ 22,770,568(a)     $     $ 4,700     $ 717     $ 35,909,984       35,899,214     $ 75,170(b)     $             
 

BlackRock Cash Funds: Treasury, SL Agency Shares

    21,469,384             (9,526,775 )(a)                   11,942,609       11,942,609       136,394          
 

iShares Core MSCI Total International Stock ETF

    1,214,723,993       138,096,978       (168,869,184     (14,651,093     (200,330,862     968,969,832       16,741,013       24,335,633          
 

iShares Developed Real Estate Index Fund, Class K

    162,162,645       19,599,484       (15,647,718     1,488,416       (40,333,973     127,268,854       14,299,871       1,504,650          
 

iShares TIPS Bond ETF

    519,704,674       47,677,577       (14,832,041     (1,671,461     (91,199,195     459,679,554       4,318,673       30,154,810          
 

iShares U.S. Intermediate Credit Bond Index Fund

          598,570,021       (175,567,577     695,200       (14,556,064     409,141,580       42,442,073       7,295,034          
 

iShares U.S. Intermediate Government Bond Index Fund

          1,046,657,528       (126,756,181     (1,100,166     (33,571,693     885,229,488       92,115,451       9,114,671          
 

iShares U.S. Long Credit Bond Index Fund

          283,494,172       (27,252,066     (3,624,308     (23,038,481     229,579,317       25,339,880       7,446,557          
 

iShares U.S. Long Government Bond Index Fund

          502,303,526       (30,318,982     (1,674,715     (59,455,023     410,854,806       48,335,859       7,728,887          

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  31


Schedule of Investments  (continued)

December 31, 2022

  

BlackRock LifePath® Index 2025 Fund

 

                   
       Affiliated Issuer   Value at
12/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
    Shares/
Investment Value
Held at
12/31/22
    Income     Capital Gain
Distributions
from
Underlying
Funds
          
 

iShares U.S. Securitized Bond Index Fund

  $     $ 925,267,178     $ (37,312,443   $ (963,674)     $ (53,157,859)     $ 833,833,202       88,989,669     $ 14,671,926     $    
 

Large Cap Index Master Portfolio

    1,806,887,366       438,478,727 (a)(c)            (20,334,252     (762,373,818     1,462,658,023     $  1,462,658,023       25,090,672          
 

Master Small Cap Index Series

    216,470,258       49,330,435 (a)(c)            (1,010,185     (92,753,978     172,036,530     $ 172,036,530       2,520,453          
 

U.S. Total Bond Index Master Portfolio(d)

    3,073,425,124             (3,222,751,882) (a)(c)      (39,758,747)       189,085,505           $       23,857,022          
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   
          $  (82,600,285   $  (1,181,684,724   $  6,007,103,779       $  153,931,879     $    
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

 

  (a)

Represents net amount purchased (sold).

 
  (b)

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 
  (c)

Inclusive of income and expense allocated from the Master Portfolio.

 
  (d)

As of period end, the entity is no longer held.

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the LifePath Index Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the LifePath Index Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the LifePath Index Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

         
      Level 1        Level 2        Level 3        Total  

Assets

                 

Investments

                 

Investment Companies

                 

Equity Funds

   $ 1,096,238,686        $        $        $ 1,096,238,686  

Fixed-Income Funds

     3,228,317,947                            3,228,317,947  

Money Market Funds

     47,852,593                            47,852,593  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $  4,372,409,226        $                 —        $                 —          4,372,409,226  
  

 

 

      

 

 

      

 

 

      

 

 

 

Investments Valued at NAV(a)

                    1,634,694,553  
                 

 

 

 
                  $  6,007,103,779  
                 

 

 

 

 

  (a)

Certain investments of the Fund were fair valued using NAV as a practical expedient or its equivalent as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

See notes to financial statements.

 

 

32  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

December 31, 2022

  

BlackRock LifePath® Index 2030 Fund

(Percentages shown are based on Net Assets)

 

Security   Shares/
Investment Value
    Value  

 

 

Investment Companies(a)

 

Equity Funds — 58.3%            

iShares Core MSCI Total International Stock ETF

    36,176,830     $ 2,093,914,920  

iShares Developed Real Estate Index Fund, Class K

    31,101,067       276,799,500  

Large Cap Index Master Portfolio

  $     3,269,247,166       3,269,247,166  

Master Small Cap Index Series

  $ 231,709,920       231,709,920  
   

 

 

 
      5,871,671,506  
Fixed-Income Funds — 41.7%  

iShares TIPS Bond ETF

    6,442,457       685,735,123  

iShares U.S. Intermediate Credit Bond Index Fund

    53,009,466       511,011,250  

iShares U.S. Intermediate Government Bond Index Fund

    96,237,587       924,843,207  

iShares U.S. Long Credit Bond Index Fund

    52,942,365       479,657,829  

iShares U.S. Long Government Bond Index Fund

    63,249,969       537,624,735  

iShares U.S. Securitized Bond Index Fund

    112,931,173         1,058,165,089  
   

 

 

 
      4,197,037,233  
Security       
Shares
    Value  

 

 
Money Market Funds — 0.0%            

BlackRock Cash Funds: Treasury, SL Agency Shares, 4.12%(b)

    5,274,503     $ 5,274,503  
   

 

 

 

Total Investments — 100.0%
(Cost: $9,323,805,799)

 

    10,073,983,242  

Liabilities in Excess of Other Assets — 0.0%

 

    (3,682,508
   

 

 

 

Net Assets — 100.0%

 

  $   10,070,300,734  
   

 

 

 

 

(a) 

Affiliate of the Fund.

(b) 

Annualized 7-day yield as of period end.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the LifePath Index Fund during the year ended December 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

                   
    Affiliated Issuer  

Value at

12/31/21

    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
    Shares/
Investment Value
Held at
12/31/22
    Income     Capital Gain
Distributions
from
Underlying
Funds
          

    

 

BlackRock Cash Funds: Institutional, SL Agency Shares(a)

  $     $     $ (14,783 )(b)     $ 14,783     $     $           $ 108,724 (c)     $    
 

BlackRock Cash Funds: Treasury, SL Agency Shares

    22,317,782             (17,043,279 )(b)                  5,274,503       5,274,503       267,346          
 

iShares Core MSCI Total International Stock ETF

    2,588,907,132       270,704,349       (297,575,388     (40,289,477     (427,831,696     2,093,914,920       36,176,830       52,575,168          
 

iShares Developed Real Estate Index Fund, Class K

    343,539,076       41,977,436       (23,757,379     1,238,643       (86,198,276     276,799,500       31,101,067       3,251,640          
 

iShares TIPS Bond ETF

    726,695,219       95,605,838       (3,402,856     (229,138     (132,933,940     685,735,123       6,442,457       43,334,825          
 

iShares U.S. Intermediate Credit Bond Index Fund

          744,310,357       (216,208,277     1,131,393       (18,222,223     511,011,250       53,009,466       8,975,059          
 

iShares U.S. Intermediate Government Bond Index Fund

          1,304,291,747       (344,094,553     (986,212     (34,367,775     924,843,207       96,237,587       9,372,367          

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  33


Schedule of Investments  (continued)

December 31, 2022

  

BlackRock LifePath® Index 2030 Fund

 

                   
       Affiliated Issuer   Value at
12/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
   

Shares/
Investment Value
Held at

12/31/22

    Income     Capital Gain
Distributions
from
Underlying
Funds
          
 

iShares U.S. Long Credit Bond Index Fund

  $     $ 550,618,865     $ (18,849,721   $ (1,690,109   $ (50,421,206   $ 479,657,829       52,942,365     $ 14,243,203     $    
 

iShares U.S. Long Government Bond Index Fund

          642,751,927       (26,006,186     (1,132,658     (77,988,348     537,624,735       63,249,969       10,000,050          
 

iShares U.S. Securitized Bond Index Fund

          1,156,217,324       (30,908,757     (432,799     (66,710,679     1,058,165,089       112,931,173       18,338,085          
 

Large Cap Index Master Portfolio

    3,772,067,042       1,020,180,258 (b)(d)            (43,522,011     (1,479,478,123     3,269,247,166     $ 3,269,247,166       53,551,777          
 

Master Small Cap Index Series

    271,166,860       72,612,122 (b)(d)             59,258       (112,128,320     231,709,920     $ 231,709,920       3,364,507          
 

U.S. Total Bond Index Master Portfolio(a)

    3,746,795,000             (4,155,447,578 )(b)(d)      (41,114,726     449,767,304           $       29,101,618          
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   
          $  (126,953,053   $ (2,036,513,282   $  10,073,983,242       $  246,484,369     $             —    
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

 

  (a)

As of period end, the entity is no longer held.

 
  (b)

Represents net amount purchased (sold).

 
  (c)

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 
  (d)

Inclusive of income and expense allocated from the Master Portfolio.

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the LifePath Index Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the LifePath Index Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the LifePath Index Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

         
      Level 1        Level 2        Level 3        Total  

Assets

                 

Investments

                 

Investment Companies

                 

Equity Funds

   $ 2,370,714,420        $        $        $ 2,370,714,420  

Fixed-Income Funds

     4,197,037,233                            4,197,037,233  

Money Market Funds

     5,274,503                            5,274,503  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $   6,573,026,156        $                 —        $                 —          6,573,026,156  
  

 

 

      

 

 

      

 

 

      

 

 

 

Investments Valued at NAV(a)

                    3,500,957,086  
                 

 

 

 
                  $  10,073,983,242  
                 

 

 

 

 

  (a)

Certain investments of the Fund were fair valued using NAV as a practical expedient or its equivalent as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

See notes to financial statements.

 

 

34  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

December 31, 2022

  

BlackRock LifePath® Index 2035 Fund

(Percentages shown are based on Net Assets)

 

Security   Shares/
Investment Value
    Value  

Investment Companies(a)

 

Equity Funds — 70.0%  

iShares Core MSCI Total International Stock
ETF(b)

    29,369,901     $ 1,699,929,870  

iShares Developed Real Estate Index Fund,
Class K

    25,593,295       227,780,329  

Large Cap Index Master Portfolio

  $     2,702,987,818        2,702,987,818  

Master Small Cap Index Series

  $ 123,113,851       123,113,851  
   

 

 

 
      4,753,811,868  
Fixed-Income Funds — 30.0%  

iShares TIPS Bond ETF

    3,555,426       378,439,543  

iShares U.S. Intermediate Credit Bond Index
Fund

    25,006,149       241,059,275  

iShares U.S. Intermediate Government Bond
Index Fund

    35,468,351       340,850,850  

iShares U.S. Long Credit Bond Index Fund

    34,551,884       313,040,066  

iShares U.S. Long Government Bond Index
Fund

    31,605,272       268,644,814  

iShares U.S. Securitized Bond Index Fund

    53,363,485       500,015,858  
   

 

 

 
      2,042,050,406  
Security  

 

Shares

    Value  

Money Market Funds — 0.1%

 

BlackRock Cash Funds: Institutional, SL Agency
Shares, 4.53%(c)(d)

    131,645     $ 131,684  

BlackRock Cash Funds: Treasury, SL Agency
Shares, 4.12%(c)

    8,490,298       8,490,298  
   

 

 

 
      8,621,982  
   

 

 

 

Total Investments — 100.1%
(Cost: $6,298,153,218)

      6,804,484,256  

Liabilities in Excess of Other Assets — (0.1)%

      (9,500,548
   

 

 

 

Net Assets — 100.0%

    $  6,794,983,708  
   

 

 

 

 

(a)

Affiliate of the Fund.

(b)

All or a portion of this security is on loan.

(c)

Annualized 7-day yield as of period end.

(d)

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the LifePath Index Fund during the year ended December 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

                   
       Affiliated Issuer   Value at
12/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
    Shares/
Investment Value
Held at
12/31/22
    Income     Capital Gain
Distributions
from
Underlying
Funds
          
 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 60,128,772     $         $ (59,998,363 )(a)    $ 1,210     $ 65     $ 131,684       131,645     $ 144,108 (b)    $        
 

BlackRock Cash Funds: Treasury, SL Agency Shares

    14,442,571                 (5,952,273 )(a)                           8,490,298       8,490,298       206,477              
 

iShares Core MSCI Total International Stock ETF

    2,022,661,285       313,892,190       (265,622,278     (45,381,419     (325,619,908     1,699,929,870       29,369,901       41,832,673              
 

iShares Developed Real Estate Index Fund, Class K

    263,691,275       46,541,646       (14,972,022     20,875       (67,501,445     227,780,329       25,593,295       2,618,531              
 

iShares TIPS Bond ETF

    370,275,572       82,513,860       (3,253,248     (244,084     (70,852,557     378,439,543       3,555,426       23,250,751              
 

iShares U.S. Intermediate Credit Bond Index Fund

              339,698,001       (90,610,546     310,290       (8,338,470     241,059,275       25,006,149       4,199,916              
 

iShares U.S. Intermediate Government Bond Index Fund

              613,307,610       (260,244,066     (126,140     (12,086,554     340,850,850       35,468,351       3,311,907              
 

iShares U.S. Long Credit Bond Index Fund

              359,730,606       (13,856,188     (722,485     (32,111,867     313,040,066       34,551,884       8,873,117              
 

iShares U.S. Long Government Bond Index Fund

              322,467,858       (16,000,237     (526,260     (37,296,547     268,644,814       31,605,272       4,915,682              

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  35


Schedule of Investments  (continued)

December 31, 2022

  

BlackRock LifePath® Index 2035 Fund

 

                   
       Affiliated Issuer   Value at
12/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
    Shares/
Investment Value
Held at
12/31/22
    Income     Capital Gain
Distributions
from
Underlying
Funds
          
 

iShares U.S. Securitized Bond Index Fund

  $     $ 561,010,113     $ (30,344,923   $ (274,330   $ (30,375,002   $ 500,015,858       53,363,485     $ 8,517,009     $    
 

Large Cap Index Master Portfolio

    2,902,084,735       775,282,700 (a)(c)            (34,776,292     (939,603,325     2,702,987,818     $ 2,702,987,818       42,711,192          
 

Master Small Cap Index Series

    120,270,344       46,963,429 (a)(c)            348,910       (44,468,832     123,113,851     $ 123,113,851       1,688,855          
 

U.S. Total Bond Index Master Portfolio(d)

    1,640,150,722             (1,840,953,337 )(a)(c)      (27,085,145     227,887,760           $       13,007,859          
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   
          $  (108,454,870   $  (1,340,366,682   $  6,804,484,256       $  155,278,077     $             —    
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

 

  (a)

Represents net amount purchased (sold).

 
  (b)

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 
  (c)

Inclusive of income and expense allocated from the Master Portfolio.

 
  (d)

As of period end, the entity is no longer held.

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the LifePath Index Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the LifePath Index Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the LifePath Index Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

         
      Level 1        Level 2        Level 3      Total  

Assets

               

Investments

               

Investment Companies

               

Equity Funds

   $ 1,927,710,199        $        $      $ 1,927,710,199  

Fixed-Income Funds

      2,042,050,406                          2,042,050,406  

Money Market Funds

     8,621,982                          8,621,982  
  

 

 

      

 

 

      

 

 

    

 

 

 
   $  3,978,382,587        $                 —        $                 —        3,978,382,587  
  

 

 

      

 

 

      

 

 

    

 

 

 

Investments Valued at NAV(a)

                  2,826,101,669  
               

 

 

 
                $  6,804,484,256  
               

 

 

 

 

  (a)

Certain investments of the Fund were fair valued using NAV as a practical expedient or its equivalent as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

See notes to financial statements.

 

 

36  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

December 31, 2022

  

BlackRock LifePath® Index 2040 Fund

(Percentages shown are based on Net Assets)

 

Security   Shares/
Investment Value
    Value  

Investment Companies(a)

   
Equity Funds — 81.1%            

iShares Core MSCI Total International Stock ETF

    44,334,421     $  2,566,076,287  

iShares Developed Real Estate Index Fund, Class K

    38,913,311       346,328,466  

Large Cap Index Master Portfolio

  $     4,136,964,921       4,136,964,921  

Master Small Cap Index Series

  $ 118,270,322       118,270,322  
   

 

 

 
      7,167,639,996  
Fixed-Income Funds — 18.9%            

iShares TIPS Bond ETF

    3,365,416       358,214,879  

iShares U.S. Intermediate Credit Bond Index Fund

    15,267,420       147,177,930  

iShares U.S. Intermediate Government Bond Index Fund

    15,629,422       150,198,746  

iShares U.S. Long Credit Bond Index Fund

    44,385,010       402,128,191  

iShares U.S. Long Government Bond Index Fund

    25,024,723       212,710,145  

iShares U.S. Securitized Bond Index Fund

    42,306,293       396,409,965  
   

 

 

 
      1,666,839,856  
Security  

 

Shares

     Value  

Money Market Funds — 0.1%

    

BlackRock Cash Funds: Treasury, SL Agency Shares, 4.12%(b)

    9,930,447      $ 9,930,447  
    

 

 

 

Total Investments — 100.1%
(Cost: $7,793,615,733)

       8,844,410,299  

Liabilities in Excess of Other Assets — (0.1)%

 

     (7,481,404
    

 

 

 

Net Assets — 100.0%

     $  8,836,928,895  
    

 

 

 

 

(a) 

Affiliate of the Fund.

(b) 

Annualized 7-day yield as of period end.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the LifePath Index Fund during the year ended December 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

                   
       Affiliated Issuer   Value at
12/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
    Shares/
Investment Value
Held at
12/31/22
    Income     Capital Gain
Distributions
from
Underlying
Funds
          
 

BlackRock Cash Funds: Institutional, SL Agency Shares(a)

  $ 59,841,573     $     $ (59,805,527 )(b)    $ (36,046  ) $          $           $ 117,540 (c)    $    
 

BlackRock Cash Funds: Treasury, SL Agency Shares

    19,633,954             (9,703,507 )(b)                   9,930,447       9,930,447       271,035          
 

iShares Core MSCI Total International Stock ETF

    3,173,265,025       414,391,438       (441,353,185     (75,751,028     (504,475,963     2,566,076,287       44,334,421       63,862,243          
 

iShares Developed Real Estate Index Fund, Class K

    409,392,522       70,046,482       (29,554,082     154,006       (103,710,462     346,328,466       38,913,311       4,059,549          
 

iShares TIPS Bond ETF

    346,369,567       83,920,086       (5,307,427     (345,881     (66,421,466     358,214,879       3,365,416       21,860,564          
 

iShares U.S. Intermediate Credit Bond Index Fund

          265,532,835       (114,233,370     642,688       (4,764,223     147,177,930       15,267,420       2,456,878          
 

iShares U.S. Intermediate Government Bond Index Fund

          461,950,493       (307,002,886     (30,719     (4,718,142     150,198,746       15,629,422       1,382,627          
 

iShares U.S. Long Credit Bond Index Fund

          466,785,699       (21,227,661     (385,854     (43,043,993     402,128,191       44,385,010       11,283,983          
 

iShares U.S. Long Government Bond Index Fund

          243,156,352       (1,118,365     (185,178     (29,142,664     212,710,145       25,024,723       3,764,373          

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  37


Schedule of Investments  (continued)

December 31, 2022

  

BlackRock LifePath® Index 2040 Fund

 

                   
    Affiliated Issuer   Value at
12/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
    Shares/
Investment Value
Held at
12/31/22
    Income     Capital Gain
Distributions
from
Underlying
Funds
       

    

 

iShares U.S. Securitized Bond Index Fund

  $     $ 445,415,889     $ (25,137,906)     $ (103,116   $ (23,764,902   $ 396,409,965       42,306,293     $ 6,663,665     $    
 

Large Cap Index Master Portfolio

    4,499,777,050       895,686,308 (b)(d)            (52,884,939     (1,205,613,498     4,136,964,921     $ 4,136,964,921       65,054,794                   
 

Master Small Cap Index Series

    103,532,845       47,876,432 (b)(d)            4,391,188       (37,530,143     118,270,322     $ 118,270,322       1,612,911          
 

U.S. Total Bond Index Master Portfolio(a)

    1,280,940,996             (1,458,972,748 )(b)(d)      (18,621,903     196,653,655           $       10,065,893          
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   
          $  (143,156,782)     $  (1,826,531,801)     $  8,844,410,299       $  192,456,055     $    
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

 

  (a)

As of period end, the entity is no longer held.

 
  (b)

Represents net amount purchased (sold).

 
  (c)

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 
  (d)

Inclusive of income and expense allocated from the Master Portfolio.

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the LifePath Index Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the LifePath Index Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the LifePath Index Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1      Level 2      Level 3      Total  

Assets

           

Investments

           

Investment Companies

           

Equity Funds

   $ 2,912,404,753      $      $      $ 2,912,404,753  

Fixed-Income Funds

     1,666,839,856                      1,666,839,856  

Money Market Funds

     9,930,447                      9,930,447  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $  4,589,175,056      $                 —      $                 —        4,589,175,056  
  

 

 

    

 

 

    

 

 

    

 

 

 

Investments Valued at NAV(a)

              4,255,235,243  
           

 

 

 
            $  8,844,410,299  
           

 

 

 

 

  (a)

Certain investments of the Fund were fair valued using NAV as a practical expedient or its equivalent as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

See notes to financial statements.

 

 

38  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

December 31, 2022

  

BlackRock LifePath® Index 2045 Fund

(Percentages shown are based on Net Assets)

 

Security   Shares/
Investment Value
     Value  

Investment Companies(a)

    
Equity Funds — 91.1%             

iShares Core MSCI Total International Stock ETF(b)

    30,635,686      $ 1,773,193,506  

iShares Developed Real Estate Index Fund, Class K

    26,947,567        239,833,349  

Large Cap Index Master Portfolio

  $     2,879,759,331          2,879,759,331  

Master Small Cap Index Series

  $ 56,668,668        56,668,668  
    

 

 

 
       4,949,454,854  
Fixed-Income Funds — 8.9%             

iShares TIPS Bond ETF(b)

    1,203,208        128,069,460  

iShares U.S. Intermediate Credit Bond Index Fund

    54,654        526,865  

iShares U.S. Long Credit Bond Index Fund

    24,191,611        219,175,996  

iShares U.S. Long Government Bond Index Fund

    3,256,970        27,684,246  

iShares U.S. Securitized Bond Index Fund

    11,725,413        109,867,118  
    

 

 

 
       485,323,685  
Security  

 

Shares

     Value  

Money Market Funds — 0.5%

    

BlackRock Cash Funds: Institutional, SL Agency Shares, 4.53%(c)(d)

    22,597,545      $ 22,604,324  

BlackRock Cash Funds: Treasury, SL Agency Shares, 4.12%(c)

    2,963,435        2,963,435  
    

 

 

 
       25,567,759  
    

 

 

 

Total Investments — 100.5%
(Cost: $4,889,388,271)

       5,460,346,298  

Liabilities in Excess of Other Assets — (0.5)%

 

     (26,162,447
    

 

 

 

Net Assets — 100.0%

     $  5,434,183,851  
    

 

 

 

 

(a)

Affiliate of the Fund.

(b)

All or a portion of this security is on loan.

(c)

Annualized 7-day yield as of period end.

(d)

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the LifePath Index Fund during the year ended December 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

                   
       Affiliated Issuer   Value at
12/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
    Shares/
Investment Value
Held at
12/31/22
    Income     Capital Gain
Distributions
from
Underlying
Funds
          
 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 14,882,333     $ 7,717,055 (a)     $     $ 3,411     $ 1,525     $ 22,604,324       22,597,545     $ 57,262 (b)     $    
 

BlackRock Cash Funds: Treasury, SL Agency Shares

    11,608,495             (8,645,060 )(a)                   2,963,435       2,963,435       183,145          
 

iShares Core MSCI Total International Stock ETF

    2,105,562,337       386,145,530       (329,189,331     (61,954,485     (327,370,545     1,773,193,506       30,635,686       43,338,050          
 

iShares Developed Real Estate Index Fund, Class K

    266,713,921       63,902,881       (21,894,634     (651,807     (68,237,012     239,833,349       26,947,567       2,742,196          
 

iShares TIPS Bond ETF

    111,228,667       41,368,903       (2,276,070     (181,187     (22,070,853     128,069,460       1,203,208       7,312,711          
 

iShares U.S. Intermediate Credit Bond Index Fund

          1,292,902       (719,175     (31,232     (15,630     526,865       54,654       20,154          
 

iShares U.S. Long Credit Bond Index Fund

          244,028,088       (3,074,975     (351,323     (21,425,794     219,175,996       24,191,611       5,632,397          
 

iShares U.S. Long Government Bond Index Fund

          31,230,787       (264,723     (36,408     (3,245,410     27,684,246       3,256,970       425,718          
 

iShares U.S. Securitized Bond Index Fund

          118,473,789       (2,050,519     (131,954     (6,424,198     109,867,118       11,725,413       1,727,920          
 

Large Cap Index Master Portfolio

    2,927,892,266       657,200,503 (a)(c)            (35,664,015     (669,669,423     2,879,759,331     $ 2,879,759,331       43,797,439          

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  39


Schedule of Investments  (continued)

December 31, 2022

  

BlackRock LifePath® Index 2045 Fund

 

                   
       Affiliated Issuer   Value at
12/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
    Shares/
Investment Value
Held at
12/31/22
    Income     Capital Gain
Distributions
from
Underlying
Funds
          
 

Master Small Cap Index Series

  $ 60,324,977     $ 10,338,986 (a)(c)    $     $ 1,385,395     $ (15,380,690   $ 56,668,668     $ 56,668,668     $ 806,690     $    
 

U.S. Total Bond Index Master Portfolio(d)

    320,887,184             (358,321,834 )(a)(c)      (10,273,170     47,707,820           $       2,822,598          
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   
          $  (107,886,775   $  (1,086,130,210)     $  5,460,346,298       $  108,866,280     $    
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

 

  (a)

Represents net amount purchased (sold).

 
  (b)

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 
  (c)

Inclusive of income and expense allocated from the Master Portfolio.

 
  (d)

As of period end, the entity is no longer held.

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the LifePath Index Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the LifePath Index Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the LifePath Index Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

         
      Level 1        Level 2        Level 3        Total  

Assets

                 

Investments

                 

Investment Companies

                 

Equity Funds

   $ 2,013,026,855        $        $        $ 2,013,026,855  

Fixed-Income Funds

     485,323,685                            485,323,685  

Money Market Funds

     25,567,759                            25,567,759  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $  2,523,918,299        $                 —        $                 —          2,523,918,299  
  

 

 

      

 

 

      

 

 

      

 

 

 

Investments Valued at NAV(a)

                    2,936,427,999  
                 

 

 

 
                  $  5,460,346,298  
                 

 

 

 

 

  (a)

Certain investments of the Fund were fair valued using NAV as a practical expedient or its equivalent as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

See notes to financial statements.

 

 

40  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

December 31, 2022

  

BlackRock LifePath® Index 2050 Fund

(Percentages shown are based on Net Assets)

 

Security   Shares/
Investment Value
    Value  

Investment Companies(a)

   
Equity Funds — 97.3%            

iShares Core MSCI Total International Stock ETF(b)

    33,754,975     $   1,953,737,953  

iShares Developed Real Estate Index Fund, Class K

    29,720,049       264,508,436  

Large Cap Index Master Portfolio

  $     3,168,904,503       3,168,904,503  

Master Small Cap Index Series

  $ 58,228,378       58,228,378  
   

 

 

 
      5,445,379,270  
Fixed-Income Funds — 2.7%            

iShares TIPS Bond ETF(b)

    442,230       47,070,961  

iShares U.S. Long Credit Bond Index Fund

    11,637,004       105,431,254  

iShares U.S. Long Government Bond Index Fund

    84,636       719,406  
   

 

 

 
      153,221,621  
Security  

 

Shares

    Value  

Money Market Funds — 0.9%

   

BlackRock Cash Funds: Institutional, SL Agency Shares, 4.53%(c)(d)

    48,351,537     $ 48,366,043  

BlackRock Cash Funds: Treasury, SL Agency Shares, 4.12%(c)

    3,651,195       3,651,195  
   

 

 

 
      52,017,238  
   

 

 

 

Total Investments — 100.9%
(Cost: $5,002,573,880)

      5,650,618,129  

Liabilities in Excess of Other Assets — (0.9)%

      (52,516,896
   

 

 

 

Net Assets — 100.0%

 

  $  5,598,101,233  
   

 

 

 

 

(a)

Affiliate of the Fund.

(b)

All or a portion of this security is on loan.

(c)

Annualized 7-day yield as of period end.

(d)

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the LifePath Index Fund during the year ended December 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

                   
       Affiliated Issuer   Value at
12/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
    Shares/
Investment Value
Held at
12/31/22
    Income     Capital Gain
Distributions
from
Underlying
Funds
          
 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 36,642,450     $ 11,684,723 (a)    $     $ 37,881     $ 989     $ 48,366,043       48,351,537     $ 62,639 (b)     $    
 

BlackRock Cash Funds: Treasury, SL Agency Shares

    11,773,635             (8,122,440 )(a)                   3,651,195       3,651,195       200,232          
 

iShares Core MSCI Total International Stock ETF

    2,268,568,269       461,937,137       (353,986,338     (68,295,131     (354,485,984     1,953,737,953       33,754,975       47,326,207          
 

iShares Developed Real Estate Index Fund, Class K

    284,551,080       74,843,286       (20,850,355     (508,791     (73,526,784     264,508,436       29,720,049       2,953,890          
 

iShares TIPS Bond ETF

    40,716,863       15,093,829       (1,060,083     (22,589     (7,657,059     47,070,961       442,230       2,517,594          
 

iShares U.S. Long Credit Bond Index Fund

          119,520,996       (4,206,904     (511,041     (9,371,797     105,431,254       11,637,004       2,654,541          
 

iShares U.S. Long Government Bond Index Fund

          1,888,930       (924,723     (146,460     (98,341     719,406       84,636       30,326          
 

Large Cap Index Master Portfolio

    3,141,691,157       730,626,810 (a)(c)            (38,616,072     (664,797,392     3,168,904,503     $ 3,168,904,503       47,434,288          
 

Master Small Cap Index Series

    56,950,901       14,936,818 (a)(c)            672,992       (14,332,333     58,228,378     $ 58,228,378       790,517          
 

U.S. Total Bond Index Master Portfolio(d)

    89,694,292             (97,435,632 )(a)(c)      (2,540,374     10,281,714           $       796,978          
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   
          $  (109,929,585   $  (1,113,986,987   $  5,650,618,129       $  104,767,212     $    
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

 

  (a) 

Represents net amount purchased (sold).

 
  (b)

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 
  (c)

Inclusive of income and expense allocated from the Master Portfolio.

 
  (d)

As of period end, the entity is no longer held.

 

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  41


Schedule of Investments  (continued)

December 31, 2022

  

BlackRock LifePath® Index 2050 Fund

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the LifePath Index Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the LifePath Index Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the LifePath Index Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Assets

                 

Investments

                 

Investment Companies

                 

Equity Funds

   $ 2,218,246,389        $        $        $ 2,218,246,389  

Fixed-Income Funds

     153,221,621                            153,221,621  

Money Market Funds

     52,017,238                            52,017,238  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $  2,423,485,248        $                 —        $                 —          2,423,485,248  
  

 

 

      

 

 

      

 

 

      

 

 

 

Investments Valued at NAV(a)

                    3,227,132,881  
                 

 

 

 
                  $  5,650,618,129  
                 

 

 

 

 

  (a)

Certain investments of the Fund were fair valued using NAV as a practical expedient or its equivalent as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

See notes to financial statements.

 

 

42  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

December 31, 2022

  

BlackRock LifePath® Index 2055 Fund

(Percentages shown are based on Net Assets)

 

Security   Shares/
Investment Value
    Value  

Investment Companies(a)

   
Equity Funds — 98.9%            

iShares Core MSCI Total International Stock ETF(b)

    20,665,368     $ 1,196,111,500  

iShares Developed Real Estate Index Fund, Class K

    18,134,117       161,393,638  

Large Cap Index Master Portfolio

  $     1,940,060,778       1,940,060,778  

Master Small Cap Index Series

  $ 34,923,955       34,923,955  
   

 

 

 
      3,332,489,871  
Fixed-Income Funds — 1.0%            

iShares TIPS Bond ETF

    73,263       7,798,114  

iShares U.S. Long Credit Bond Index Fund

    2,876,687       26,062,783  
   

 

 

 
      33,860,897  
Security  

 

Shares

     Value  
Money Market Funds — 8.3%             

BlackRock Cash Funds: Institutional, SL Agency Shares, 4.53%(c)(d)

    275,815,659      $ 275,898,404  

BlackRock Cash Funds: Treasury, SL Agency Shares, 4.12%(c)

    2,614,281        2,614,281  
    

 

 

 
     278,512,685  
    

 

 

 

Total Investments — 108.2%
(Cost: $3,355,272,398)

 

     3,644,863,453  

Liabilities in Excess of Other Assets — (8.2)%

 

     (275,056,789
    

 

 

 

Net Assets — 100.0%

 

   $   3,369,806,664  
    

 

 

 

 

(a)

Affiliate of the Fund.

(b)

All or a portion of this security is on loan.

(c)

Annualized 7-day yield as of period end.

(d)

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the LifePath Index Fund during the year ended December 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

                   
       Affiliated Issuer   Value at
12/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
    Shares/
Investment Value
Held at
12/31/22
    Income     Capital Gain
Distributions
from
Underlying
Funds
          
 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $     $  275,873,160 (a)    $     $ 25,201     $ 43     $ 275,898,404       275,815,659     $ 56,177 (b)     $    
 

BlackRock Cash Funds: Treasury, SL Agency Shares

    8,237,127             (5,622,846 )(a)                   2,614,281       2,614,281       127,585          
 

iShares Core MSCI Total International Stock ETF

    1,307,747,686       345,389,617       (210,953,573     (42,529,352     (203,542,878     1,196,111,500       20,665,368       28,257,134          
 

iShares Developed Real Estate Index Fund, Class K

    164,094,511       53,086,114       (12,002,419     (523,847     (43,260,721     161,393,638       18,134,117       1,759,470          
 

iShares TIPS Bond ETF

    6,781,579       2,499,922       (130,364     (3,236     (1,349,787     7,798,114       73,263       446,280          
 

iShares U.S. Long Credit Bond Index Fund

          30,461,606       (1,463,519     (179,207     (2,756,097     26,062,783       2,876,687       727,993          
 

Large Cap Index Master Portfolio

    1,802,473,470       543,537,326 (a)(c)            (22,917,994     (383,032,024     1,940,060,778     $  1,940,060,778       28,162,433          
 

Master Small Cap Index Series

    33,806,031       9,021,941 (a)(c)            (397,193     (7,506,824     34,923,955     $ 34,923,955       465,494          
 

U.S. Total Bond Index Master Portfolio(d)

    26,674,467             (29,587,102 )(a)(c)      (704,626     3,617,261           $       239,523          
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   
          $  ( 67,230,254   $  (637,831,027   $  3,644,863,453       $  60,242,089     $    
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

 

  (a)

Represents net amount purchased (sold).

 
  (b)

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 
  (c)

Inclusive of income and expense allocated from the Master Portfolio.

 
  (d)

As of period end, the entity is no longer held.

 

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  43


Schedule of Investments  (continued)

December 31, 2022

  

BlackRock LifePath® Index 2055 Fund

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the LifePath Index Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the LifePath Index Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the LifePath Index Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

         
      Level 1        Level 2        Level 3        Total  

Assets

                 

Investments

                 

Investment Companies

                 

Equity Funds

   $ 1,357,505,138        $        $        $ 1,357,505,138  

Fixed-Income Funds

     33,860,897                            33,860,897  

Money Market Funds

     278,512,685                            278,512,685  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $  1,669,878,720        $                 —        $                 —          1,669,878,720  
  

 

 

      

 

 

      

 

 

      

 

 

 

Investments Valued at NAV(a)

                    1,974,984,733  
                 

 

 

 
                  $  3,644,863,453  
                 

 

 

 

 

  (a)

Certain investments of the Fund were fair valued using NAV as a practical expedient or its equivalent as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

See notes to financial statements.

 

 

44  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

December 31, 2022

  

BlackRock LifePath® Index 2060 Fund

(Percentages shown are based on Net Assets)

 

Security  

Shares/

Investment Value

    Value  

Investment Companies(a)

 

Equity Funds — 99.0%            

iShares Core MSCI Total International Stock ETF(b)

    9,773,594     $ 565,695,620  

iShares Developed Real Estate Index Fund, Class K

    8,593,693       76,483,865  

Large Cap Index Master Portfolio

  $     914,724,274         914,724,274  

Master Small Cap Index Series

  $ 16,406,516       16,406,516  
   

 

 

 
      1,573,310,275  
Fixed-Income Funds — 1.0%  

iShares TIPS Bond ETF

    21,422       2,280,158  

iShares U.S. Long Credit Bond Index Fund

    1,515,773       13,732,900  
   

 

 

 
      16,013,058  
Security  

 

Shares

    Value  
Money Market Funds — 0.1%            

BlackRock Cash Funds: Institutional, SL Agency Shares, 4.53%(c)(d)

    1,636,908     $ 1,637,400  

BlackRock Cash Funds: Treasury, SL Agency Shares, 4.12%(c)

    862,982       862,982  
   

 

 

 
      2,500,382  
   

 

 

 

Total Investments — 100.1%
(Cost: $1,537,726,976)

 

    1,591,823,715  

Liabilities in Excess of Other Assets — (0.1)%

 

    (2,004,782
   

 

 

 

Net Assets — 100.0%

 

  $   1,589,818,933  
   

 

 

 

 

(a)

Affiliate of the Fund.

(b)

All or a portion of this security is on loan.

(c)

Annualized 7-day yield as of period end.

(d)

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the LifePath Index Fund during the year ended December 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

                   
    Affiliated Issuer   Value at
12/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
    Shares/
Investment Value
Held at
12/31/22
    Income     Capital Gain
Distributions
from
Underlying
Funds
          

    

 

BlackRock Cash
Funds: Institutional, SL
Agency Shares

  $ 66,039,050     $     $ (64,403,282 )(a)    $ (5,534   $ 7,166     $ 1,637,400       1,636,908     $ 4,887 (b)     $    
 

BlackRock Cash
Funds: Treasury, SL Agency
Shares

    2,691,288             (1,828,306 )(a)                  862,982       862,982       67,566          
 

iShares Core MSCI Total
International Stock ETF

    532,536,223       220,482,127       (84,492,543     (17,680,753     (85,149,434     565,695,620       9,773,594       12,643,570          
 

iShares Developed Real
Estate Index Fund, Class K

    66,685,745       33,412,389       (4,866,617     (189,919     (18,557,733     76,483,865       8,593,693       772,448          
 

iShares TIPS Bond ETF

    1,680,763       1,017,396       (60,292     (412     (357,297     2,280,158       21,422       120,028          
 

iShares U.S. Long Credit Bond
Index Fund

          15,829,806       (669,111     (84,310     (1,343,485     13,732,900       1,515,773       363,930          
 

Large Cap Index Master
Portfolio

    730,149,170       356,954,842 (a)(c)            (10,186,322     (162,193,416     914,724,274     $ 914,724,274       12,420,976          
 

Master Small Cap Index
Series

    13,358,342       6,332,936 (a)(c)            (568,477     (2,716,285     16,406,516     $ 16,406,516       205,598          
 

U.S. Total Bond Index Master
Portfolio(d)

    11,880,508             (12,622,584 )(a)(c)      (388,799     1,130,875           $       110,026          
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   
          $  (29,104,526   $  (269,179,609   $  1,591,823,715       $  26,709,029     $             —    
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

 

  (a)

Represents net amount purchased (sold).

 
  (b)

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 
  (c)

Inclusive of income and expense allocated from the Master Portfolio.

 
  (d)

As of period end, the entity is no longer held.

 

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  45


Schedule of Investments  (continued)

December 31, 2022

  

BlackRock LifePath® Index 2060 Fund

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the LifePath Index Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the LifePath Index Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the LifePath Index Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Assets

                 

Investments

                 

Investment Companies

                 

Equity Funds

   $ 642,179,485        $        $        $ 642,179,485  

Fixed-Income Funds

     16,013,058                            16,013,058  

Money Market Funds

     2,500,382                            2,500,382  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $  660,692,925        $                 —        $                 —          660,692,925  
  

 

 

      

 

 

      

 

 

      

 

 

 

Investments Valued at NAV(a)

                    931,130,790  
                 

 

 

 
                  $  1,591,823,715  
                 

 

 

 

 

  (a)

Certain investments of the Fund were fair valued using NAV as a practical expedient or its equivalent as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

See notes to financial statements.

 

 

46  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

December 31, 2022

  

BlackRock LifePath® Index 2065 Fund

(Percentages shown are based on Net Assets)

 

Security   Shares/
Investment Value
    Value  

Investment Companies(a)

   
Equity Funds — 99.0%            

iShares Core MSCI Total International Stock ETF

    1,535,940     $ 88,900,207  

iShares Developed Real Estate Index Fund, Class K

    1,354,730       12,057,092  

Large Cap Index Master Portfolio

  $     143,985,307       143,985,307  

Master Small Cap Index Series

  $ 2,524,461       2,524,461  
   

 

 

 
       247,467,067  
Fixed-Income Funds — 1.0%            

iShares U.S. Long Credit Bond Index Fund

    284,420       2,576,847  
   

 

 

 
Security  

 

Shares

    Value  

Money Market Funds — 0.4%

   

BlackRock Cash Funds: Treasury, SL Agency Shares, 4.12%(b)

    832,979     $ 832,979  
   

 

 

 

Total Investments — 100.4%
(Cost: $254,459,442)

      250,876,893  

Liabilities in Excess of Other Assets — (0.4)%

      (924,116
   

 

 

 

Net Assets — 100.0%

    $  249,952,777  
   

 

 

 

 

(a) 

Affiliate of the Fund.

(b) 

Annualized 7-day yield as of period end.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the LifePath Index Fund during the year ended December 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

    Affiliated Issuer   Value at
12/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
12/31/22
    Shares/
Investment Value
Held at
12/31/22
    Income     Capital Gain
Distributions
from
Underlying
Funds
       

    

 

BlackRock Cash Funds: Treasury, SL Agency Shares

  $ 971,478     $     $ (138,499 )(a)    $     $     $ 832,979       832,979     $ 13,094     $             
 

iShares Core MSCI Total International Stock ETF

    52,862,076       56,957,177       (9,372,077     (2,226,515     (9,320,454     88,900,207       1,535,940       1,727,856          
 

iShares Developed Real Estate Index Fund, Class K

    6,491,326       8,270,441       (412,346     (38,043     (2,254,286     12,057,092       1,354,730       103,106          
 

iShares U.S. Long Credit Bond Index Fund

          2,858,877       (66,967     (2,618     (212,445     2,576,847       284,420       59,477          
 

Large Cap Index Master Portfolio

    72,403,896       91,821,946 (a)(b)            (15,900,607     (4,339,928     143,985,307     $ 143,985,307       1,649,538          
 

Master Small Cap Index Series

    1,379,763       1,541,888 (a)(b)            (407,361     10,171       2,524,461     $ 2,524,461       27,623          
 

U.S. Total Bond Index Master Portfolio(c)

    1,339,518             (1,239,249 )(a)(b)      (47,583     (52,686         $       14,425          
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   
          $ (18,622,727   $ (16,169,628   $ 250,876,893       $ 3,595,119     $  
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

 

  (a)

Represents net amount purchased (sold).

 
  (b)

Inclusive of income and expense allocated from the Master Portfolio.

 
  (c)

As of period end, the entity is no longer held.

 

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  47


Schedule of Investments  (continued)

December 31, 2022

  

BlackRock LifePath® Index 2065 Fund

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the LifePath Index Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the LifePath Index Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the LifePath Index Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Assets

                 

Investments

                 

Investment Companies

                 

Equity Funds

   $ 100,957,299        $        $        $ 100,957,299  

Fixed-Income Funds

     2,576,847                            2,576,847  

Money Market Funds

     832,979                            832,979  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $  104,367,125        $                 —        $                 —          104,367,125  
  

 

 

      

 

 

      

 

 

      

 

 

 

Investments Valued at NAV(a)

                    146,509,768  
                 

 

 

 
                  $  250,876,893  
                 

 

 

 

 

  (a)

Certain investments of the Fund were fair valued using NAV as a practical expedient or its equivalent as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

See notes to financial statements.

 

 

48  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


 

Statements of Assets and Liabilities

December 31, 2022

 

     BlackRock
LifePath® Index
Retirement Fund
     BlackRock
LifePath® Index
2025 Fund
    

BlackRock

LifePath® Index

2030 Fund

     BlackRock
LifePath® Index
2035 Fund
 

ASSETS

          

Investments, at value — affiliated(a)(b)

  $ 7,178,908,367      $ 6,007,103,779      $ 10,073,983,242      $ 6,804,484,256  

Receivables:

          

Investments sold

    65,892,178        68,195,246        117,315,496        97,123,831  

Securities lending income — affiliated

    1,071        2,540        2,523        4,469  

Capital shares sold

    5,270,250        7,451,840        6,410,252        5,747,004  

Dividends — affiliated

    8,707,270        6,633,513        8,848,361        4,408,597  

From the Manager

                         20,319  
 

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

    7,258,779,136        6,089,386,918        10,206,559,874        6,911,788,476  
 

 

 

    

 

 

    

 

 

    

 

 

 

LIABILITIES

          

Collateral on securities loaned

           35,909,267               113,525  

Payables:

          

Investments purchased

    53,004,636        49,594,890        87,977,602        69,913,586  

Administration fees

    351,765        219,063        446,273        244,761  

Capital shares redeemed

    27,684,573        42,247,324        47,333,248        46,429,178  

Investment advisory fees

    67,562        38,630        16,892         

Trustees’ and Officer’s fees

    15,722        12,914        20,607        14,050  

Professional fees

    61,839        63,009        60,833        55,602  

Service fees

    454,071        40,692        403,685        34,066  
 

 

 

    

 

 

    

 

 

    

 

 

 

Total liabilities

    81,640,168        128,125,789        136,259,140        116,804,768  
 

 

 

    

 

 

    

 

 

    

 

 

 

NET ASSETS

  $ 7,177,138,968      $ 5,961,261,129      $  10,070,300,734      $ 6,794,983,708  
 

 

 

    

 

 

    

 

 

    

 

 

 

NET ASSETS CONSIST OF

          

Paid-in capital

  $ 6,554,751,039      $ 5,529,970,147      $ 9,195,279,461      $ 6,283,024,383  

Accumulated earnings

    622,387,929        431,290,982        875,021,273        511,959,325  
 

 

 

    

 

 

    

 

 

    

 

 

 

NET ASSETS

  $ 7,177,138,968      $ 5,961,261,129      $ 10,070,300,734      $ 6,794,983,708  
 

 

 

    

 

 

    

 

 

    

 

 

 

(a) Investments, at cost — affiliated

  $  6,763,945,011      $  5,721,586,114      $ 9,323,805,799      $  6,298,153,218  

(b) Securities loaned, at value

  $      $ 34,859,049      $      $ 109,972  

 

 

F I N A N C I A L   S T A T E M E N T S

  49


 

Statements of Assets and Liabilities  (continued)

December 31, 2022

 

    

BlackRock

LifePath® Index
Retirement Fund

    

BlackRock

LifePath® Index

2025 Fund

    

BlackRock

LifePath® Index

2030 Fund

    

BlackRock

LifePath® Index

2035 Fund

 

NET ASSET VALUE

          

Institutional

          

Net assets

  $ 380,959,372      $ 183,574,979      $ 504,974,076      $ 176,179,226  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares outstanding

    31,217,755        13,461,111        35,065,035        11,473,141  
 

 

 

    

 

 

    

 

 

    

 

 

 

Net asset value

  $ 12.20      $ 13.64      $ 14.40      $ 15.36  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares authorized

    Unlimited        Unlimited        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

    

 

 

 

Par value

    No par value        No par value        No par value        No par value  
 

 

 

    

 

 

    

 

 

    

 

 

 

Investor A

          

Net assets

  $ 171,553,306      $ 105,643,493      $ 180,699,100      $ 119,860,741  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares outstanding

    14,074,379        7,755,391        12,549,559        7,825,328  
 

 

 

    

 

 

    

 

 

    

 

 

 

Net asset value

  $ 12.19      $ 13.62      $ 14.40      $ 15.32  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares authorized

    Unlimited        Unlimited        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

    

 

 

 

Par value

    No par value        No par value        No par value        No par value  
 

 

 

    

 

 

    

 

 

    

 

 

 

Investor P

          

Net assets

  $ 1,912,267,824      $ 87,149,966      $ 1,683,132,344      $ 41,439,381  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares outstanding

    157,034,779        6,412,967        116,991,246        2,711,231  
 

 

 

    

 

 

    

 

 

    

 

 

 

Net asset value

  $ 12.18      $ 13.59      $ 14.39      $ 15.28  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares authorized

    Unlimited        Unlimited        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

    

 

 

 

Par value

    No par value        No par value        No par value        No par value  
 

 

 

    

 

 

    

 

 

    

 

 

 

Class K

          

Net assets

  $  4,712,358,466      $  5,584,892,691      $  7,701,495,214      $  6,457,504,360  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares outstanding

    386,399,598        409,359,972        535,307,503        420,929,854  
 

 

 

    

 

 

    

 

 

    

 

 

 

Net asset value

  $ 12.20      $ 13.64      $ 14.39      $ 15.34  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares authorized

    Unlimited        Unlimited        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

    

 

 

 

Par value

    No par value        No par value        No par value        No par value  
 

 

 

    

 

 

    

 

 

    

 

 

 

 

 

50  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


 

Statements of Assets and Liabilities  (continued)

December 31, 2022

 

   

BlackRock

LifePath® Index

2040 Fund

    

BlackRock

LifePath® Index

2045 Fund

    

BlackRock

LifePath® Index

2050 Fund

    

BlackRock

LifePath® Index

2055 Fund

 

 

 

ASSETS

          

Investments, at value — affiliated(a)(b)

  $ 8,844,410,299      $ 5,460,346,298      $ 5,650,618,129      $ 3,644,863,453  

Receivables:

          

Investments sold

    111,925,717        81,740,244        88,701,068        49,565,829  

Securities lending income — affiliated

    2,041        2,694        3,780        5,066  

Capital shares sold

    6,545,186        5,555,671        6,894,235        4,835,629  

Dividends — affiliated

    3,788,632        1,239,578        458,322        129,939  

From the Manager

    56,228        49,767        55,355        33,936  
 

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

    8,966,728,103        5,548,934,252        5,746,730,889        3,699,433,852  
 

 

 

    

 

 

    

 

 

    

 

 

 

LIABILITIES

          

Collateral on securities loaned

           22,603,443        48,353,266        275,871,785  

Payables:

          

Investments purchased

    92,155,147        59,252,379        62,587,532        33,706,900  

Administration fees

    391,435        195,119        219,817        120,204  

Capital shares redeemed

    36,840,031        32,613,213        37,284,787        19,854,695  

Trustees’ and Officer’s fees

    17,808        11,257        11,515        7,331  

Professional fees

    61,633        50,644        50,416        49,576  

Service fees

    333,154        24,346        122,323        16,697  
 

 

 

    

 

 

    

 

 

    

 

 

 

Total liabilities

    129,799,208        114,750,401        148,629,656        329,627,188  
 

 

 

    

 

 

    

 

 

    

 

 

 

NET ASSETS

  $ 8,836,928,895      $ 5,434,183,851      $ 5,598,101,233      $ 3,369,806,664  
 

 

 

    

 

 

    

 

 

    

 

 

 

NET ASSETS CONSIST OF

          

Paid-in capital

  $ 7,880,855,964      $ 5,002,205,470      $ 5,097,201,934      $ 3,172,367,757  

Accumulated earnings

    956,072,931        431,978,381        500,899,299        197,438,907  
 

 

 

    

 

 

    

 

 

    

 

 

 

NET ASSETS

  $  8,836,928,895      $  5,434,183,851      $  5,598,101,233      $  3,369,806,664  
 

 

 

    

 

 

    

 

 

    

 

 

 

(a) Investments, at cost — affiliated

  $ 7,793,615,733      $ 4,889,388,271      $ 5,002,573,880      $ 3,355,272,398  

(b) Securities loaned, at value

  $      $ 21,912,005      $ 46,671,413      $ 267,237,748  

 

 

F I N A N C I A L   S T A T E M E N T S

  51


 

Statements of Assets and Liabilities  (continued)

December 31, 2022

 

     BlackRock
LifePath® Index
2040 Fund
     BlackRock
LifePath® Index
2045 Fund
     BlackRock
LifePath® Index
2050 Fund
     BlackRock
LifePath® Index
2055 Fund
 

NET ASSET VALUE

          

Institutional

          

Net assets

  $ 592,121,299      $ 146,616,417      $ 132,970,219      $ 111,510,603  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares outstanding

    36,818,138        8,682,843        7,661,498        6,263,565  
 

 

 

    

 

 

    

 

 

    

 

 

 

Net asset value

  $ 16.08      $ 16.89      $ 17.36      $ 17.80  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares authorized

    Unlimited        Unlimited        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

    

 

 

 

Par value

    No par value        No par value        No par value        No par value  
 

 

 

    

 

 

    

 

 

    

 

 

 

Investor A

          

Net assets

  $ 138,977,259      $ 102,379,001      $ 102,123,521      $ 72,842,035  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares outstanding

    8,657,555        6,076,379        5,899,070        4,100,918  
 

 

 

    

 

 

    

 

 

    

 

 

 

Net asset value

  $ 16.05      $ 16.85      $ 17.31      $ 17.76  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares authorized

    Unlimited        Unlimited        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

    

 

 

 

Par value

    No par value        No par value        No par value        No par value  
 

 

 

    

 

 

    

 

 

    

 

 

 

Investor P

          

Net assets

  $ 1,411,638,182      $ 14,412,884      $ 470,795,008      $ 7,427,215  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares outstanding

    88,018,948        857,175        27,219,043        418,717  
 

 

 

    

 

 

    

 

 

    

 

 

 

Net asset value

  $ 16.04      $ 16.81      $ 17.30      $ 17.74  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares authorized

    Unlimited        Unlimited        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

    

 

 

 

Par value

    No par value        No par value        No par value        No par value  
 

 

 

    

 

 

    

 

 

    

 

 

 

Class K

          

Net assets

  $  6,694,192,155      $  5,170,775,549      $  4,892,212,485      $  3,178,026,811  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares outstanding

    416,317,473        305,965,533        281,929,186        178,474,707  
 

 

 

    

 

 

    

 

 

    

 

 

 

Net asset value

  $ 16.08      $ 16.90      $ 17.35      $ 17.81  
 

 

 

    

 

 

    

 

 

    

 

 

 

Shares authorized

    Unlimited        Unlimited        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

    

 

 

 

Par value

    No par value        No par value        No par value        No par value  
 

 

 

    

 

 

    

 

 

    

 

 

 

 

 

52  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


 

Statements of Assets and Liabilities  (continued)

December 31, 2022

 

   

BlackRock

LifePath® Index

2060 Fund

    

BlackRock

LifePath® Index
2065 Fund

 

 

 

ASSETS

    

Investments, at value — affiliated(a)(b)

  $ 1,591,823,715      $ 250,876,893  

Receivables:

    

Investments sold

    22,303,955        2,609,822  

Securities lending income — affiliated

    155         

Capital shares sold

    4,216,609        990,346  

Dividends — affiliated

    68,776        12,768  

From the Manager

    17,044        3,102  
 

 

 

    

 

 

 

Total assets

    1,618,430,254        254,492,931  
 

 

 

    

 

 

 

LIABILITIES

    

Collateral on securities loaned

    1,637,150         

Payables:

    

Investments purchased

    14,746,391        2,190,701  

Administration fees

    54,421        7,056  

Capital shares redeemed

    12,112,486        2,307,798  

Trustees’ and Officer’s fees

    4,317        1,677  

Professional fees

    50,876        31,849  

Service fees

    5,680        1,073  
 

 

 

    

 

 

 

Total liabilities

    28,611,321        4,540,154  
 

 

 

    

 

 

 

NET ASSETS

  $ 1,589,818,933      $ 249,952,777  
 

 

 

    

 

 

 

NET ASSETS CONSIST OF

    

Paid-in capital

  $ 1,585,933,966      $ 272,857,425  

Accumulated earnings (loss)

    3,884,967        (22,904,648
 

 

 

    

 

 

 

NET ASSETS

  $  1,589,818,933      $  249,952,777  
 

 

 

    

 

 

 

(a) Investments, at cost — affiliated

  $ 1,537,726,976      $ 254,459,442  

(b) Securities loaned, at value

  $ 1,585,912      $  

 

 

F I N A N C I A L   S T A T E M E N T S

  53


 

Statements of Assets and Liabilities  (continued)

December 31, 2022

 

     BlackRock
LifePath® Index
2060 Fund
     BlackRock
LifePath® Index
2065 Fund
 

NET ASSET VALUE

    

Institutional

    

Net assets

  $ 37,045,186      $ 10,487,349  
 

 

 

    

 

 

 

Shares outstanding

    2,332,159        939,769  
 

 

 

    

 

 

 

Net asset value

  $ 15.88      $ 11.16  
 

 

 

    

 

 

 

Shares authorized

    Unlimited        Unlimited  
 

 

 

    

 

 

 

Par value

    No par value        No par value  
 

 

 

    

 

 

 

Investor A

    

Net assets

  $ 18,404,995      $ 1,067,522  
 

 

 

    

 

 

 

Shares outstanding

    1,161,248        95,720  
 

 

 

    

 

 

 

Net asset value

  $ 15.85      $ 11.15  
 

 

 

    

 

 

 

Shares authorized

    Unlimited        Unlimited  
 

 

 

    

 

 

 

Par value

    No par value        No par value  
 

 

 

    

 

 

 

Investor P

    

Net assets

  $ 9,662,625      $ 4,282,542  
 

 

 

    

 

 

 

Shares outstanding

    610,185        384,211  
 

 

 

    

 

 

 

Net asset value

  $ 15.84      $ 11.15  
 

 

 

    

 

 

 

Shares authorized

    Unlimited        Unlimited  
 

 

 

    

 

 

 

Par value

    No par value        No par value  
 

 

 

    

 

 

 

Class K

    

Net assets

  $  1,524,706,127      $  234,115,364  
 

 

 

    

 

 

 

Shares outstanding

    95,957,987        20,976,762  
 

 

 

    

 

 

 

Net asset value

  $ 15.89      $ 11.16  
 

 

 

    

 

 

 

Shares authorized

    Unlimited        Unlimited  
 

 

 

    

 

 

 

Par value

    No par value        No par value  
 

 

 

    

 

 

 

See notes to financial statements.

 

 

54  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


 

Statements of Operations

Year Ended December 31, 2022

 

     BlackRock
LifePath® Index
Retirement Fund
    BlackRock
LifePath® Index
2025 Fund
    BlackRock
LifePath® Index
2030 Fund
    BlackRock
LifePath® Index
2035 Fund
 

INVESTMENT INCOME

       

Dividends — affiliated

  $ 129,269,378     $ 102,388,562     $ 160,357,743     $ 97,726,288  

Securities lending income — affiliated — net

    75,575       75,170       108,724       143,883  

Net investment income allocated from the applicable affiliated Underlying Master Portfolio

       

Dividends — affiliated

    29,537,770       27,594,119       56,835,491       44,317,245  

Interest — affiliated

    37,173,540       24,826,597       30,831,602       14,225,070  

Expenses

    (1,353,391     (1,069,259     (1,804,005     (1,213,669

Fees waived

    169,478       116,690       154,814       79,260  
 

 

 

   

 

 

   

 

 

   

 

 

 

Total investment income

    194,872,350       153,931,879       246,484,369       155,278,077  
 

 

 

   

 

 

   

 

 

   

 

 

 

EXPENSES

       

Service — class specific

    5,912,056       536,509       5,129,048       432,514  

Administration — class specific

    4,555,298       2,713,220       5,447,649       2,907,835  

Investment advisory

    3,948,834       3,135,914       5,191,897       3,416,601  

Trustees and Officer

    54,830       42,789       77,351       51,887  

Professional

    21,705       22,354       23,425       22,354  

Miscellaneous

    4,594       4,635       4,634       4,635  
 

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses

    14,497,317       6,455,421       15,874,004       6,835,826  

Less:

       

Fees waived and/or reimbursed by the Administrator/Manager

    (3,560,004     (2,980,762     (5,374,143     (3,808,113
 

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    10,937,313       3,474,659       10,499,861       3,027,713  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    183,935,037       150,457,220       235,984,508       152,250,364  
 

 

 

   

 

 

   

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

       

Net realized gain (loss) from:

       

Investments — unaffiliated

    105,238       65,252       150,708        

Investments — affiliated

    (29,661,553     (21,497,101     (42,375,574     (46,942,343

Net realized gain (loss) from investments, futures contracts, forward foreign currency exchange contracts and foreign currency transactions allocated from the applicable affiliated Underlying Master Portfolio

    (45,361,451     (61,103,184     (84,577,479     (61,512,527
 

 

 

   

 

 

   

 

 

   

 

 

 
    (74,917,766     (82,535,033     (126,802,345     (108,454,870
 

 

 

   

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation) on:

       

Investments — affiliated

    (615,179,063     (515,642,433     (894,674,143     (584,182,285

Net change in unrealized appreciation (depreciation) from investments, futures contracts, forward foreign currency exchange contracts and foreign currency translations allocated from the applicable affiliated Underlying Master Portfolio

    (876,693,912     (666,042,291     (1,141,839,139     (756,184,397
 

 

 

   

 

 

   

 

 

   

 

 

 
    (1,491,872,975     (1,181,684,724     (2,036,513,282     (1,340,366,682
 

 

 

   

 

 

   

 

 

   

 

 

 

Net realized and unrealized loss

    (1,566,790,741     (1,264,219,757     (2,163,315,627     (1,448,821,552
 

 

 

   

 

 

   

 

 

   

 

 

 

NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $ (1,382,855,704   $ (1,113,762,537   $ (1,927,331,119   $ (1,296,571,188
 

 

 

   

 

 

   

 

 

   

 

 

 

See notes to financial statements.

 

 

F I N A N C I A L   S T A T E M E N T S

  55


 

Statements of Operations  (continued)

Year Ended December 31, 2022

 

     BlackRock
LifePath® Index
2040 Fund
    BlackRock
LifePath® Index
2045 Fund
    BlackRock
LifePath® Index
2050 Fund
    BlackRock
LifePath® Index
2055 Fund
 

INVESTMENT INCOME

       

Dividends — affiliated

  $ 115,606,760     $ 61,382,291     $ 55,682,790     $ 31,318,462  

Securities lending income — affiliated — net

    115,697       57,262       62,639       56,177  

Net investment income allocated from the applicable affiliated Underlying Master Portfolio

       

Dividends — affiliated

    66,533,775       44,505,318       48,095,900       28,543,634  

Interest — affiliated

    11,756,737       3,903,525       1,947,698       925,512  

Expenses

    (1,635,486     (1,018,958     (1,051,388     (618,179

Fees waived

    78,572       36,842       29,573       16,483  
 

 

 

   

 

 

   

 

 

   

 

 

 

Total investment income

    192,456,055       108,866,280       104,767,212       60,242,089  
 

 

 

   

 

 

   

 

 

   

 

 

 

EXPENSES

       

Administration — class specific

    4,725,447       2,285,727       2,563,525       1,379,235  

Investment advisory

    4,475,374       2,693,037       2,744,462       1,606,518  

Service — class specific

    4,186,145       297,999       1,521,673       203,607  

Trustees and Officer

    63,269       41,229       42,022       28,486  

Professional

    22,995       21,991       22,019       21,378  

Miscellaneous

    4,635       5,010       5,010       4,510  
 

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses

    13,477,865       5,344,993       6,898,711       3,243,734  

Less:

       

Fees waived and/or reimbursed by the Administrator/Manager

    (5,245,266     (3,286,465     (3,379,656     (1,993,753
 

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    8,232,599       2,058,528       3,519,055       1,249,981  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    184,223,456       106,807,752       101,248,157       58,992,108  
 

 

 

   

 

 

   

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

       

Net realized loss from:

       

Investments — unaffiliated

          (1,018            

Investments — affiliated

    (76,041,128     (63,334,985     (69,446,131     (43,210,441

Net realized gain (loss) from investments, futures contracts, forward foreign currency exchange contracts and foreign currency transactions allocated from the applicable affiliated Underlying Master Portfolio

    (67,115,654     (44,551,790     (40,483,454     (24,019,813
 

 

 

   

 

 

   

 

 

   

 

 

 
    (143,156,782     (107,887,793     (109,929,585     (67,230,254
 

 

 

   

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation) on:

       

Investments — affiliated

    (780,041,815     (448,787,917     (445,138,976     (250,909,440

Net change in unrealized appreciation (depreciation) from investments, futures contracts, forward foreign currency exchange contracts and foreign currency translations allocated from the applicable affiliated Underlying Master Portfolio

    (1,046,489,986     (637,342,293     (668,848,011     (386,921,587
 

 

 

   

 

 

   

 

 

   

 

 

 
    (1,826,531,801     (1,086,130,210     (1,113,986,987     (637,831,027
 

 

 

   

 

 

   

 

 

   

 

 

 

Net realized and unrealized loss

    (1,969,688,583     (1,194,018,003     (1,223,916,572     (705,061,281
 

 

 

   

 

 

   

 

 

   

 

 

 

NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $ (1,785,465,127   $ (1,087,210,251   $ (1,122,668,415   $ (646,069,173
 

 

 

   

 

 

   

 

 

   

 

 

 

See notes to financial statements.

 

 

56  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


 

Statements of Operations  (continued)

Year Ended December 31, 2022

 

     BlackRock
LifePath® Index
2060 Fund
    BlackRock
LifePath® Index
2065 Fund
 

INVESTMENT INCOME

   

Dividends — affiliated

  $ 13,967,542     $ 1,903,533  

Securities lending income — affiliated — net

    4,887        

Net investment income allocated from the applicable affiliated Underlying Master Portfolio

   

Dividends — affiliated

    12,583,459       1,669,468  

Interest — affiliated

    417,656       56,979  

Expenses

    (271,783     (35,823

Fees waived

    7,268       962  
 

 

 

   

 

 

 

Total investment income

    26,709,029       3,595,119  
 

 

 

   

 

 

 

EXPENSES

   

Investment advisory

    704,310       92,289  

Administration — class specific

    593,268       80,121  

Service — class specific

    67,312       10,749  

Professional

    20,970       22,072  

Trustees and Officer

    15,576       6,354  

Miscellaneous

    2,135       171  
 

 

 

   

 

 

 

Total expenses

    1,403,571       211,756  

Less:

   

Fees waived and/or reimbursed by the Administrator/Manager

    (897,163     (144,265
 

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    506,408       67,491  
 

 

 

   

 

 

 

Net investment income

    26,202,621       3,527,628  
 

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

   

Net realized loss from:

   

Investments — affiliated

    (17,960,928     (2,267,176

Net realized gain (loss) from investments, futures contracts, forward foreign currency exchange contracts and foreign currency transactions allocated from the applicable affiliated Underlying Master Portfolio

    (11,143,598     (16,355,551
 

 

 

   

 

 

 
    (29,104,526     (18,622,727
 

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation) on:

   

Investments — affiliated

    (105,400,783     (11,787,185

Net change in unrealized appreciation (depreciation) from investments, futures contracts, forward foreign currency exchange contracts and foreign currency translations allocated from the applicable affiliated Underlying Master Portfolio

    (163,778,826     (4,382,443
 

 

 

   

 

 

 
    (269,179,609     (16,169,628
 

 

 

   

 

 

 

Net realized and unrealized loss

    (298,284,135     (34,792,355
 

 

 

   

 

 

 

NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $ (272,081,514   $ (31,264,727
 

 

 

   

 

 

 

See notes to financial statements.

 

 

F I N A N C I A L   S T A T E M E N T S

  57


 

Statements of Changes in Net Assets

 

    BlackRock
LifePath® Index
Retirement Fund
           BlackRock
LifePath® Index
2025 Fund
 
    

Year Ended

12/31/22

   

Year Ended

12/31/21

           

Year Ended

12/31/22

   

Year Ended

12/31/21

 

INCREASE (DECREASE) IN NET ASSETS

          

OPERATIONS

          

Net investment income

  $ 183,935,037     $ 186,233,814        $ 150,457,220     $ 142,956,861  

Net realized gain (loss)

    (74,917,766     62,066,930          (82,535,033     30,715,055  

Net change in unrealized appreciation (depreciation)

    (1,491,872,975     338,552,052          (1,181,684,724     377,361,825  
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

    (1,382,855,704     586,852,796          (1,113,762,537     551,033,741  
 

 

 

   

 

 

      

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

          

Institutional

    (10,520,771     (15,134,462        (4,584,259     (5,617,714

Investor A

    (4,331,472     (6,282,398        (2,455,320     (3,521,386

Investor P

    (48,257,638     (66,966,390        (2,000,705     (2,048,991

Class K

    (130,483,386     (164,684,311        (141,953,512     (160,637,154
 

 

 

   

 

 

      

 

 

   

 

 

 

Decrease in net assets resulting from distributions to shareholders

    (193,593,267     (253,067,561        (150,993,796     (171,825,245
 

 

 

   

 

 

      

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

          

Net increase (decrease) in net assets derived from capital share transactions

    (331,626,403     50,581,543          243,809,939       692,163,769  
 

 

 

   

 

 

      

 

 

   

 

 

 

NET ASSETS

          

Total increase (decrease) in net assets

    (1,908,075,374     384,366,778          (1,020,946,394     1,071,372,265  

Beginning of year

    9,085,214,342       8,700,847,564          6,982,207,523       5,910,835,258  
 

 

 

   

 

 

      

 

 

   

 

 

 

End of year

  $  7,177,138,968     $  9,085,214,342        $  5,961,261,129     $  6,982,207,523  
 

 

 

   

 

 

      

 

 

   

 

 

 

 

(a)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

58  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


 

Statements of Changes in Net Assets  (continued)

 

    BlackRock
LifePath® Index
2030 Fund
           BlackRock
LifePath® Index
2035 Fund
 
    

Year Ended

12/31/22

   

Year Ended

12/31/21

           

Year Ended

12/31/22

   

Year Ended

12/31/21

 

INCREASE (DECREASE) IN NET ASSETS

          

OPERATIONS

          

Net investment income

  $ 235,984,508     $ 227,192,856        $ 152,250,364     $ 145,819,750  

Net realized gain (loss)

    (126,802,345     51,486,705          (108,454,870     22,923,213  

Net change in unrealized appreciation (depreciation)

    (2,036,513,282     839,878,945          (1,340,366,682     652,507,916  
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

    (1,927,331,119     1,118,558,506          (1,296,571,188     821,250,879  
 

 

 

   

 

 

      

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

          

Institutional

    (12,609,861     (17,004,693        (3,971,857     (4,557,414

Investor A

    (4,064,285     (5,769,193        (2,540,945     (3,493,199

Investor P

    (38,598,312     (51,485,648        (861,635     (817,094

Class K

    (191,709,058     (212,710,745        (150,431,754     (160,833,130
 

 

 

   

 

 

      

 

 

   

 

 

 

Decrease in net assets resulting from distributions to shareholders

    (246,981,516     (286,970,279        (157,806,191     (169,700,837
 

 

 

   

 

 

      

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

          

Net increase in net assets derived from capital share transactions

    806,214,328       1,128,649,673          940,698,810       1,142,213,455  
 

 

 

   

 

 

      

 

 

   

 

 

 

NET ASSETS

          

Total increase (decrease) in net assets

    (1,368,098,307     1,960,237,900          (513,678,569     1,793,763,497  

Beginning of year

    11,438,399,041       9,478,161,141          7,308,662,277       5,514,898,780  
 

 

 

   

 

 

      

 

 

   

 

 

 

End of year

  $  10,070,300,734     $  11,438,399,041        $  6,794,983,708     $  7,308,662,277  
 

 

 

   

 

 

      

 

 

   

 

 

 

 

(a)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

F I N A N C I A L   S T A T E M E N T S

  59


 

Statements of Changes in Net Assets  (continued)

 

    BlackRock
LifePath® Index
2040 Fund
           BlackRock
LifePath® Index
2045 Fund
 
    

Year Ended

12/31/22

   

Year Ended

12/31/21

           

Year Ended

12/31/22

   

Year Ended

12/31/21

 

INCREASE (DECREASE) IN NET ASSETS

          

OPERATIONS

          

Net investment income

  $ 184,223,456     $ 193,268,329        $ 106,807,752     $ 113,858,722  

Net realized gain (loss)

    (143,156,782     36,932,763          (107,887,793     15,586,682  

Net change in unrealized appreciation (depreciation)

    (1,826,531,801     1,065,414,039          (1,086,130,210     677,322,924  
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

    (1,785,465,127     1,295,615,131          (1,087,210,251     806,768,328  
 

 

 

   

 

 

      

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

          

Institutional

    (13,282,237     (17,361,244        (2,767,676     (3,582,922

Investor A

    (2,764,924     (4,008,410        (1,748,465     (2,643,501

Investor P

    (28,834,129     (38,709,980        (220,096     (250,532

Class K

    (150,192,476     (168,518,667        (101,390,471     (124,143,549
 

 

 

   

 

 

      

 

 

   

 

 

 

Decrease in net assets resulting from distributions to shareholders

    (195,073,766     (228,598,301        (106,126,708     (130,620,504
 

 

 

   

 

 

      

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

          

Net increase in net assets derived from capital share transactions

    1,024,962,475       928,790,520          856,813,921       876,051,772  
 

 

 

   

 

 

      

 

 

   

 

 

 

NET ASSETS

          

Total increase (decrease) in net assets

    (955,576,418     1,995,807,350          (336,523,038     1,552,199,596  

Beginning of year

    9,792,505,313       7,796,697,963          5,770,706,889       4,218,507,293  
 

 

 

   

 

 

      

 

 

   

 

 

 

End of year

  $  8,836,928,895     $  9,792,505,313        $  5,434,183,851     $  5,770,706,889  
 

 

 

   

 

 

      

 

 

   

 

 

 

 

(a)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

60  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


 

Statements of Changes in Net Assets  (continued)

 

    BlackRock
LifePath® Index
2050 Fund
           BlackRock
LifePath® Index
2055 Fund
 
    

Year Ended

12/31/22

   

Year Ended

12/31/21

           

Year Ended

12/31/22

   

Year Ended

12/31/21

 

INCREASE (DECREASE) IN NET ASSETS

          

OPERATIONS

          

Net investment income

  $ 101,248,157     $ 113,602,664        $ 58,992,108     $ 63,903,933  

Net realized gain (loss)

    (109,929,585     19,464,992          (67,230,254     8,646,505  

Net change in unrealized appreciation (depreciation)

    (1,113,986,987     729,563,580          (637,831,027     402,097,521  
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

    (1,122,668,415     862,631,236          (646,069,173     474,647,959  
 

 

 

   

 

 

      

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

          

Institutional

    (2,472,803     (3,355,283        (2,021,394     (2,261,929

Investor A

    (1,758,287     (2,391,539        (1,184,877     (1,567,004

Investor P

    (8,272,052     (11,302,061        (112,278     (107,710

Class K

    (95,603,262     (106,023,764        (59,146,049     (62,033,583
 

 

 

   

 

 

      

 

 

   

 

 

 

Decrease in net assets resulting from distributions to shareholders

    (108,106,404     (123,072,647        (62,464,598     (65,970,226
 

 

 

   

 

 

      

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

          

Net increase in net assets derived from capital share transactions

    966,629,172       788,237,812          744,042,079       630,204,790  
 

 

 

   

 

 

      

 

 

   

 

 

 

NET ASSETS

          

Total increase (decrease) in net assets

    (264,145,647     1,527,796,401          35,508,308       1,038,882,523  

Beginning of year

    5,862,246,880       4,334,450,479          3,334,298,356       2,295,415,833  
 

 

 

   

 

 

      

 

 

   

 

 

 

End of year

  $  5,598,101,233     $  5,862,246,880        $  3,369,806,664     $  3,334,298,356  
 

 

 

   

 

 

      

 

 

   

 

 

 

 

(a)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

F I N A N C I A L   S T A T E M E N T S

  61


 

Statements of Changes in Net Assets  (continued)

 

    BlackRock
LifePath® Index
2060 Fund
           BlackRock
LifePath® Index
2065 Fund
 
     Year Ended
12/31/22
    Year Ended
12/31/21
            Year Ended
12/31/22
    Year Ended
12/31/21
 

INCREASE (DECREASE) IN NET ASSETS

          

OPERATIONS

          

Net investment income

  $ 26,202,621     $ 25,184,094        $ 3,527,628     $ 1,880,819  

Net realized gain (loss)

    (29,104,526     2,438,042          (18,622,727     (221,336

Net change in unrealized appreciation (depreciation)

    (269,179,609     152,481,758          (16,169,628     8,831,055  
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

    (272,081,514     180,103,894          (31,264,727     10,490,538  
 

 

 

   

 

 

      

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

          

Institutional

    (589,785     (709,121        (153,389     (96,341

Investor A

    (264,596     (352,814        (11,976     (6,821

Investor P

    (134,218     (128,935        (55,022     (36,953

Class K

    (25,102,756     (24,176,955        (3,302,893     (1,750,092
 

 

 

   

 

 

      

 

 

   

 

 

 

Decrease in net assets resulting from distributions to shareholders

    (26,091,355     (25,367,825        (3,523,280     (1,890,207
 

 

 

   

 

 

      

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

          

Net increase in net assets derived from capital share transactions

    537,957,371       384,319,385          150,818,250       100,202,728  
 

 

 

   

 

 

      

 

 

   

 

 

 

NET ASSETS

          

Total increase in net assets

    239,784,502       539,055,454          116,030,243       108,803,059  

Beginning of year

    1,350,034,431       810,978,977          133,922,534       25,119,475  
 

 

 

   

 

 

      

 

 

   

 

 

 

End of year

  $  1,589,818,933     $  1,350,034,431        $  249,952,777     $  133,922,534  
 

 

 

   

 

 

      

 

 

   

 

 

 

 

(a)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

62  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index Retirement Fund  
    Institutional  
     Year Ended
12/31/22
    Year Ended
12/31/21
    Year Ended
12/31/20
    Year Ended
12/31/19
        
Year Ended
12/31/18
 

Net asset value, beginning of year

  $ 14.79     $ 14.24     $ 13.05     $ 11.55     $ 12.26  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.31       0.31       0.26       0.37       0.30  

Net realized and unrealized gain (loss)

    (2.57     0.66       1.30       1.44       (0.73
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.26     0.97       1.56       1.81       (0.43
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.31     (0.31     (0.27     (0.30     (0.27

From net realized gain

    (0.02     (0.11     (0.10     (0.01     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.33     (0.42     (0.37     (0.31     (0.28
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 12.20     $ 14.79     $ 14.24     $ 13.05     $ 11.55  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (15.31 )%      6.86     12.16     15.84     (3.55 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.16     0.17     0.18     0.17 %(e)       0.18 %(f)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.11     0.11     0.11     0.12 %(e)       0.12 %(f)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    2.35     2.11     1.98     2.92     2.51
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $  380,959     $  533,068     $  546,055     $  532,913     $  145,418  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    71 %(g)       9 %(g)       20 %(h)       13 %(i)       25 %(i)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes reorganization cost. Without this cost, total expenses and total expenses after fees waived and/or reimbursed would have been 0.17% and 0.12%, respectively.

(f) 

Includes reorganization, offering, and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.17% and 0.12%, respectively.

(g) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(i) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  63


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index Retirement Fund (continued)  
    Investor A  
     Year Ended
12/31/22
    Year Ended
12/31/21
    Year Ended
12/31/20
    Year Ended
12/31/19
        
Year Ended
12/31/18
 

Net asset value, beginning of year

  $ 14.77     $ 14.22     $ 13.04     $ 11.54     $ 12.25  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.27       0.27       0.23       0.34       0.27  

Net realized and unrealized gain (loss)

    (2.55     0.67       1.29       1.45       (0.73
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.28     0.94       1.52       1.79       (0.46
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.28     (0.28     (0.24     (0.28     (0.24

From net realized gain

    (0.02     (0.11     (0.10     (0.01     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.30     (0.39     (0.34     (0.29     (0.25
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 12.19     $ 14.77     $ 14.22     $ 13.04     $ 11.54  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (15.48 )%      6.60     11.81     15.60     (3.80 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.41     0.42     0.43     0.47 %(e)       0.44 %(f) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.36     0.36     0.36     0.37 %(e)       0.38 %(f) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    2.10     1.85     1.72     2.67     2.24
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $  171,553     $  232,876     $  256,714     $  306,254     $  82,454  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    71 %(g)       9 %(g)       20 %(h)       13 %(i)       25 %(i)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes reorganization cost. Without this cost, total expenses and total expenses after fees waived and/or reimbursed would have been 0.47% and 0.37%, respectively.

(f) 

Includes reorganization, offering, and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed have been 0.43% and 0.38%, respectively.

(g) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(i) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

64  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index Retirement Fund (continued)  
    Investor P  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

Period from
08/06/18

to 12/31/18

 
(a)  

 

Net asset value, beginning of period

  $ 14.76     $ 14.21     $ 13.02     $ 11.53     $ 12.23  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.27       0.27       0.23       0.34       0.12  

Net realized and unrealized gain (loss)

    (2.55     0.67       1.30       1.43       (0.67
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.28     0.94       1.53       1.77       (0.55
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(c)

         

From net investment income

    (0.28     (0.28     (0.24     (0.27     (0.14

From net realized gain

    (0.02     (0.11     (0.10     (0.01     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.30     (0.39     (0.34     (0.28     (0.15
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 12.18     $ 14.76     $ 14.21     $ 13.02     $ 11.53  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

         

Based on net asset value

    (15.49 )%      6.61     11.90     15.52     (4.56 )%(e) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

         

Total expenses

    0.41     0.42     0.43     0.42 %(g)       0.41 %(h)(i)(j) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.36     0.36     0.36     0.37 %(g)       0.36 %(h)(i)(j) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    2.11     1.86     1.73     2.67     2.47 %(i)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of period (000)

  $  1,912,268     $  2,580,045     $  2,590,635     $  2,547,420     $  912,090  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    71 %(k)       9 %(k)       20 %(l)       13 %(m)       25 %(m)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Includes reorganization cost. Without this cost, total expenses and total expenses after fees waived and/or reimbursed would have been 0.41% and 0.37%, respectively.

(h) 

Reorganization, offering, and board realignment and consolidation costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses and total expenses after fees waived and/or reimbursed would have been 0.42% and 0.37%, respectively.

(i) 

Annualized.

(j) 

Includes reorganization, offering, and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.39% and 0.36%, respectively.

(k) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(l) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(m) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  65


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index Retirement Fund (continued)  
    Class K  
     Year Ended
12/31/22
    Year Ended
12/31/21
    Year Ended
12/31/20
    Year Ended
12/31/19
        
Year Ended
12/31/18
 

Net asset value, beginning of year

  $ 14.78     $ 14.23     $ 13.04     $ 11.54     $ 12.25  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.32       0.32       0.27       0.38       0.31  

Net realized and unrealized gain (loss)

    (2.56     0.66       1.30       1.44       (0.73
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.24     0.98       1.57       1.82       (0.42
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.32     (0.32     (0.28     (0.31     (0.28

From net realized gain

    (0.02     (0.11     (0.10     (0.01     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.34     (0.43     (0.38     (0.32     (0.29
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 12.20     $ 14.78     $ 14.23     $ 13.04     $ 11.54  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (15.20 )%      6.92     12.22     15.90     (3.51 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.11     0.12     0.12     0.11 %(e)       0.13 %(f)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.06     0.06     0.06     0.07 %(e)       0.08 %(f)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    2.43     2.17     2.03     2.96     2.54
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $  4,712,358     $  5,739,227     $  5,307,443     $  4,462,412     $  1,160,344  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    71 %(g)       9 %(g)       20 %(h)       13 %(i)       25 %(i)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes reorganization cost. Without this cost, total expenses and total expenses after fees waived and/or reimbursed would have been 0.11% and 0.07%, respectively.

(f) 

Includes reorganization, offering, and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.12% and 0.08%, respectively.

(g) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(i) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

66  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2025 Fund  
    Institutional  
     Year Ended
12/31/22
    Year Ended
12/31/21
    Year Ended
12/31/20
    Year Ended
12/31/19
        
Year Ended
12/31/18
 

Net asset value, beginning of year

  $ 16.61     $ 15.64     $ 14.24     $ 12.35     $ 13.31  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.34       0.35       0.28       0.37       0.32  

Net realized and unrealized gain (loss)

    (2.96     1.03       1.46       1.94       (0.95
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.62     1.38       1.74       2.31       (0.63
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.34     (0.34     (0.28     (0.36     (0.30

From net realized gain

    (0.01     (0.07     (0.06     (0.06     (0.03
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.35     (0.41     (0.34     (0.42     (0.33
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 13.64     $ 16.61     $ 15.64     $ 14.24     $ 12.35  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (15.81 )%      8.89     12.44     18.84     (4.83 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.16     0.17     0.17     0.16     0.16
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.11     0.11     0.10     0.11     0.12
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    2.35     2.12     1.94     2.69     2.41
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $  183,575     $  227,070     $  220,702     $  189,202     $  104,908  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    64 %(e)       11 %(e)       16 %(f)       11 %(g)       11 %(g)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(f) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  67


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2025 Fund (continued)  
    Investor A  
     Year Ended
12/31/22
    Year Ended
12/31/21
    Year Ended
12/31/20
    Year Ended
12/31/19
        
Year Ended
12/31/18
 

Net asset value, beginning of year

  $ 16.58     $ 15.62     $ 14.22     $ 12.33     $ 13.29  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.30       0.30       0.24       0.32       0.28  

Net realized and unrealized gain (loss)

    (2.95     1.03       1.47       1.96       (0.94
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.65     1.33       1.71       2.28       (0.66
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.30     (0.30     (0.25     (0.33     (0.27

From net realized gain

    (0.01     (0.07     (0.06     (0.06     (0.03
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.31     (0.37     (0.31     (0.39     (0.30
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 13.62     $ 16.58     $ 15.62     $ 14.22     $ 12.33  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (16.01 )%      8.55     12.18     18.59     (5.08 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.41     0.42     0.41     0.42     0.41
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.36     0.36     0.35     0.36     0.37
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    2.07     1.84     1.69     2.37     2.10
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $  105,643     $  148,954     $  167,418     $  157,606     $  119,566  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    64 %(e)       11 %(e)       16 %(f)       11 %(g)       11 %(g)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(f) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

68  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2025 Fund (continued)  
    Investor P  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

Period from
08/06/18

to 12/31/18

 
(a)  

 

Net asset value, beginning of period

  $ 16.55     $ 15.59     $ 14.20     $ 12.32     $ 13.38  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.31       0.31       0.24       0.35       0.17  

Net realized and unrealized gain (loss)

    (2.96     1.03       1.46       1.93       (1.04
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.65     1.34       1.70       2.28       (0.87
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(c)

         

From net investment income

    (0.30     (0.31     (0.25     (0.34     (0.16

From net realized gain

    (0.01     (0.07     (0.06     (0.06     (0.03
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.31     (0.38     (0.31     (0.40     (0.19
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 13.59     $ 16.55     $ 15.59     $ 14.20     $ 12.32  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

         

Based on net asset value

    (16.03 )%      8.60     12.15     18.60     (6.57 )%(e) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

         

Total expenses

    0.41     0.42     0.42     0.41     0.40 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.36     0.36     0.35     0.36     0.35 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    2.11     1.93     1.72     2.59     3.53 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of period (000)

  $  87,150     $  100,306     $  63,916     $  34,190     $  1,810  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    64 %(h)       11 %(h)       16 %(i)       11 %(j)       11 %(j)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(i) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(j) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  69


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2025 Fund (continued)  
    Class K  
     Year Ended
12/31/22
    Year Ended
12/31/21
    Year Ended
12/31/20
    Year Ended
12/31/19
        
Year Ended
12/31/18
 

Net asset value, beginning of year

  $ 16.61     $ 15.64     $ 14.25     $ 12.35     $ 13.31  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.35       0.36       0.29       0.36       0.33  

Net realized and unrealized gain (loss)

    (2.96     1.03       1.45       1.97       (0.95
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.61     1.39       1.74       2.33       (0.62
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.35     (0.35     (0.29     (0.37     (0.31

From net realized gain

    (0.01     (0.07     (0.06     (0.06     (0.03
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.36     (0.42     (0.35     (0.43     (0.34
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 13.64     $ 16.61     $ 15.64     $ 14.25     $ 12.35  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (15.77 )%      8.94     12.42     18.98     (4.78 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.11     0.12     0.12     0.10     0.11
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.06     0.06     0.05     0.06     0.07
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    2.41     2.19     2.00     2.68     2.47
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $  5,584,893     $  6,505,877     $  5,458,799     $  4,134,270     $  2,777,710  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    64 %(e)       11 %(e)       16 %(f)       11 %(g)       11 %(g)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(f) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

70  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2030 Fund  
    Institutional  
     Year Ended
12/31/22
    Year Ended
12/31/21
    Year Ended
12/31/20
    Year Ended
12/31/19
        
Year Ended
12/31/18
 

Net asset value, beginning of year

  $ 17.68     $ 16.30     $ 14.72     $ 12.57     $ 13.62  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.35       0.37       0.28       0.37       0.38  

Net realized and unrealized gain (loss)

    (3.27     1.47       1.60       2.25       (1.13
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.92     1.84       1.88       2.62       (0.75
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.34     (0.37     (0.28     (0.38     (0.29

From net realized gain

    (0.02     (0.09     (0.02     (0.09     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.36     (0.46     (0.30     (0.47     (0.30
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 14.40     $ 17.68     $ 16.30     $ 14.72     $ 12.57  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (16.49 )%      11.35     13.05     21.00     (5.60 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.16     0.16     0.16     0.17     0.16 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.11     0.10     0.10     0.11     0.11 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    2.26     2.14     1.91     2.66     2.82
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $  504,974     $  661,550     $  610,774     $  561,902     $  393,584  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    50 %(f)       9 %(f)       14 %(g)       14 %(h)       15 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes reorganization, offering, and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.15% and 0.11%, respectively.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  71


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2030 Fund (continued)  
    Investor A  
     Year Ended
12/31/22
    Year Ended
12/31/21
    Year Ended
12/31/20
    Year Ended
12/31/19
        
Year Ended
12/31/18
 

Net asset value, beginning of year

  $ 17.68     $ 16.29     $ 14.72     $ 12.56     $ 13.62  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.31       0.32       0.24       0.33       0.30  

Net realized and unrealized gain (loss)

    (3.27     1.48       1.60       2.26       (1.09
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.96     1.80       1.84       2.59       (0.79
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.30     (0.32     (0.25     (0.34     (0.26

From net realized gain

    (0.02     (0.09     (0.02     (0.09     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.32     (0.41     (0.27     (0.43     (0.27
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 14.40     $ 17.68     $ 16.29     $ 14.72     $ 12.56  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (16.71 )%      11.13     12.70     20.81     (5.92 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.41     0.41     0.42     0.47     0.41 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.35     0.35     0.36     0.36 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.99     1.85     1.65     2.36     2.23
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $  180,699     $  235,293     $  251,040     $  343,033     $  283,011  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    50 %(f)       9 %(f)       14 %(g)       14 %(h)       15 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes reorganization, offering, and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.40% and 0.36%, respectively.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

72  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2030 Fund (continued)  
    Investor P  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

Period from

08/06/18

to 12/31/18

 

(a) 

 

Net asset value, beginning of period

  $ 17.66     $ 16.28     $ 14.71     $ 12.56     $ 13.77  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.31       0.32       0.24       0.33       0.21  

Net realized and unrealized gain (loss)

    (3.26     1.47       1.60       2.25       (1.27
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.95     1.79       1.84       2.58       (1.06
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(c)

         

From net investment income

    (0.30     (0.32     (0.25     (0.34     (0.15

From net realized gain

    (0.02     (0.09     (0.02     (0.09     (0.00 )(d)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.32     (0.41     (0.27     (0.43     (0.15
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 14.39     $ 17.66     $ 16.28     $ 14.71     $ 12.56  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(e)

         

Based on net asset value

    (16.68 )%      11.08     12.70     20.72     (7.73 )%(f)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(g)

         

Total expenses

    0.41     0.41     0.41     0.41     0.39 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.35     0.35     0.36     0.35 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    2.00     1.88     1.66     2.35     3.95 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of period (000)

  $  1,683,132     $  2,196,216     $  2,104,701     $  2,003,430     $  1,802,660  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    50 %(i)       9 %(i)       14 %(j)       14 %(k)       15 %(k)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Amount is greater than $(0.005) per share.

(e) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(f) 

Not annualized.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

(i) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(j) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(k) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  73


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2030 Fund (continued)  
    Class K  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 17.66     $ 16.28     $ 14.71     $ 12.56     $ 13.61  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.36       0.38       0.29       0.38       0.34  

Net realized and unrealized gain (loss)

    (3.26     1.47       1.59       2.25       (1.08
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.90     1.85       1.88       2.63       (0.74
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.35     (0.38     (0.29     (0.39     (0.30

From net realized gain

    (0.02     (0.09     (0.02     (0.09     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.37     (0.47     (0.31     (0.48     (0.31
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 14.39     $ 17.66     $ 16.28     $ 14.71     $ 12.56  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (16.41 )%      11.42     13.05     21.08     (5.56 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.11     0.11     0.11     0.10     0.11 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.06     0.05     0.05     0.06     0.06 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    2.34     2.22     1.97     2.70     2.55
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $  7,701,495     $  8,345,340     $  6,511,647     $  4,892,278     $  3,250,556  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    50 %(f)       9 %(f)       14 %(g)       14 %(h)       15 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes reorganization, offering, and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.10% and 0.06%, respectively.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

74  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2035 Fund  
    Institutional  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 18.96     $ 17.07     $ 15.33     $ 12.88     $ 14.08  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.36       0.40       0.28       0.40       0.34  

Net realized and unrealized gain (loss)

    (3.59     1.94       1.76       2.55       (1.23
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.23     2.34       2.04       2.95       (0.89
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.35     (0.39     (0.28     (0.39     (0.31

From net realized gain

    (0.02     (0.06     (0.02     (0.11     (0.00 )(c)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.37     (0.45     (0.30     (0.50     (0.31
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 15.36     $ 18.96     $ 17.07     $ 15.33     $ 12.88  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

         

Based on net asset value

    (17.06 )%      13.78     13.58     23.08     (6.40 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

         

Total expenses

    0.16     0.16     0.16     0.15     0.16
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.10     0.10     0.10     0.10     0.11
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    2.18     2.17     1.89     2.73     2.41
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $  176,179     $  197,919     $  164,602     $  148,827     $  94,316  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    39 %(f)       9 %(f)       10 %(g)       13 %(h)       10 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Amount is greater than $(0.005) per share.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  75


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2035 Fund (continued)  
    Investor A  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 18.91     $ 17.03     $ 15.29     $ 12.85     $ 14.04  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.31       0.34       0.25       0.35       0.29  

Net realized and unrealized gain (loss)

    (3.57     1.94       1.76       2.56       (1.21
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.26     2.28       2.01       2.91       (0.92
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.31     (0.34     (0.25     (0.36     (0.27

From net realized gain

    (0.02     (0.06     (0.02     (0.11     (0.00 )(c)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.33     (0.40     (0.27     (0.47     (0.27
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 15.32     $ 18.91     $ 17.03     $ 15.29     $ 12.85  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

         

Based on net asset value

    (17.27 )%      13.46     13.34     22.77     (6.59 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

         

Total expenses

    0.41     0.41     0.41     0.41     0.41
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.35     0.35     0.35     0.36
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.91     1.83     1.64     2.45     2.08
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $  119,861     $  154,072     $  168,305     $  158,773     $  103,712  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    39 %(f)       9 %(f)       10 %(g)       13 %(h)       10 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Amount is greater than $(0.005) per share.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

76  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2035 Fund (continued)  
    Investor P  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

Period from

08/06/18

to 12/31/18

 

(a) 

 

Net asset value, beginning of period

  $ 18.88     $ 17.00     $ 15.27     $ 12.84     $ 14.26  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.32       0.37       0.26       0.42       0.17  

Net realized and unrealized gain (loss)

    (3.59     1.92       1.74       2.49       (1.43
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.27     2.29       2.00       2.91       (1.26
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(c)

         

From net investment income

    (0.31     (0.35     (0.25     (0.37     (0.16

From net realized gain

    (0.02     (0.06     (0.02     (0.11     (0.00 )(d) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.33     (0.41     (0.27     (0.48     (0.16
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 15.28     $ 18.88     $ 17.00     $ 15.27     $  12.84  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(e)

         

Based on net asset value

    (17.34 )%      13.52     13.32     22.79     (8.87 )%(f) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(g)

         

Total expenses

    0.41     0.41     0.41     0.43     0.38 %(h) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.35     0.35     0.35     0.34 %(h) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.95     2.02     1.72     2.85     3.22 %(h) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of period (000)

  $  41,439     $  42,291     $  24,416     $  12,054     $ 561  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    39 %(i)       9 %(i)       10 %(j)       13 %(k)       10 %(k)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Amount is greater than $(0.005) per share.

(e) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(f) 

Not annualized.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

(i) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(j) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(k) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  77


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2035 Fund (continued)  
    Class K  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 18.95     $ 17.06     $ 15.31     $ 12.87     $ 14.07  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.37       0.41       0.30       0.40       0.35  

Net realized and unrealized gain (loss)

    (3.60     1.94       1.76       2.55       (1.23
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.23     2.35       2.06       2.95       (0.88
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.36     (0.40     (0.29     (0.40     (0.32

From net realized gain

    (0.02     (0.06     (0.02     (0.11     (0.00 )(c)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.38     (0.46     (0.31     (0.51     (0.32
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 15.34     $ 18.95     $ 17.06     $ 15.31     $ 12.87  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

         

Based on net asset value

    (17.07 )%      13.84     13.72     23.08     (6.36 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

         

Total expenses

    0.11     0.11     0.11     0.09     0.10
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.05     0.05     0.05     0.05     0.06
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    2.24     2.24     1.97     2.74     2.51
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $  6,457,504     $  6,914,380     $  5,157,576     $  3,758,092     $  2,393,634  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    39 %(f)       9 %(f)       10 %(g)       13 %(h)       10 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Amount is greater than $(0.005) per share.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

78  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2040 Fund  
    Institutional  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 19.99     $ 17.66     $ 15.78     $ 13.07     $ 14.39  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.35       0.41       0.29       0.40       0.47  

Net realized and unrealized gain (loss)

    (3.89     2.40       1.89       2.84       (1.48
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.54     2.81       2.18       3.24       (1.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.35     (0.41     (0.29     (0.42     (0.30

From net realized gain

    (0.02     (0.07     (0.01     (0.11     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.37     (0.48     (0.30     (0.53     (0.31
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 16.08     $ 19.99     $ 17.66     $ 15.78     $ 13.07  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (17.70 )%      15.99     14.04     24.95     (7.12 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.16     0.16     0.16     0.17     0.15 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.10     0.10     0.10     0.10     0.10 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    2.05     2.14     1.87     2.67     3.29
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $  592,121     $  733,350     $  646,477     $  577,303     $  446,192  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    29 %(f)       7 %(f)       9 %(g)       14 %(h)       12 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes reorganization, offering, and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.14% and 0.10%, respectively.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  79


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2040 Fund (continued)  
    Investor A  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 19.95     $ 17.63     $ 15.75     $ 13.05     $ 14.36  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.30       0.35       0.25       0.36       0.32  

Net realized and unrealized gain (loss)

    (3.88     2.40       1.89       2.83       (1.35
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.58     2.75       2.14       3.19       (1.03
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.30     (0.36     (0.25     (0.38     (0.27

From net realized gain

    (0.02     (0.07     (0.01     (0.11     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.32     (0.43     (0.26     (0.49     (0.28
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 16.05     $ 19.95     $ 17.63     $ 15.75     $ 13.05  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (17.90 )%      15.67     13.78     24.62     (7.30 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.41     0.41     0.42     0.45     0.40 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.35     0.35     0.35     0.35 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.77     1.84     1.61     2.45     2.21
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $  138,977     $  179,444     $  176,175     $  240,112     $  174,340  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    29 %(f)       7 %(f)       9 %(g)       14 %(h)       12 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c)

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes reorganization, offering, and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.39% and 0.35%, respectively.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

80  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2040 Fund (continued)  
    Investor P  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

Period from

08/06/18

to 12/31/18

 

(a) 

 

Net asset value, beginning of period

  $ 19.94     $ 17.61     $ 15.74     $ 13.04     $ 14.64  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.31       0.36       0.25       0.35       0.28  

Net realized and unrealized gain (loss)

    (3.89     2.40       1.88       2.84       (1.72
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.58     2.76       2.13       3.19       (1.44
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(c)

         

From net investment income

    (0.30     (0.36     (0.25     (0.38     (0.15

From net realized gain

    (0.02     (0.07     (0.01     (0.11     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.32     (0.43     (0.26     (0.49     (0.16
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 16.04     $ 19.94     $ 17.61     $ 15.74     $ 13.04  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

         

Based on net asset value

    (17.91 )%      15.75     13.73     24.63     (9.89 )%(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

         

Total expenses

    0.41     0.41     0.41     0.41     0.38 %(g)(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.35     0.35     0.35     0.34 %(g)(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.79     1.89     1.62     2.39     4.99 %(g)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of period (000)

  $  1,411,638     $  1,794,746     $  1,621,834     $  1,499,042     $  1,285,686  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    29 %(i)       7 %(i)       9 %(j)       14 %(k)       12 %(k)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d)

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(e)

Not annualized.

(f)

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h)

Includes reorganization, offering, and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.37% and 0.34%, respectively.

(i)

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(j)

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(k)

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  81


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2040 Fund (continued)  
    Class K  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 19.99     $ 17.66     $ 15.78     $ 13.07     $ 14.39  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.36       0.43       0.30       0.41       0.37  

Net realized and unrealized gain (loss)

    (3.90     2.39       1.88       2.84       (1.37
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.54     2.82       2.18       3.25       (1.00
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.35     (0.42     (0.29     (0.43     (0.31

From net realized gain

    (0.02     (0.07     (0.01     (0.11     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.37     (0.49     (0.30     (0.54     (0.32
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 16.08     $ 19.99     $ 17.66     $ 15.78     $ 13.07  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (17.65 )%      16.05     14.10     25.01     (7.08 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.11     0.11     0.11     0.09     0.10 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.05     0.05     0.05     0.05     0.05 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    2.13     2.23     1.95     2.77     2.57
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $ 6,694,192     $ 7,084,966     $ 5,352,212     $ 3,849,265     $ 2,478,916  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    29 %(f)       7 %(f)       9 %(g)       14 %(h)       12 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes reorganization, offering, and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.09% and 0.05%, respectively.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

82  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2045 Fund  
    Institutional  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 21.04     $ 18.29     $ 16.25     $ 13.33     $ 14.75  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.35       0.43       0.29       0.42       0.36  

Net realized and unrealized gain (loss)

    (4.16     2.81       2.05       3.04       (1.45
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.81     3.24       2.34       3.46       (1.09
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.34     (0.43     (0.29     (0.43     (0.32

From net realized gain

    (0.00 )(c)       (0.06     (0.01     (0.11     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.34     (0.49     (0.30     (0.54     (0.33
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 16.89     $ 21.04     $ 18.29     $ 16.25     $ 13.33  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

         

Based on net asset value

    (18.10 )%      17.76     14.67     26.14     (7.56 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

         

Total expenses

    0.16     0.16     0.16     0.15     0.15
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.10     0.10     0.10     0.10     0.10
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.94     2.16     1.87     2.78     2.43
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $ 146,616     $ 159,947     $ 132,688     $ 116,727     $ 70,629  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    16 %(f)       7 %(f)       7 %(g)       12 %(h)       8 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Amount is greater than $(0.005) per share.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  83


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2045 Fund (continued)  
    Investor A  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 20.99     $ 18.25     $ 16.22     $ 13.30     $ 14.73  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.30       0.36       0.25       0.39       0.31  

Net realized and unrealized gain (loss)

    (4.15     2.81       2.04       3.03       (1.45
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.85     3.17       2.29       3.42       (1.14
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.29     (0.37     (0.25     (0.39     (0.28

From net realized gain

    (0.00 )(c)       (0.06     (0.01     (0.11     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.29     (0.43     (0.26     (0.50     (0.29
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 16.85     $ 20.99     $ 18.25     $ 16.22     $ 13.30  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

         

Based on net asset value

    (18.31 )%      17.44     14.35     25.91     (7.87 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

         

Total expenses

    0.41     0.41     0.41     0.41     0.40
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.35     0.35     0.35     0.35
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.68     1.81     1.62     2.56     2.12
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $ 102,379     $ 121,865     $ 129,106     $ 120,718     $ 65,642  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    16 %(f)       7 %(f)       7 %(g)       12 %(h)       8 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Amount is greater than $(0.005) per share.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

84  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2045 Fund (continued)  
    Investor P  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

Period from

08/06/18

to 12/31/18

 

(a) 

 

Net asset value, beginning of period

  $ 20.95     $ 18.22     $ 16.20     $ 13.29     $ 15.05  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.31       0.40       0.28       0.44       0.16  

Net realized and unrealized gain (loss)

    (4.15     2.77       2.01       2.98       (1.75
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.84     3.17       2.29       3.42       (1.59
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(c)

         

From net investment income

    (0.30     (0.38     (0.26     (0.40     (0.16

From net realized gain

    (0.00 )(d)      (0.06     (0.01     (0.11     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.30     (0.44     (0.27     (0.51     (0.17
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 16.81     $ 20.95     $ 18.22     $ 16.20     $ 13.29  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(e)

         

Based on net asset value

    (18.33 )%      17.44     14.34     25.91     (10.64 )%(f) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(g)

         

Total expenses

    0.41     0.41     0.41     0.49     0.37 %(h) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.35     0.35     0.35     0.32 %(h) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.75     1.98     1.75     2.87     2.71 %(h) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of period (000)

  $ 14,413     $ 12,722     $ 8,154     $ 3,376     $ 249  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    16 %(i)       7 %(i)       7 %(j)       12 %(k)       8 %(k)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Amount is greater than $(0.005) per share.

(e) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(f) 

Not annualized.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

(i) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(j) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(k) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  85


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2045 Fund (continued)  
    Class K  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 21.05     $ 18.30     $ 16.27     $ 13.34     $ 14.76  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.36       0.45       0.31       0.42       0.37  

Net realized and unrealized gain (loss)

    (4.16     2.80       2.03       3.06       (1.46
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.80     3.25       2.34       3.48       (1.09
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.35     (0.44     (0.30     (0.44     (0.32

From net realized gain

    (0.00 )(c)       (0.06     (0.01     (0.11     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.35     (0.50     (0.31     (0.55     (0.33
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 16.90     $ 21.05     $ 18.30     $ 16.27     $ 13.34  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

         

Based on net asset value

    (18.05 )%      17.81     14.64     26.25     (7.50 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

         

Total expenses

    0.11     0.11     0.11     0.09     0.10
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.05     0.05     0.05     0.05     0.05
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.99     2.24     1.96     2.80     2.55
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $ 5,170,776     $ 5,476,173     $ 3,948,559     $ 2,720,014     $ 1,645,042  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    16 %(f)       7 %(f)       7 %(g)       12 %(h)       8 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Amount is greater than $(0.005) per share.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

86  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2050 Fund  
    Institutional  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 21.69     $ 18.68     $ 16.55     $ 13.51     $ 14.99  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.34       0.44       0.30       0.43       0.37  

Net realized and unrealized gain (loss)

    (4.32     3.04       2.13       3.15       (1.53
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.98     3.48       2.43       3.58       (1.16
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.32     (0.43     (0.29     (0.44     (0.31

From net realized gain

    (0.03     (0.04     (0.01     (0.10     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.35     (0.47     (0.30     (0.54     (0.32
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 17.36     $ 21.69     $ 18.68     $ 16.55     $ 13.51  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (18.32 )%      18.69     14.98     26.71     (7.87 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.16     0.16     0.16     0.15     0.16 %(e) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.10     0.10     0.10     0.10     0.10 %(e) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.82     2.14     1.88     2.78     2.45
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $ 132,970     $ 161,630     $ 132,633     $ 111,105     $ 68,949  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    11 %(f)       6 %(f)       6 %(g)       12 %(h)       11 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes reorganization, offering, and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.15% and 0.10%, respectively.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  87


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2050 Fund (continued)  
    Investor A  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 21.63     $ 18.63     $ 16.51     $ 13.48     $ 14.96  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.29       0.37       0.26       0.39       0.33  

Net realized and unrealized gain (loss)

    (4.30     3.04       2.12       3.14       (1.52
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (4.01     3.41       2.38       3.53       (1.19
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.28     (0.37     (0.25     (0.40     (0.28

From net realized gain

    (0.03     (0.04     (0.01     (0.10     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.31     (0.41     (0.26     (0.50     (0.29
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 17.31     $ 21.63     $ 18.63     $ 16.51     $ 13.48  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (18.54 )%      18.38     14.67     26.40     (8.11 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.41     0.41     0.41     0.44     0.42 %(e) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.35     0.35     0.35     0.35 %(e) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.56     1.81     1.62     2.53     2.18
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $ 102,124     $ 119,705     $ 112,240     $ 138,397     $ 82,677  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    11 %(f)       6 %(f)       6 %(g)       12 %(h)       11 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes reorganization, offering, and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.41% and 0.35%, respectively.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

88  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2050 Fund (continued)  
    Investor P  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

Period from

08/06/18

to 12/31/18

 

(a) 

 

Net asset value, beginning of period

  $ 21.61     $ 18.62     $ 16.50     $ 13.47     $ 15.30  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.29       0.38       0.26       0.37       0.34  

Net realized and unrealized gain (loss)

    (4.29     3.02       2.12       3.16       (2.00
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (4.00     3.40       2.38       3.53       (1.66
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(c)

         

From net investment income

    (0.28     (0.37     (0.25     (0.40     (0.16

From net realized gain

    (0.03     (0.04     (0.01     (0.10     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.31     (0.41     (0.26     (0.50     (0.17
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 17.30     $ 21.61     $ 18.62     $ 16.50     $ 13.47  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

         

Based on net asset value

    (18.51 )%      18.35     14.67     26.40     (10.93 )%(e) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

         

Total expenses

    0.41     0.41     0.41     0.42     0.39 %(g)(h)(i) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.35     0.35     0.35     0.34 %(g)(h)(i) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.55     1.87     1.62     2.41     5.73 %(g)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of period (000)

  $ 470,795     $ 592,827     $ 522,176     $ 473,345     $ 393,442  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    11 %(j)       6 %(j)       6 %(k)       12 %(l)       11 %(l)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Includes reorganization, offering, and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.38% and 0.34%, respectively.

(i) 

Reorganization, offering, and board realignment and consolidation costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses and total expenses after fees waived and/or reimbursed would have been 0.40% and 0.34%, respectively.

(j) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(k) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(l) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  89


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2050 Fund (continued)  
    Class K  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 21.69     $ 18.68     $ 16.55     $ 13.51     $ 14.99  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.35       0.46       0.31       0.43       0.38  

Net realized and unrealized gain (loss)

    (4.33     3.03       2.13       3.16       (1.53
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.98     3.49       2.44       3.59       (1.15
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.33     (0.44     (0.30     (0.45     (0.32

From net realized gain

    (0.03     (0.04     (0.01     (0.10     (0.01
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.36     (0.48     (0.31     (0.55     (0.33
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 17.35     $ 21.69     $ 18.68     $ 16.55     $ 13.51  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (18.33 )%      18.75     15.04     26.77     (7.82 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.11     0.11     0.11     0.09     0.11 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.05     0.05     0.05     0.05     0.05 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.88     2.23     1.97     2.81     2.57
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $ 4,892,212     $ 4,988,085     $ 3,567,402     $ 2,388,475     $ 1,420,616  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    11 %(f)       6 %(f)       6 %(g)       12 %(h)       11 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes reorganization, offering, and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.10% and 0.05%, respectively.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

90  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2055 Fund  
    Institutional  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 22.24     $ 19.12     $ 16.93     $ 13.77     $ 15.27  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.34       0.46       0.31       0.42       0.38  

Net realized and unrealized gain (loss)

    (4.43     3.11       2.19       3.24       (1.56
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (4.09     3.57       2.50       3.66       (1.18
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.33     (0.43     (0.30     (0.44     (0.32

From net realized gain

    (0.02     (0.02     (0.01     (0.06      
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.35     (0.45     (0.31     (0.50     (0.32
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 17.80     $ 22.24     $ 19.12     $ 16.93     $ 13.77  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (18.38 )%      18.76     15.03     26.75     (7.83 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.16     0.16     0.16     0.16     0.17
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.10     0.10     0.09     0.09     0.09
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.79     2.15     1.89     2.70     2.49
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $ 111,511     $ 114,774     $ 89,290     $ 76,250     $ 60,993  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    10 %(e)       6 %(e)       6 %(f)       12 %(g)       8 %(g)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(f) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  91


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2055 Fund (continued)  
    Investor A  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 22.19     $ 19.07     $ 16.89     $ 13.74     $ 15.24  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.29       0.38       0.26       0.40       0.34  

Net realized and unrealized gain (loss)

    (4.42     3.14       2.19       3.22       (1.55
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (4.13     3.52       2.45       3.62       (1.21
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.28     (0.38     (0.26     (0.41     (0.29

From net realized gain

    (0.02     (0.02     (0.01     (0.06      
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.30     (0.40     (0.27     (0.47     (0.29
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 17.76     $ 22.19     $ 19.07     $ 16.89     $ 13.74  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (18.59 )%      18.51     14.72     26.46     (8.08 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.41     0.41     0.41     0.43     0.43
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.35     0.34     0.34     0.34
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.53     1.82     1.61     2.57     2.23
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $ 72,842     $ 84,965     $ 78,100     $ 78,919     $ 41,909  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    10 %(e)       6 %(e)       6 %(f)       12 %(g)       8 %(g)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(f) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

92  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2055 Fund (continued)  
    Investor P  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

Period from

08/06/18

to 12/31/18

 

(a) 

 

Net asset value, beginning of period

  $ 22.16     $ 19.05     $ 16.88     $ 13.73     $ 15.60  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.29       0.42       0.28       0.47       0.16  

Net realized and unrealized gain (loss)

    (4.41     3.09       2.16       3.15       (1.87
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (4.12     3.51       2.44       3.62       (1.71
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(c)

         

From net investment income

    (0.28     (0.38     (0.26     (0.41     (0.16

From net realized gain

    (0.02     (0.02     (0.01     (0.06      
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.30     (0.40     (0.27     (0.47     (0.16
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 17.74     $ 22.16     $ 19.05     $ 16.88     $ 13.73  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

         

Based on net asset value

    (18.55 )%      18.50     14.69     26.54     (11.00 )%(e) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

         

Total expenses

    0.41     0.41     0.42     0.59     0.37 %(g)(h) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.35     0.34     0.34     0.32 %(g)(h) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.56     1.97     1.74     2.99     2.63 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of period (000)

  $ 7,427     $ 6,407     $ 3,826     $ 1,866     $ 209  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    10 %(i)       6 %(i)       6 %(j)       12 %(k)       8 %(k)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Offering and board realignment and consolidation costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses and total expenses after fees waived and/or reimbursed would have been 0.38% and 0.32%, respectively.

(i) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(j) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(k) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  93


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2055 Fund (continued)  
    Class K  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 22.25     $ 19.12     $ 16.94     $ 13.77     $ 15.27  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.35       0.48       0.32       0.45       0.40  

Net realized and unrealized gain (loss)

    (4.44     3.11       2.18       3.23       (1.57
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (4.09     3.59       2.50       3.68       (1.17
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

         

From net investment income

    (0.33     (0.44     (0.31     (0.45     (0.33

From net realized gain

    (0.02     (0.02     (0.01     (0.06      
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

    (0.35     (0.46     (0.32     (0.51     (0.33
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 17.81     $ 22.25     $ 19.12     $ 16.94     $ 13.77  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (18.33 )%      18.87     15.02     26.89     (7.79 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.11     0.11     0.11     0.09     0.11
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.05     0.05     0.04     0.04     0.04
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.85     2.24     1.98     2.86     2.60
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $ 3,178,027     $ 3,128,153     $ 2,124,200     $ 1,344,554     $ 716,634  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    10 %(e)       6 %(e)       6 %(f)       12 %(g)       8 %(g)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(f) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

94  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2060 Fund  
    Institutional  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 19.82     $ 17.02     $ 15.06     $ 12.19     $ 13.50  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.31       0.42       0.29       0.44       0.36  

Net realized and unrealized gain (loss)

    (3.96     2.77       1.93       2.80       (1.40
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.65     3.19       2.22       3.24       (1.04
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net investment income(b)

    (0.29     (0.39     (0.26     (0.37     (0.27
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 15.88     $ 19.82     $ 17.02     $ 15.06     $ 12.19  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (18.42 )%      18.81     15.02     26.78     (7.82 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.16     0.16     0.18     0.29     0.37 %(e) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.10     0.10     0.09     0.09     0.09 %(e) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.81     2.23     1.96     3.11     2.68
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $ 37,045     $ 38,667     $ 22,343     $ 11,132     $ 2,773  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    9 %(f)       6 %(f)       6 %(g)       11 %(h)       13 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes offering and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.34% and 0.09%, respectively.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  95


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2060 Fund (continued)  
    Investor A  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 19.77     $ 16.98     $ 15.03     $ 12.17     $ 13.48  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.25       0.35       0.25       0.37       0.31  

Net realized and unrealized gain (loss)

    (3.93     2.78       1.93       2.83       (1.38
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.68     3.13       2.18       3.20       (1.07
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net investment income(b)

    (0.24     (0.34     (0.23     (0.34     (0.24
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 15.85     $ 19.77     $ 16.98     $ 15.03     $ 12.17  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (18.58 )%      18.50     14.71     26.46     (8.04 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.41     0.41     0.44     0.57     0.61 %(e) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.35     0.34     0.34     0.34 %(e) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.50     1.88     1.71     2.66     2.29
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $ 18,405     $ 20,045     $ 14,564     $ 11,358     $ 4,371  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    9 %(f)       6 %(f)       6 %(g)       11 %(h)       13 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes offering and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.58% and 0.34%, respectively.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

96  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2060 Fund (continued)  
    Investor P  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

Period from

08/06/18

to 12/31/18

 

(a) 

 

Net asset value, beginning of period

  $ 19.76     $ 16.97     $ 15.03     $ 12.17     $ 13.81  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.26       0.38       0.25       0.42       0.15  

Net realized and unrealized gain (loss)

    (3.93     2.75       1.92       2.79       (1.65
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.67     3.13       2.17       3.21       (1.50
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net investment income(c)

    (0.25     (0.34     (0.23     (0.35     (0.14
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 15.84     $ 19.76     $ 16.97     $ 15.03     $ 12.17  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

         

Based on net asset value

    (18.57 )%      18.53     14.65     26.51     (10.92 )%(e) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

         

Total expenses

    0.41     0.41     0.44     0.65     0.47 %(g)(h)(i) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.35     0.34     0.34     0.33 %(g)(h)(i) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.57     1.99     1.74     2.97     2.86 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of period (000)

  $ 9,663     $ 7,993     $ 4,675     $ 2,039     $ 259  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    9 %(j)       6 %(j)       6 %(k)       11 %(l)       13 %(l)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Offering costs, board realignment and consolidation costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses and total expenses after fees waived and/or reimbursed would have been 0.49% and 0.33%, respectively.

(i) 

Includes offering and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.46% and 0.33%, respectively.

(j) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(k) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(l) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  97


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2060 Fund (continued)  
    Class K  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   
Year Ended
12/31/19
 
 
   

    
Year Ended
12/31/18

 
 

Net asset value, beginning of year

  $ 19.82     $ 17.03     $ 15.07     $ 12.19     $ 13.51  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.31       0.43       0.29       0.42       0.36  

Net realized and unrealized gain (loss)

    (3.94     2.76       1.94       2.84       (1.40
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (3.63     3.19       2.23       3.26       (1.04
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net investment income(b)

    (0.30     (0.40     (0.27     (0.38     (0.28
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 15.89     $ 19.82     $ 17.03     $ 15.07     $ 12.19  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(c)

         

Based on net asset value

    (18.32 )%      18.80     15.06     26.92     (7.84 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(d)

         

Total expenses

    0.11     0.11     0.13     0.15     0.24 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.05     0.05     0.04     0.04     0.04 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.87     2.28     2.02     2.98     2.71
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

         

Net assets, end of year (000)

  $ 1,524,706     $ 1,283,329     $ 769,397     $ 386,113     $ 150,118  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    9 %(f)       6 %(f)       6 %(g)       11 %(h)       13 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(e) 

Includes offering and board realignment and consolidation costs. Without these costs, total expenses and total expenses after fees waived and/or reimbursed would have been 0.21% and 0.04%, respectively.

(f) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(g) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(h) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series, Total International ex U.S. Index Master Portfolio and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

98  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2065 Fund  
    Institutional  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   

Period from

10/30/19

to 12/31/19

 

(a) 

 

Net asset value, beginning of period

  $ 13.90     $     11.92     $     10.48     $     10.00  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.22       0.33       0.23       0.11  

Net realized and unrealized gain (loss)

    (2.77     1.90       1.36       0.46  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.55     2.23       1.59       0.57  
 

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net investment income(c)

    (0.19     (0.25     (0.15     (0.09
 

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 11.16     $ 13.90     $ 11.92     $ 10.48  
 

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

       

Based on net asset value

    (18.30 )%      18.74     15.43     5.71 %(e) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

       

Total expenses

    0.17     0.21     0.50     13.00 %(g)(h) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.10     0.09     0.08     0.11 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.89     2.50     2.23     6.26 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

       

Net assets, end of period (000)

  $ 10,487     $ 6,545     $ 1,360     $ 52  
 

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    8 %(i)       9 %(i)       48 %(j)       1 %(k)  
 

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Audit, offering and organization costs were not annualized in the calculation of expense ratios. If these expenses were annualized, the total expenses would have been 44.41%.

(i) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(j) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(k) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  99


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2065 Fund (continued)  
    Investor A  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   

Period from

10/30/19

to 12/31/19

 

(a) 

 

Net asset value, beginning of period

  $ 13.90     $ 11.92     $ 10.48     $ 10.00  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.19       0.28       0.22       0.11  

Net realized and unrealized gain (loss)

    (2.77     1.92       1.35       0.46  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.58     2.20       1.57       0.57  
 

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net investment income(c)

    (0.17     (0.22     (0.13     (0.09
 

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 11.15     $ 13.90     $ 11.92     $ 10.48  
 

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

       

Based on net asset value

    (18.56 )%      18.48     15.14     5.67 %(e) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

       

Total expenses

    0.42     0.46     2.02     13.24 %(g)(h) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.34     0.34     0.36 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.61     2.08     2.10     6.03 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

       

Net assets, end of period (000)

  $ 1,068     $ 523     $ 123     $ 53  
 

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    8 %(i)       9 %(i)       48 %(j)      1 %(k)  
 

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Audit, offering and organization costs were not annualized in the calculation of expense ratios. If these expenses were annualized, the total expenses would have been 44.60%.

(i) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(j) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(k) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

100  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2065 Fund (continued)  
    Investor P  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   

Period from

10/30/19

to 12/31/19

 

(a) 

 

Net asset value, beginning of period

  $ 13.89     $ 11.91     $ 10.48     $ 10.00  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.19       0.36       0.20       0.11  

Net realized and unrealized gain (loss)

    (2.76     1.84       1.36       0.46  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.57     2.20       1.56       0.57  
 

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net investment income(c)

    (0.17     (0.22     (0.13     (0.09
 

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 11.15     $ 13.89     $ 11.91     $ 10.48  
 

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

       

Based on net asset value

    (18.51 )%      18.52     15.12     5.67 %(e) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

       

Total expenses

    0.42     0.46     1.00     13.25 %(g)(h) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.35     0.34     0.33     0.36 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.61     2.68     1.86     6.01 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

       

Net assets, end of period (000)

  $ 4,283     $ 3,022     $ 532     $ 52  
 

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    8 %(i)       9 %(i)       48 %(j)       1 %(k)  
 

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Audit, offering and organization costs were not annualized in the calculation of expense ratios. If these expenses were annualized, the total expenses would have been 44.67%.

(i) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(j) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(k) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  101


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    BlackRock LifePath® Index 2065 Fund (continued)  
    Class K  
     
Year Ended
12/31/22
 
 
   
Year Ended
12/31/21
 
 
   
Year Ended
12/31/20
 
 
   

Period from

10/30/19

to 12/31/19

 

(a) 

 

Net asset value, beginning of period

  $ 13.91     $ 11.92     $ 10.48     $ 10.00  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income(b)

    0.22       0.36       0.24       0.12  

Net realized and unrealized gain (loss)

    (2.77     1.88       1.36       0.45  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (2.55     2.24       1.60       0.57  
 

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net investment income(c)

    (0.20     (0.25     (0.16     (0.09
 

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 11.16     $ 13.91     $ 11.92     $ 10.48  
 

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

       

Based on net asset value

    (18.32 )%      18.87     15.47     5.72 %(e)  
 

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

       

Total expenses

    0.12     0.16     0.79     11.12 %(g)(h) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.05     0.04     0.03     0.06 %(g)  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    1.92     2.67     2.32     7.08 %(g)  
 

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

       

Net assets, end of period (000)

  $  234,115     $  123,833     $  23,104     $  1,940  
 

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    8 %(i)       9 %(i)       48 %(j)       1 %(k)  
 

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Audit, offering and organization costs were not annualized in the calculation of expense ratios. If these expenses were annualized, the total expenses would have been 35.79%.

(i) 

Includes the purchases and sales of the underlying funds and the Underlying Master Portfolios.

(j) 

From January 1, 2020 through March 1, 2020, the rate includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and the Underlying Master Portfolios. Beginning March 2, 2020, the rate includes the LifePath Index Fund’s purchases and sales of the underlying funds and the Underlying Master Portfolios.

(k) 

Includes the LifePath Index Master Portfolio’s purchases and sales of the underlying funds and Large Cap Index Master Portfolio, Master Small Cap Index Series and U.S. Total Bond Index Master Portfolio.

See notes to financial statements.

 

 

102  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements

 

1.

ORGANIZATION

BlackRock Funds III (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Trust is organized as a Delaware statutory trust. The following, each of which is a series of the Trust, are referred to herein collectively as the “Funds” or individually as a “Fund”:

 

     
Fund Name   Herein Referred To As      Diversification
    Classification
 

BlackRock LifePath® Index Retirement Fund

    LifePath Index Retirement Fund        Diversified  

BlackRock LifePath® Index 2025 Fund

    LifePath Index 2025 Fund        Diversified  

BlackRock LifePath® Index 2030 Fund

    LifePath Index 2030 Fund        Diversified  

BlackRock LifePath® Index 2035 Fund

    LifePath Index 2035 Fund        Diversified  

BlackRock LifePath® Index 2040 Fund

    LifePath Index 2040 Fund        Diversified  

BlackRock LifePath® Index 2045 Fund

    LifePath Index 2045 Fund        Diversified  

BlackRock LifePath® Index 2050 Fund

    LifePath Index 2050 Fund        Diversified  

BlackRock LifePath® Index 2055 Fund

    LifePath Index 2055 Fund        Diversified  

BlackRock LifePath® Index 2060 Fund

    LifePath Index 2060 Fund        Diversified  

BlackRock LifePath® Index 2065 Fund

    LifePath Index 2065 Fund        Diversified  

As of period end, the investment of LifePath Index Retirement Fund, LifePath Index 2025 Fund, LifePath Index 2030 Fund, LifePath Index 2035 Fund, LifePath Index 2040 Fund, LifePath Index 2045 Fund, LifePath Index 2050 Fund, LifePath Index 2055 Fund, LifePath Index 2060 Fund and LifePath Index 2065 Fund in Large Cap Index Master Portfolio represented 20.7%, 24.5%, 32.5%, 39.8%, 46.8%, 53.0%, 56.6%, 57.6%, 57.6% and 57.6%, respectively, of net assets. As such, financial statements of Large Cap Index Master Portfolio, including the Schedules of Investments, should be read in conjunction with each respective Fund’s financial statements. Large Cap Index Master Portfolio’s financial statements are available, without charge, on the U.S. Securities and Exchange Commission’s (“SEC’s”) website at sec.gov.

The Funds will generally invest in other registered investment companies (each, an “Underlying Fund” and collectively, the “Underlying Funds”) that are managed by subsidiaries of BlackRock, Inc. (“BlackRock”) and its affiliates, which are affiliates of the Funds. The Funds may also invest in other master portfolios (“Underlying Master Portfolios”) that are managed by subsidiaries of BlackRock.

The value of a Fund’s investment in Large Cap Index Master Portfolio and Master Small Cap Index Series reflects that Fund’s proportionate interest in the net assets of that master portfolio. As of period end, the Funds held interests in Underlying Master Portfolios as follows:

 

     
Fund Name    Large Cap
Index
Master Portfolio
    Master
Small Cap
Index Series
 

LifePath Index Retirement Fund

     6.5     6.1

LifePath Index 2025 Fund

     6.4       4.7  

LifePath Index 2030 Fund

     14.3       6.4  

LifePath Index 2035 Fund

     11.8       3.4  

LifePath Index 2040 Fund

     18.1       3.2  

LifePath Index 2045 Fund

     12.6       1.6  

LifePath Index 2050 Fund

     13.9       1.6  

LifePath Index 2055 Fund

     8.5       1.0  

LifePath Index 2060 Fund

     4.0       0.5  

LifePath Index 2065 Fund

     0.6       0.1  

Each Fund offers multiple classes of shares. All classes of shares have identical voting, dividend, liquidation and other rights and are subject to the same terms and conditions, except that certain classes bear expenses related to the shareholder servicing and distribution of such shares. Institutional and Class K Shares are sold without a sales charge and only to certain eligible investors. Investor A and Investor P Shares bear certain expenses related to shareholder servicing of such shares. Investor A Shares are generally available through financial intermediaries. Investor P Shares are only available through registered representatives of an insurance company’s broker-dealer that has entered into an agreement with the Fund’s distributor to offer such shares. Each class has exclusive voting rights with respect to matters relating to its shareholder servicing and distribution expenditures.

 

       
Share Class   Initial Sales Charge      CDSC      Conversion Privilege

Institutional, Investor A and Class K Shares

  No        No      None

Investor P Shares

  Yes        No (a)     None

 

  (a) 

Investor P Shares may be subject to a contingent deferred sales charge (“CDSC”) for certain redemptions where no initial sales charge was paid at the time of purchase.

 

The Funds, together with certain other registered investment companies advised by BlackRock Fund Advisors (“BFA” or the “Manager”) or its affiliates, are included in a complex of funds referred to as the BlackRock Multi-Asset Complex.

 

2.

SIGNIFICANT ACCOUNTING POLICIES

The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which may require management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the financial statements, disclosure of contingent assets and

 

 

N O T E S   T O   F I N A N C I A L   S T A T E M E N T S

  103


Notes to Financial Statements    (continued)

 

liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. Each Fund is considered an investment company under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies. Below is a summary of significant accounting policies:

Investment Transactions and Income Recognition: For financial reporting purposes, investment transactions are recorded on the dates the transactions are executed. Realized gains and losses on investment transactions are determined using the specific identification method. Dividend income and capital gain distributions, if any, are recorded on the ex-dividend dates. Non-cash dividends, if any, are recorded on the ex-dividend dates at fair value. Income, expenses and realized and unrealized gains and losses are allocated daily to each class based on its relative net assets.

Each Fund records daily its proportionate share of the Large Cap Index Master Portfolio and Master Small Cap Index Series income, expenses and realized and unrealized gains and losses.

Distributions: Distributions paid by the Funds are recorded on the ex-dividend dates. Distributions from net investment income are declared and paid quarterly. Distributions of capital gains are recorded on the ex-dividend dates and made at least annually. The character and timing of distributions are determined in accordance with U.S. federal income tax regulations, which may differ from U.S. GAAP.

Indemnifications: In the normal course of business, a Fund enters into contracts that contain a variety of representations that provide general indemnification. A Fund’s maximum exposure under these arrangements is unknown because it involves future potential claims against a Fund, which cannot be predicted with any certainty.

Other: Expenses directly related to a Fund or its classes are charged to that Fund or the applicable class. Expenses directly related to the Funds and other shared expenses prorated to the Funds are allocated daily to each class based on their relative net assets or other appropriate methods. Other operating expenses shared by several funds, including other funds managed by the Manager, are prorated among those funds on the basis of relative net assets or other appropriate methods.

 

3.

INVESTMENT VALUATION AND FAIR VALUE MEASUREMENTS

Investment Valuation Policies: Each Fund’s investments are valued at fair value (also referred to as “market value” within the financial statements) each day that the Fund is open for business and, for financial reporting purposes, as of the report date. U.S. GAAP defines fair value as the price a fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. The Board of Trustees of each Fund (the “Board”) has approved the designation of each Fund’s Manager as the valuation designee for each Fund. Each Fund determines the fair values of its financial instruments using various independent dealers or pricing services under the Manager’s policies. If a security’s market price is not readily available or does not otherwise accurately represent the fair value of the security, the security will be valued in accordance with the Manager’s policies and procedures as reflecting fair value. The Manager has formed a committee (the “Valuation Committee”) to develop pricing policies and procedures and to oversee the pricing function for all financial instruments, with assistance from other BlackRock pricing committees.

Fair Value Inputs and Methodologies: The following methods and inputs are used to establish the fair value of each Fund’s assets and liabilities:

 

   

Exchange-traded funds (“ETFs”) and closed-end funds traded on a recognized securities exchange are valued at that day’s official closing price, as applicable, on the exchange where the stock is primarily traded. ETFs and closed-end funds traded on a recognized exchange for which there were no sales on that day may be valued at the last available bid (long positions) or ask (short positions) price.

 

   

Investments in open-end U.S. mutual funds (including money market funds) are valued at that day’s published net asset value (“NAV”).

 

   

The Funds record their proportionate investment in the Underlying Master Portfolios at fair value, which is based upon their pro rata ownership in the net assets of the Underlying Master Portfolios.

If events (e.g., market volatility, company announcement or a natural disaster) occur that are expected to materially affect the value of such investment, or in the event that application of these methods of valuation results in a price for an investment that is deemed not to be representative of the market value of such investment, or if a price is not available, the investment will be valued by the Valuation Committee in accordance with the Manager’s policies and procedures as reflecting fair value (“Fair Valued Investments”). The fair valuation approaches that may be used by the Valuation Committee include market approach, income approach and cost approach. Valuation techniques such as discounted cash flow, use of market comparables and matrix pricing are types of valuation approaches and are typically used in determining fair value. When determining the price for Fair Valued Investments, the Valuation Committee seeks to determine the price that each Fund might reasonably expect to receive or pay from the current sale or purchase of that asset or liability in an arm’s-length transaction. Fair value determinations shall be based upon all available factors that the Valuation Committee deems relevant and consistent with the principles of fair value measurement.

Fair Value Hierarchy: Various inputs are used in determining the fair value of financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:

 

   

Level 1 – Unadjusted price quotations in active markets/exchanges for identical assets or liabilities that each Fund has the ability to access;

 

   

Level 2 – Other observable inputs (including, but not limited to, quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other market–corroborated inputs); and

 

   

Level 3 – Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Valuation Committee’s assumptions used in determining the fair value of financial instruments).

 

 

104  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements    (continued)

 

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Investments classified within Level 3 have significant unobservable inputs used by the Valuation Committee in determining the price for Fair Valued Investments. Level 3 investments include equity or debt issued by privately held companies or funds that may not have a secondary market and/or may have a limited number of investors. The categorization of a value determined for financial instruments is based on the pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities.

As of December 31, 2022, certain investments of the Funds were fair valued using NAV as a practical expedient or its equivalent as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

4.

SECURITIES AND OTHER INVESTMENTS

Securities Lending: Certain Funds may lend their securities to approved borrowers, such as brokers, dealers and other financial institutions. The borrower pledges and maintains with the Funds collateral consisting of cash, an irrevocable letter of credit issued by a bank, or securities issued or guaranteed by the U.S. Government. The initial collateral received by each Fund is required to have a value of at least 102% of the current value of the loaned securities for securities traded on U.S. exchanges and a value of at least 105% for all other securities. The collateral is maintained thereafter at a value equal to at least 100% of the current market value of the securities on loan. The market value of the loaned securities is determined at the close of each business day of the Fund and any additional required collateral is delivered to the Fund, or excess collateral returned by the Fund, on the next business day. During the term of the loan, the Funds are entitled to all distributions made on or in respect of the loaned securities, but do not receive interest income on securities received as collateral. Loans of securities are terminable at any time and the borrower, after notice, is required to return borrowed securities within the standard time period for settlement of securities transactions.

As of period end, any securities on loan were collateralized by cash and/or U.S. Government obligations. Cash collateral invested by the securities lending agent, BlackRock Institutional Trust Company, N.A. (“BTC”), if any, is disclosed in the Schedules of Investments. Any non-cash collateral received cannot be sold, re-invested or pledged by the Fund, except in the event of borrower default. The securities on loan, if any, are disclosed in the Funds’ Schedules of Investments. The market value of any securities on loan and the value of any related collateral are shown separately in the Statements of Assets and Liabilities as a component of investments at value – affiliated and collateral on securities loaned, respectively.

Securities lending transactions are entered into by the Funds under Master Securities Lending Agreements (each, an “MSLA”), which provide the right, in the event of default (including bankruptcy or insolvency), for the non-defaulting party to liquidate the collateral and calculate a net exposure to the defaulting party or request additional collateral. In the event that a borrower defaults, the Funds, as lender, would offset the market value of the collateral received against the market value of the securities loaned. When the value of the collateral is greater than that of the market value of the securities loaned, the lender is left with a net amount payable to the defaulting party. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against such a right of offset in the event of an MSLA counterparty’s bankruptcy or insolvency. Under the MSLA, absent an event of default, the borrower can resell or re-pledge the loaned securities, and the Funds can reinvest cash collateral received in connection with loaned securities. Upon an event of default, the parties’ obligations to return the securities or collateral to the other party are extinguished, and the parties can resell or re-pledge the loaned securities or the collateral received in connection with the loaned securities in order to satisfy the defaulting party’s net payment obligation for all transactions under the MSLA. The defaulting party remains liable for any deficiency.

As of period end, the following table is a summary of the Funds’ securities on loan by counterparty which are subject to offset under an MSLA:

 

LifePath Index Fund Name/Counterparty    
Securities
Loaned at Value
 
 
    
Cash Collateral
Received
 
(a)  
   
Non-Cash Collateral
Received, at Fair Value
 
(a) 
   
Net
Amount
 
 

LifePath Index 2025 Fund

        

BNP Paribas SA

  $ 1,339,232      $ (1,339,232   $     $  

J.P. Morgan Securities LLC

    8,195,880        (8,195,880            

Mizuho Securities USA LLC

    4,960,316        (4,960,316            

Morgan Stanley

    17,676,552        (17,676,552            

Scotia Capital (USA), Inc.

    74,508        (74,508            

Toronto-Dominion Bank

    557,533        (557,533            

Wells Fargo Bank N.A.

    2,055,028        (2,055,028            
 

 

 

    

 

 

   

 

 

   

 

 

 
  $ 34,859,049      $ (34,859,049   $     $  
 

 

 

    

 

 

   

 

 

   

 

 

 

LifePath Index 2035 Fund

        

Wells Fargo Bank N.A.

  $ 109,972      $ (109,972   $     $  
 

 

 

    

 

 

   

 

 

   

 

 

 

LifePath Index 2045 Fund

        

J.P. Morgan Securities LLC

  $ 5,788      $ (5,788   $     $  

Morgan Stanley

    2,471,476        (2,471,476            

RBC Capital Markets LLC

    17,335,060        (17,335,060            

Toronto-Dominion Bank

    213        (213            

Virtu Americas LLC

    98,396        (98,396            

Wells Fargo Bank N.A.

    2,001,072        (2,001,072            
 

 

 

    

 

 

   

 

 

   

 

 

 
  $ 21,912,005      $ (21,912,005   $     $  
 

 

 

    

 

 

   

 

 

   

 

 

 

LifePath Index 2050 Fund

        

BNP Paribas SA

  $ 63,668      $ (63,668   $     $  

 

 

N O T E S   T O   F I N A N C I A L   S T A T E M E N T S

  105


Notes to Financial Statements    (continued)

 

LifePath Index Fund Name/Counterparty    
Securities
Loaned at Value
 
 
    
Cash Collateral
Received
 
(a)  
   
Non-Cash Collateral
Received, at Fair Value
 
(a) 
   
Net
Amount
 
 

LifePath Index 2050 Fund (continued)

        

J.P. Morgan Securities LLC

  $ 44,594,572      $ (44,594,572   $     $  

Mizuho Securities USA LLC

    1,603,276        (1,603,276            

Morgan Stanley

    167,852        (167,852            

Toronto-Dominion Bank

    7,877        (7,877            

Wells Fargo Bank N.A

    234,168        (234,168            
 

 

 

    

 

 

   

 

 

   

 

 

 
  $ 46,671,413      $ (46,671,413   $     $  
 

 

 

    

 

 

   

 

 

   

 

 

 

LifePath Index 2055 Fund

        

Jefferies LLC

  $ 57,880      $ (57,880   $     $  

Toronto-Dominion Bank

    266,248,000         (266,248,000            

Virtu Americas LLC

    931,868        (931,868            
 

 

 

    

 

 

   

 

 

   

 

 

 
  $  267,237,748      $ (267,237,748   $     $  
 

 

 

    

 

 

   

 

 

   

 

 

 

LifePath Index 2060 Fund

        

Barclays Bank PLC

  $ 1,585,912      $ (1,585,912   $  —     $  —  
 

 

 

    

 

 

   

 

 

   

 

 

 

 

  (a) 

Collateral received, if any, in excess of the market value of securities on loan is not presented in this table. The total cash collateral received by each Fund is disclosed in the Fund’s Statements of Assets and Liabilities.

 

The risks of securities lending include the risk that the borrower may not provide additional collateral when required or may not return the securities when due. To mitigate these risks, the Funds benefit from a borrower default indemnity provided by BlackRock. BlackRock’s indemnity allows for full replacement of the securities loaned to the extent the collateral received does not cover the value on the securities loaned in the event of borrower default. Each Fund could incur a loss if the value of an investment purchased with cash collateral falls below the market value of loaned securities or if the value of an investment purchased with cash collateral falls below the value of the original cash collateral received. Such losses are borne entirely by the Funds.

 

5.

INVESTMENT ADVISORY AGREEMENT AND OTHER TRANSACTIONS WITH AFFILIATES

Investment Advisory: The Trust, on behalf of each Fund, entered into an Investment Advisory Agreement with BFA, the Funds’ investment adviser and an indirect, wholly-owned subsidiary of BlackRock, to provide investment advisory services. The Manager is responsible for the management of each Fund’s portfolio and provides the personnel, facilities, equipment and certain other services necessary to the operations of each Fund.

For such services, each Fund pays the Manager a monthly fee at an annual rate equal to 0.05% of the average daily value of each Fund’s net assets.

Service Fees: The Trust, on behalf of each Fund, entered into a Distribution Agreement and a Distribution and Service Plan with BlackRock Investments, LLC (“BRIL”),an affiliate of the Manager. Pursuant to the Distribution and Service Plan and in accordance with Rule 12b-1 under the 1940 Act, each Fund pays BRIL ongoing service fees. The fees are accrued daily and paid monthly at an annual rate of 0.25% based upon the average daily net assets of each Fund’s Investor A and Investor P Shares.

BRIL and broker-dealers, pursuant to sub-agreements with BRIL, provide shareholder servicing to the Funds. The ongoing service fee compensates BRIL and each broker-dealer for providing shareholder servicing related services to shareholders.

For the year ended December 31, 2022, the following table shows the class specific service fees borne directly by each share class of each Fund:

 

Fund Name   Investor A      Investor P      Total

LifePath Index Retirement Fund

  $  488,817      $  5,423,239      $ 5,912,056

LifePath Index 2025 Fund

    302,311        234,198      536,509

LifePath Index 2030 Fund

    493,570        4,635,478      5,129,048

LifePath Index 2035 Fund

    327,390        105,124      432,514

LifePath Index 2040 Fund

    374,569        3,811,576      4,186,145

LifePath Index 2045 Fund

    266,825        31,174      297,999

LifePath Index 2050 Fund

    266,359        1,255,314      1,521,673

LifePath Index 2055 Fund

    187,157        16,450      203,607

LifePath Index 2060 Fund

    46,054        21,258      67,312

LifePath Index 2065 Fund

    1,837        8,912      10,749

Administration: The Trust, on behalf of each Fund, entered into an Administration Agreement with BlackRock Advisors, LLC (“BAL” or the “Administrator”), an indirect, wholly-owned subsidiary of BlackRock, to provide general administrative services (other than investment advice and related portfolio activities). BAL has agreed to bear all of the Funds’ ordinary operating expenses, excluding, generally, investment advisory fees, distribution fees, brokerage and other expenses related to the execution of portfolio transactions, extraordinary expenses and certain other expenses which are borne by the Funds. BAL may delegate certain of its administration duties to sub-administrators. BAL is entitled to receive for these administrative services an annual fee of 0.09% based on the average daily net assets of each Fund’s Institutional, Investor A and Investor P Shares and 0.04% of the average daily net assets of each Fund’s Class K Shares.

From time to time, BAL may waive such fees in whole or in part. Any such waiver will reduce the expenses of the Funds and, accordingly, have a favorable impact on their performance. BAL may delegate certain of its administration duties to sub-administrators.

 

 

106  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements    (continued)

 

For the year ended December 31, 2022, the following table shows the class specific administration fees borne directly by each share class of each Fund:

 

Fund Name   Institutional      Investor A      Investor P      Class K      Total  

LifePath Index Retirement Fund

  $ 384,876      $ 175,974      $ 1,952,366      $  2,042,082      $  4,555,298  

LifePath Index 2025 Fund

    174,937        108,832        84,311        2,345,140        2,713,220  

LifePath Index 2030 Fund

    482,979        177,686        1,668,772        3,118,212        5,447,649  

LifePath Index 2035 Fund

    158,492        117,860        37,845        2,593,638        2,907,835  

LifePath Index 2040 Fund

    554,254        134,845        1,372,167        2,664,181        4,725,447  

LifePath Index 2045 Fund

    129,055        96,057        11,223        2,049,392        2,285,727  

LifePath Index 2050 Fund

    114,518        95,889        451,913        1,901,205        2,563,525  

LifePath Index 2055 Fund

    95,939        67,376        5,922        1,209,998        1,379,235  

LifePath Index 2060 Fund

    29,444        16,579        7,653        539,592        593,268  

LifePath Index 2065 Fund

    7,453        661        3,208        68,799        80,121  

Transfer Agent: Pursuant to written agreements, certain financial intermediaries, some of which may be affiliates, provide the Funds with sub-accounting, recordkeeping, sub-transfer agency and other administrative services with respect to servicing of underlying investor accounts. For these services, these entities receive an asset-based fee or an annual fee per shareholder account, which will vary depending on share class and/or net assets. For the year ended December 31, 2022, the Funds did not pay any amounts to affiliates in return for these services.

Other Fees: For the year ended December 31, 2022, affiliates earned underwriting discounts, direct commissions and dealer concessions on sales of each Fund’s Investor P Shares as follows:

 

Fund Name   Investor P  

LifePath Index Retirement Fund

  $  101,220  

LifePath Index 2025 Fund

    29,248  

LifePath Index 2030 Fund

    110,616  

LifePath Index 2035 Fund

    17,102  

LifePath Index 2040 Fund

    117,156  

LifePath Index 2045 Fund

    7,208  

LifePath Index 2050 Fund

    59,621  

LifePath Index 2055 Fund

    5,152  

LifePath Index 2060 Fund

    5,592  

LifePath Index 2065 Fund

    2,008  

For the year ended December 31, 2022, affiliates received CDSCs as follows:

 

Fund Name   Investor P  

LifePath Index Retirement Fund

  $   3,164  

LifePath Index 2025 Fund

    731  

LifePath Index 2030 Fund

    860  

LifePath Index 2035 Fund

    849  

LifePath Index 2040 Fund

    58  

Expense Waivers and Reimbursements: With respect to each Fund, the Manager contractually agreed to waive its investment advisory fees by the amount of investment advisory fees each Fund pays to BFA indirectly through its investment in affiliated money market funds (the “affiliated money market fund waiver”) through June 30, 2023. The contractual agreement may be terminated upon 90 days’ notice by a majority of the trustees who are not “interested persons” of the Funds, as defined in the 1940 Act (“Independent Trustees”), or by a vote of a majority of the outstanding voting securities of the Funds. These amounts are included in fees waived and/or reimbursed by the Administrator/Manager in the Statements of Operations. For the year ended December 31, 2022, the amounts waived were as follows:

 

Fund Name   Fees Waived and/or Reimbursed
by the Administrator/Manager
 

LifePath Index Retirement Fund

  $   5,906  

LifePath Index 2025 Fund

    6,506  

LifePath Index 2030 Fund

    12,678  

LifePath Index 2035 Fund

    9,684  

LifePath Index 2040 Fund

    12,740  

LifePath Index 2045 Fund

    8,662  

LifePath Index 2050 Fund

    9,264  

LifePath Index 2055 Fund

    5,896  

LifePath Index 2060 Fund

    2,998  

LifePath Index 2065 Fund

    556  

The Manager and the Administrator have contractually agreed to reimburse each Fund for acquired fund fees and expenses up to a maximum amount equal to the combined investment advisory fee and administration fee of each share class through June 30, 2023. The contractual agreement may be terminated upon 90 days’ notice by a majority of the Independent Trustees, or by a vote of a majority of the outstanding voting securities of the Funds. These amounts are included in fees waived and/or reimbursed by the

 

 

N O T E S   T O   F I N A N C I A L   S T A T E M E N T S

  107


Notes to Financial Statements    (continued)

 

Administrator/Manager in the Statements of Operations. For the year ended December 31, 2022, the amounts waived in investment advisory fees pursuant to these arrangements were as follows:

 

LifePath Index Fund Name   Fees Waived and/or Reimbursed
by the Administrator/Manager
 

LifePath Index Retirement Fund

  $                                 3,477,563  

LifePath Index 2025 Fund

    2,909,113  

LifePath Index 2030 Fund

    5,260,689  

LifePath Index 2035 Fund

    3,724,189  

LifePath Index 2040 Fund

    5,146,262  

LifePath Index 2045 Fund

    3,214,583  

LifePath Index 2050 Fund

    3,306,351  

LifePath Index 2055 Fund

    1,937,993  

LifePath Index 2060 Fund

    857,619  

LifePath Index 2065 Fund

    115,283  

The fees and expenses of the Funds’ Independent Trustees, counsel to the Independent Trustees and the Funds’ independent registered public accounting firm (together, the “independent expenses”) are paid directly by the Funds. Each of BAL and BFA has contractually agreed to reimburse the Funds or provide an offsetting credit for such independent expenses through June 30, 2032. These amounts are included in fees waived and/or reimbursed by the Administrator/Manager in the Statements of Operations. For the year ended December 31, 2022, the amounts waived were as follows:

 

Fund Name   Fees Waived and/or Reimbursed
by the Administrator/Manager
 

LifePath Index Retirement Fund

  $                                      76,535  

LifePath Index 2025 Fund

    65,143  

LifePath Index 2030 Fund

    100,776  

LifePath Index 2035 Fund

    74,240  

LifePath Index 2040 Fund

    86,264  

LifePath Index 2045 Fund

    63,220  

LifePath Index 2050 Fund

    64,041  

LifePath Index 2055 Fund

    49,864  

LifePath Index 2060 Fund

    36,546  

LifePath Index 2065 Fund

    28,426  

Securities Lending: The SEC has issued an exemptive order which permits BTC, an affiliate of the Manager, to serve as securities lending agent for the Funds, subject to applicable conditions. As securities lending agent, BTC bears all operational costs directly related to securities lending, including any custodial costs. The Funds are responsible for fees in connection with the investment of cash collateral received for securities on loan (the “collateral investment fees”). The cash collateral is invested in a money market fund, BlackRock Cash Funds: Institutional or BlackRock Cash Funds: Treasury, managed by the Manager or its affiliates. However, BTC has agreed to reduce the amount of securities lending income it receives in order to effectively limit the collateral investment fees the Funds bear to an annual rate of 0.04%. The SL Agency Shares of such money market fund will not be subject to a sales load, distribution fee or service fee. The money market fund in which the cash collateral has been invested may, under certain circumstances, impose a liquidity fee of up to 2% of the value redeemed or temporarily restrict redemptions for up to 10 business days during a 90 day period, in the event that the money market fund’s weekly liquid assets fall below certain thresholds.

Securities lending income is equal to the total of income earned from the reinvestment of cash collateral, net of fees and other payments to and from borrowers of securities, and less the collateral investment fees. Each Fund retains a portion of securities lending income and remits a remaining portion to BTC as compensation for its services as securities lending agent.

Pursuant to the current securities lending agreement, each Fund retains 82% of securities lending income (which excludes collateral investment fees), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment fees.

In addition, commencing the business day following the date that the aggregate securities lending income earned across the BlackRock Multi-Asset Complex in a calendar year exceeds a specified threshold, each Fund, pursuant to the securities lending agreement, will retain for the remainder of that calendar year securities lending income in an amount equal to 85% of securities lending income (which excludes collateral investment fees), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment fees.

The share of securities lending income earned by each Fund is shown as securities lending income — affiliated — net in the Statements of Operations. For the year ended December 31, 2022, each Fund paid BTC the following amounts for securities lending agent services:

 

Fund Name   Amounts  

LifePath Index Retirement Fund

  $  28,442  

LifePath Index 2025 Fund

    27,523  

LifePath Index 2030 Fund

    41,792  

LifePath Index 2035 Fund

    54,269  

LifePath Index 2040 Fund

    45,536  

LifePath Index 2045 Fund

    19,752  

LifePath Index 2050 Fund

    22,401  

 

 

108  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements    (continued)

 

Fund Name

  Amounts  

LifePath Index 2055 Fund

  $  20,204  

LifePath Index 2060 Fund

    1,809  

Interfund Lending: In accordance with an exemptive order (the “Order”) from the SEC, each Fund may participate in a joint lending and borrowing facility for temporary purposes (the “Interfund Lending Program”), subject to compliance with the terms and conditions of the Order, and to the extent permitted by each Fund’s investment policies and restrictions. Each Fund is currently permitted to borrow and lend under the Interfund Lending Program.

A lending BlackRock fund may lend in aggregate up to 15% of its net assets but may not lend more than 5% of its net assets to any one borrowing fund through the Interfund Lending Program. A borrowing BlackRock fund may not borrow through the Interfund Lending Program or from any other source more than 33 1/3% of its total assets (or any lower threshold provided for by the fund’s investment restrictions). If a borrowing BlackRock fund’s total outstanding borrowings exceed 10% of its total assets, each of its outstanding interfund loans will be subject to collateralization of at least 102% of the outstanding principal value of the loan. All interfund loans are for temporary or emergency purposes and the interest rate to be charged will be the average of the highest current overnight repurchase agreement rate available to a lending fund and the bank loan rate, as calculated according to a formula established by the Board.

During the year ended December 31, 2022, the Funds did not participate in the Interfund Lending Program.

Trustees and Officers: Certain trustees and/or officers of the Trust are directors and/or officers of BlackRock or its affiliates.

Other Transactions: Each Fund may invest its positive cash balances in certain money market funds managed by the Manager or an affiliate. The income earned on these temporary cash investments is shown as income-affiliated in the Statements of Operations.

The Funds may purchase securities from, or sell securities to, an affiliated fund provided the affiliation is due solely to having a common investment adviser, common officers, or common trustees. For the year ended December 31, 2022, the purchase and sale transactions and any net realized gains (losses) with affiliated funds in compliance with Rule 17a-7 under the 1940 Act were as follows:

 

LifePath Index Fund Name   Purchases      Sales      Net Realized
Gain (Loss)
 

LifePath Index Retirement Fund

  $   5,981,234      $      $  

LifePath Index 2025 Fund

    5,422,815                

LifePath Index 2030 Fund

    6,473,833                

LifePath Index 2045 Fund

             2,410,591        (418,902

LifePath Index 2050 Fund

           9,580,715          (1,668,520

LifePath Index 2055 Fund

           4,436,678        (797,100

LifePath Index 2060 Fund

           1,448,370        (266,105

 

6.

PURCHASES AND SALES

For the year ended December 31, 2022, purchases and sales of investments in the Underlying Funds and the Underlying Master Portfolios, excluding short-term securities, were as follows:

 

LifePath Index Fund Name   Purchases      Sales  

LifePath Index Retirement Fund

  $   5,590,736,334      $   6,005,903,239  

LifePath Index 2025 Fund

    4,156,785,844        3,978,086,440  

LifePath Index 2030 Fund

    5,860,925,252        5,163,923,627  

LifePath Index 2035 Fund

    3,561,346,461        2,693,203,198  

LifePath Index 2040 Fund

    3,493,163,814        2,579,043,026  

LifePath Index 2045 Fund

    1,657,578,338        868,813,988  

LifePath Index 2050 Fund

    1,512,452,892        621,090,902  

LifePath Index 2055 Fund

    1,033,220,440        332,228,341  

LifePath Index 2060 Fund

    645,373,441        126,791,692  

LifePath Index 2065 Fund

    163,136,844        14,468,739  

 

7.

INCOME TAX INFORMATION

It is each Fund’s policy to comply with the requirements of the Internal Revenue Code of 1986, as amended, applicable to regulated investment companies, and to distribute substantially all of its taxable income to its shareholders. Therefore, no U.S. federal income tax provision is required.

Each Fund files U.S. federal and various state and local tax returns. No income tax returns are currently under examination. The statute of limitations on each Fund’s U.S. federal tax returns generally remains open for a period of three years after they are filed. The statutes of limitations on each Fund’s state and local tax returns may remain open for an additional year depending upon the jurisdiction.

Management has analyzed tax laws and regulations and their application to the Funds as of December 31, 2022, inclusive of the open tax return years, and does not believe that there are any uncertain tax positions that require recognition of a tax liability in the Funds’ financial statements.

 

 

N O T E S   T O   F I N A N C I A L   S T A T E M E N T S

  109


Notes to Financial Statements    (continued)

 

U.S. GAAP requires that certain components of net assets be adjusted to reflect permanent differences between financial and tax reporting. These reclassifications have no effect on net assets or NAVs per share. As of period end, permanent differences attributable to the timing and recognition of partnership income were reclassified to the following accounts:

 

Fund Name   Paid-in Capital     Accumulated
Earnings (Loss)
 

LifePath Index Retirement Fund

  $   (286,600,286   $   286,600,286  

LifePath Index 2025 Fund

    (249,207,780     249,207,780  

LifePath Index 2030 Fund

    (292,555,376     292,555,376  

LifePath Index 2035 Fund

    (143,759,425     143,759,425  

LifePath Index 2040 Fund

    (109,678,483     109,678,483  

LifePath Index 2045 Fund

    (2,229,809     2,229,809  

LifePath Index 2050 Fund

    (373,590     373,590  

LifePath Index 2055 Fund

    (27,921     27,921  

LifePath Index 2060 Fund

    (72,981     72,981  

LifePath Index 2065 Fund

    (3,690     3,690  

The tax character of distributions paid was as follows:

 

Fund Name   Year Ended
12/31/22
     Year Ended
12/31/21
 

LifePath Index Retirement Fund

    

Ordinary income

  $   182,042,140      $   200,209,120  

Long-term capital gains

    11,551,127        52,858,441  
 

 

 

    

 

 

 
  $ 193,593,267      $ 253,067,561  
 

 

 

    

 

 

 

LifePath Index 2025 Fund

    

Ordinary income

  $ 148,841,260      $ 147,248,029  

Long-term capital gains

    2,152,536        24,577,216  
 

 

 

    

 

 

 
  $ 150,993,796      $ 171,825,245  
 

 

 

    

 

 

 

LifePath Index 2030 Fund

    

Ordinary income

  $ 234,391,038      $ 248,476,242  

Long-term capital gains

    12,590,478        38,494,037  
    
  $ 246,981,516      $ 286,970,279  
 

 

 

    

 

 

 

LifePath Index 2035 Fund

    

Ordinary income

  $ 151,313,926      $ 156,838,083  

Long-term capital gains

    6,492,265        12,862,754  
    
  $ 157,806,191      $ 169,700,837  
 

 

 

    

 

 

 

LifePath Index 2040 Fund

    

Ordinary income

  $ 183,767,426      $ 209,581,940  

Long-term capital gains

    11,306,340        19,016,361  
    
  $ 195,073,766      $ 228,598,301  
 

 

 

    

 

 

 

LifePath Index 2045 Fund

    

Ordinary income

  $ 106,126,708      $ 119,639,618  

Long-term capital gains

           10,980,886  
    
  $ 106,126,708      $ 130,620,504  
 

 

 

    

 

 

 

LifePath Index 2050 Fund

    

Ordinary income

  $ 102,970,542      $ 118,911,237  

Long-term capital gains

    5,135,862        4,161,410  
 

 

 

    

 

 

 
  $ 108,106,404      $ 123,072,647  
 

 

 

    

 

 

 

LifePath Index 2055 Fund

    

Ordinary income

  $ 60,106,403      $ 65,970,226  

Long-term capital gains

    2,358,195         
 

 

 

    

 

 

 
  $ 62,464,598      $ 65,970,226  
 

 

 

    

 

 

 

LifePath Index 2060 Fund

    

Ordinary income

  $ 26,091,355      $ 25,367,825  
 

 

 

    

 

 

 

LifePath Index 2065 Fund

    

Ordinary income

  $ 3,523,280      $ 1,890,207  
 

 

 

    

 

 

 

 

 

110  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements    (continued)

 

As of December 31, 2022, the tax components of accumulated earnings (loss) were as follows:

 

Fund Name   Undistributed
Ordinary Income
     Non-Expiring
Capital Loss
Carryforwards(a)
    Net Unrealized
Gains (Losses)(b)
    Total  

LifePath Index Retirement Fund

  $   2,492,199      $ (20,173,526   $   640,069,256     $   622,387,929  

LifePath Index 2025 Fund

    1,661,169        (46,501,338     476,131,151       431,290,982  

LifePath Index 2030 Fund

    3,015,888        (65,425,453     937,430,838       875,021,273  

LifePath Index 2035 Fund

    1,952,879        (51,220,292     561,226,738       511,959,325  

LifePath Index 2040 Fund

    2,870,385        (46,055,655     999,258,201       956,072,931  

LifePath Index 2045 Fund

    1,709,772        (51,270,303     481,538,912       431,978,381  

LifePath Index 2050 Fund

    1,875,467        (25,669,559     524,693,391       500,899,299  

LifePath Index 2055 Fund

    994,426        (14,249,416     210,693,897       197,438,907  

LifePath Index 2060 Fund

    50,587        (16,772,376     20,606,756       3,884,967  

LifePath Index 2065 Fund

    9,283        (16,347,800     (6,566,131     (22,904,648

 

  (a) 

Amounts available to offset future realized capital gains.

 
  (b) 

The difference between book-basis and tax-basis net unrealized gains was attributable primarily to tax deferral of losses on wash sales and the timing and recognition of partnership income.

 

As of December 31, 2022, gross unrealized appreciation and depreciation based on cost of investments (including short positions and derivatives, if any) for U.S. federal income tax purposes were as follows:

 

Fund Name   Tax Cost      Gross Unrealized
Appreciation
     Gross Unrealized
Depreciation
    Net Unrealized
Appreciation
(Depreciation)
 

LifePath Index Retirement Fund

  $   6,538,839,111      $ 672,174,301      $ (32,105,045   $   640,069,256  

LifePath Index 2025 Fund

    5,530,972,628        480,037,931        (3,906,780     476,131,151  

LifePath Index 2030 Fund

    9,136,552,404        1,042,115,927        (104,685,089     937,430,838  

LifePath Index 2035 Fund

    6,243,257,518        633,540,200        (72,313,462     561,226,738  

LifePath Index 2040 Fund

    7,845,152,098          1,153,065,474        (153,807,273     999,258,201  

LifePath Index 2045 Fund

    4,978,807,386        572,532,013        (90,993,101     481,538,912  

LifePath Index 2050 Fund

    5,125,924,738        612,234,261        (87,540,870     524,693,391  

LifePath Index 2055 Fund

    3,434,169,556        274,396,952        (63,703,055     210,693,897  

LifePath Index 2060 Fund

    1,571,216,959        65,527,415        (44,920,659     20,606,756  

LifePath Index 2065 Fund

    257,443,024               (6,566,131     (6,566,131

 

8.

BANK BORROWINGS

The Trust, on behalf of each Fund, along with certain other funds managed by the Manager and its affiliates (“Participating Funds”), are a party to a 364-day, $2.50 billion credit agreement with a group of lenders. Under this agreement, the Funds may borrow to fund shareholder redemptions. Excluding commitments designated for certain individual funds, the Participating Funds, including the Funds, can borrow up to an aggregate commitment amount of $1.75 billion at any time outstanding, subject to asset coverage and other limitations as specified in the agreement. The credit agreement has the following terms: a fee of 0.10% per annum on unused commitment amounts and interest at a rate equal to the higher of (a) Overnight Bank Funding Rate (“OBFR”) (but, in any event, not less than 0.00%) on the date the loan is made plus 0.80% per annum, (b) the Fed Funds rate (but, in any event, not less than 0.00%) in effect from time to time plus 0.80% per annum on amounts borrowed or (c) the sum of (x) Daily Simple Secured Overnight Financing Rate (“SOFR”) (but, in any event, not less than 0.00%) on the date the loan is made plus 0.10% and (y) 0.80% per annum. The agreement expires in April 2023 unless extended or renewed. These fees were allocated among such funds based upon portions of the aggregate commitment available to them and relative net assets of Participating Funds. During the year ended December 31, 2022, the Funds did not borrow under the credit agreement.

 

9.

PRINCIPAL RISKS

In the normal course of business, the Funds invest in securities or other instruments and may enter into certain transactions, and such activities subject each Fund to various risks, including among others, fluctuations in the market (market risk) or failure of an issuer to meet all of its obligations. The value of securities or other instruments may also be affected by various factors, including, without limitation: (i) the general economy; (ii) the overall market as well as local, regional or global political and/or social instability; (iii) regulation, taxation or international tax treaties between various countries; or (iv) currency, interest rate and price fluctuations. Local, regional or global events such as war, acts of terrorism, the spread of infectious illness or other public health issues, recessions, or other events could have a significant impact on the Funds and their investments. Each Fund’s prospectus provides details of the risks to which each Fund is subject.

The Funds may be exposed to additional risks when reinvesting cash collateral in money market funds that do not seek to maintain a stable NAV per share of $1.00, which may be subject to redemption gates or liquidity fees under certain circumstances.

Infectious Illness Risk: An outbreak of an infectious illness, such as the COVID-19 pandemic, may adversely impact the economies of many nations and the global economy, and may impact individual issuers and capital markets in ways that cannot be foreseen. An infectious illness outbreak may result in, among other things, closed international borders, prolonged quarantines, supply chain disruptions, market volatility or disruptions and other significant economic, social and political impacts.

 

 

N O T E S   T O   F I N A N C I A L   S T A T E M E N T S

  111


Notes to Financial Statements    (continued)

 

Counterparty Credit Risk: The Funds may be exposed to counterparty credit risk, or the risk that an entity may fail to or be unable to perform on its commitments related to unsettled or open transactions, including making timely interest and/or principal payments or otherwise honoring its obligations. The Funds manage counterparty credit risk by entering into transactions only with counterparties that the Manager believes have the financial resources to honor their obligations and by monitoring the financial stability of those counterparties. Financial assets, which potentially expose the Funds to market, issuer and counterparty credit risks, consist principally of financial instruments and receivables due from counterparties. The extent of the Funds’ exposure to market, issuer and counterparty credit risks with respect to these financial assets is approximately their value recorded in the Statements of Assets and Liabilities, less any collateral held by the Funds.

Concentration Risk: A diversified portfolio, where this is appropriate and consistent with a fund’s objectives, minimizes the risk that a price change of a particular investment will have a material impact on the NAV of a fund. The investment concentrations within each Fund’s portfolio are disclosed in its Schedule of Investments.

Significant Shareholder Redemption Risk: Certain shareholders may own or manage a substantial amount of fund shares and/or hold their fund investments for a limited period of time. Large redemptions of fund shares by these shareholders may force a fund to sell portfolio securities, which may negatively impact the fund’s NAV, increase the fund’s brokerage costs, and/or accelerate the realization of taxable income/gains and cause the fund to make additional taxable distributions to shareholders.

LIBOR Transition Risk: The United Kingdom’s Financial Conduct Authority announced a phase out of the London Interbank Offered Rate (“LIBOR”). Although many LIBOR rates ceased to be published or no longer are representative of the underlying market they seek to measure after December 31, 2021, a selection of widely used USD LIBOR rates will continue to be published through June 2023 in order to assist with the transition. The Funds may be exposed to financial instruments tied to LIBOR to determine payment obligations, financing terms, hedging strategies or investment value. The transition process away from LIBOR might lead to increased volatility and illiquidity in markets for, and reduce the effectiveness of new hedges placed against instruments whose terms currently include LIBOR. The ultimate effect of the LIBOR transition process on the Funds is uncertain.

 

10.

CAPITAL SHARE TRANSACTIONS

Transactions in capital shares for each class were as follows:

 

     Year Ended
12/31/22
    Year Ended
12/31/21
 
LifePath Index Fund Name / Share Class   Shares     Amounts     Shares     Amounts  

 

 

LifePath Index Retirement Fund

       

Institutional

       

Shares sold

    3,322,518     $ 43,530,873       3,751,788     $ 54,792,998  

Shares issued in reinvestment of distributions

    846,945       10,520,725       1,031,009       15,134,459  

Shares redeemed

    (9,000,036     (119,357,990     (7,075,257     (103,279,309
 

 

 

   

 

 

   

 

 

   

 

 

 
    (4,830,573   $ (65,306,392     (2,292,460   $ (33,351,852
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor A

       

Shares sold

    3,605,143     $ 46,130,749       3,308,198     $ 48,377,947  

Shares issued in reinvestment of distributions

    348,501       4,316,056       426,845       6,260,739  

Shares redeemed

    (5,647,114     (72,248,031     (6,015,284     (88,450,956
 

 

 

   

 

 

   

 

 

   

 

 

 
    (1,693,470   $ (21,801,226     (2,280,241   $ (33,812,270
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor P

       

Shares sold

    5,940,386     $ 78,449,437       9,337,906     $ 136,349,301  

Shares issued in reinvestment of distributions

    3,898,016       48,248,020       4,567,973       66,953,936  

Shares redeemed

    (27,659,511     (356,120,953     (21,339,515     (311,869,651
 

 

 

   

 

 

   

 

 

   

 

 

 
    (17,821,109   $   (229,423,496     (7,433,636   $ (108,566,414
 

 

 

   

 

 

   

 

 

   

 

 

 

Class K

       

Shares sold

    81,626,120     $ 1,082,601,220       95,303,751     $ 1,396,969,047  

Shares issued in reinvestment of distributions

    10,505,243       130,316,225       11,208,598       164,483,301  

Shares redeemed

    (94,074,425       (1,228,012,734     (91,038,339       (1,335,140,269
 

 

 

   

 

 

   

 

 

   

 

 

 
    (1,943,062   $ (15,095,289     15,474,010     $   226,312,079  
 

 

 

   

 

 

   

 

 

   

 

 

 
    (26,288,214   $ (331,626,403     3,467,673     $ 50,581,543  
 

 

 

   

 

 

   

 

 

   

 

 

 

 

     Year Ended
12/31/22
    Year Ended
12/31/21
 
LifePath Index Fund Name / Share Class   Shares     Amounts     Shares     Amounts  

LifePath Index 2025 Fund

       

Institutional

       

Shares sold

    2,914,599     $   42,322,635       3,108,606     $ 50,467,119  

Shares issued in reinvestment of distributions

    331,529       4,584,259       342,302       5,617,714  

Shares redeemed

    (3,459,810       (50,862,950     (3,889,288       (63,061,445
 

 

 

   

 

 

   

 

 

   

 

 

 
    (213,682   $ (3,956,056     (438,380   $ (6,976,612
 

 

 

   

 

 

   

 

 

   

 

 

 

 

 

112  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements    (continued)

 

 

 
    Year Ended
12/31/22
    Year Ended
12/31/21
 
LifePath Index Fund Name / Share Class (continued)   Shares     Amounts     Shares     Amounts  

LifePath Index 2025 Fund (continued)

       

Investor A

       

Shares sold

    1,121,924     $ 16,522,275       2,223,904     $ 36,068,232  

Shares issued in reinvestment of distributions

    177,710       2,455,027       214,867       3,521,034  

Shares redeemed

    (2,526,356     (37,060,750     (4,176,751     (68,590,249
 

 

 

   

 

 

   

 

 

   

 

 

 
    (1,226,722   $ (18,083,448     (1,737,980   $ (29,000,983
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor P

       

Shares sold

    1,662,719     $ 24,849,590       2,624,830     $ 42,825,132  

Shares issued in reinvestment of distributions

    145,042       1,996,089       124,696       2,043,400  

Shares redeemed

    (1,456,618     (20,953,206     (788,161     (12,878,946
 

 

 

   

 

 

   

 

 

   

 

 

 
    351,143     $ 5,892,473       1,961,365     $ 31,989,586  
 

 

 

   

 

 

   

 

 

   

 

 

 

Class K

       

Shares sold

    85,855,261     $ 1,260,937,785       106,844,489     $ 1,745,955,793  

Shares issued in reinvestment of distributions

    10,257,345       141,861,605       9,777,868       160,551,824  

Shares redeemed

    (78,400,268       (1,142,842,420     (73,909,800       (1,210,355,839
 

 

 

   

 

 

   

 

 

   

 

 

 
    17,712,338     $ 259,956,970       42,712,557     $ 696,151,778  
 

 

 

   

 

 

   

 

 

   

 

 

 
    16,623,077     $ 243,809,939       42,497,562     $ 692,163,769  
 

 

 

   

 

 

   

 

 

   

 

 

 
                         

 

 
    Year Ended
12/31/22
    Year Ended
12/31/21
 
LifePath Index Fund Name / Share Class   Shares     Amounts     Shares     Amounts  

LifePath Index 2030 Fund

       

Institutional

       

Shares sold

    4,157,741     $ 63,924,543       4,179,948     $ 71,692,699  

Shares issued in reinvestment of distributions

    867,050       12,609,861       975,586       17,003,935  

Shares redeemed

    (7,374,492     (118,297,753     (5,213,017     (89,488,029
 

 

 

   

 

 

   

 

 

   

 

 

 
    (2,349,701   $ (41,763,349     (57,483   $ (791,395
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor A

       

Shares sold

    2,949,627     $ 45,073,937       2,675,123     $ 45,995,725  

Shares issued in reinvestment of distributions

    278,850       4,050,078       330,252       5,756,812  

Shares redeemed

    (3,990,230     (61,098,454     (5,101,834     (88,782,944
 

 

 

   

 

 

   

 

 

   

 

 

 
    (761,753   $ (11,974,439     (2,096,459   $ (37,030,407
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor P

       

Shares sold

    4,935,905     $ 76,741,580       6,264,215     $ 107,815,062  

Shares issued in reinvestment of distributions

    2,660,021       38,593,592       2,954,072       51,479,618  

Shares redeemed

    (14,951,026     (229,599,930     (14,139,724     (243,036,439
 

 

 

   

 

 

   

 

 

   

 

 

 
    (7,355,100   $ (114,264,758     (4,921,437   $ (83,741,759
 

 

 

   

 

 

   

 

 

   

 

 

 

Class K

       

Shares sold

    121,463,311     $ 1,883,996,167       121,837,778     $ 2,101,533,352  

Shares issued in reinvestment of distributions

    13,205,336       191,673,950       12,206,714       212,627,649  

Shares redeemed

    (71,788,403     (1,101,453,243     (61,483,228     (1,063,947,767
 

 

 

   

 

 

   

 

 

   

 

 

 
    62,880,244     $ 974,216,874       72,561,264     $ 1,250,213,234  
 

 

 

   

 

 

   

 

 

   

 

 

 
    52,413,690     $ 806,214,328       65,485,885     $ 1,128,649,673  
 

 

 

   

 

 

   

 

 

   

 

 

 
       

 

 
    Year Ended
12/31/22
    Year Ended
12/31/21
 
LifePath Index Fund Name / Share Class   Shares     Amounts     Shares     Amounts  

LifePath Index 2035 Fund

       

Institutional

       

Shares sold

    2,753,122     $ 45,228,753       2,579,797     $ 47,053,215  

Shares issued in reinvestment of distributions

    257,378       3,971,855       244,649       4,557,207  

Shares redeemed

    (1,974,197     (32,963,307     (2,029,057     (36,810,681
 

 

 

   

 

 

   

 

 

   

 

 

 
    1,036,303     $ 16,237,301       795,389     $ 14,799,741  
 

 

 

   

 

 

   

 

 

   

 

 

 

 

 

N O T E S   T O   F I N A N C I A L   S T A T E M E N T S

  113


Notes to Financial Statements    (continued)

 

     Year Ended
12/31/22
    Year Ended
12/31/21
 
LifePath Index Fund Name / Share Class (continued)   Shares     Amounts     Shares     Amounts  

LifePath Index 2035 Fund (continued)

       

Investor A

       

Shares sold

    1,748,081     $   28,952,854       2,225,554     $ 40,603,091  

Shares issued in reinvestment of distributions

    165,138       2,540,944       188,101       3,493,199  

Shares redeemed

    (2,233,800     (36,590,795     (4,152,161     (76,828,765
 

 

 

   

 

 

   

 

 

   

 

 

 
    (320,581   $ (5,096,997     (1,738,506   $ (32,732,475
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor P

       

Shares sold

    886,096     $ 14,864,811       975,399     $ 17,876,124  

Shares issued in reinvestment of distributions

    55,923       857,070       43,616       811,372  

Shares redeemed

    (471,153     (7,608,330     (214,963     (3,932,413
 

 

 

   

 

 

   

 

 

   

 

 

 
    470,866     $ 8,113,551       804,052     $ 14,755,083  
 

 

 

   

 

 

   

 

 

   

 

 

 

Class K

       

Shares sold

    99,466,782     $   1,642,593,394       102,251,869     $ 1,874,324,832  

Shares issued in reinvestment of distributions

    9,760,185       150,380,730       8,637,481       160,798,184  

Shares redeemed

    (53,246,888     (871,529,169     (48,316,467     (889,731,910
 

 

 

   

 

 

   

 

 

   

 

 

 
    55,980,079     $ 921,444,955       62,572,883     $ 1,145,391,106  
 

 

 

   

 

 

   

 

 

   

 

 

 
    57,166,667     $ 940,698,810       62,433,818     $   1,142,213,455  
 

 

 

   

 

 

   

 

 

   

 

 

 
                         
     Year Ended
12/31/22
    Year Ended
12/31/21
 
LifePath Index Fund Name / Share Class   Shares     Amounts     Shares     Amounts  

LifePath Index 2040 Fund

       

Institutional

       

Shares sold

    3,980,851     $ 68,817,594       3,990,720     $ 76,317,755  

Shares issued in reinvestment of distributions

    824,339       13,278,142       885,176       17,358,012  

Shares redeemed

    (4,669,829     (84,499,843     (4,795,998     (91,196,006
 

 

 

   

 

 

   

 

 

   

 

 

 
    135,361     $ (2,404,107     79,898     $ 2,479,761  
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor A

       

Shares sold

    2,431,747     $ 41,365,509       2,149,241     $ 40,966,655  

Shares issued in reinvestment of distributions

    171,835       2,759,877       204,347       4,002,391  

Shares redeemed

    (2,939,625     (50,274,558     (3,354,215     (65,007,062
 

 

 

   

 

 

   

 

 

   

 

 

 
    (336,043   $ (6,149,172     (1,000,627   $ (20,038,016
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor P

       

Shares sold

    4,253,821     $ 73,608,165       4,718,137     $ 90,279,276  

Shares issued in reinvestment of distributions

    1,797,985       28,829,663       1,975,787       38,704,069  

Shares redeemed

    (8,061,637     (138,737,403     (8,744,820     (167,059,012
 

 

 

   

 

 

   

 

 

   

 

 

 
    (2,009,831   $ (36,299,575     (2,050,896   $ (38,075,667
 

 

 

   

 

 

   

 

 

   

 

 

 

Class K

       

Shares sold

    96,958,558     $ 1,681,275,525       88,270,697     $ 1,694,773,272  

Shares issued in reinvestment of distributions

    9,331,202       150,176,717       8,589,820       168,487,588  

Shares redeemed

    (44,419,515     (761,636,913     (45,490,602     (878,836,418
 

 

 

   

 

 

   

 

 

   

 

 

 
    61,870,245     $   1,069,815,329       51,369,915     $   984,424,442  
 

 

 

   

 

 

   

 

 

   

 

 

 
    59,659,732     $ 1,024,962,475       48,398,290     $ 928,790,520  
 

 

 

   

 

 

   

 

 

   

 

 

 
                         
    Year Ended
12/31/22
    Year Ended
12/31/21
 
LifePath Index Fund Name / Share Class   Shares     Amounts     Shares     Amounts  

LifePath Index 2045 Fund

       

Institutional

       

Shares sold

    2,369,625     $ 42,552,614       1,800,579     $   36,025,831  

Shares issued in reinvestment of distributions

    164,210       2,767,676       173,783       3,582,921  

Shares redeemed

    (1,454,300     (26,565,926     (1,626,651     (32,140,028
 

 

 

   

 

 

   

 

 

   

 

 

 
    1,079,535     $   18,754,364       347,711     $ 7,468,724  
 

 

 

   

 

 

   

 

 

   

 

 

 

 

 

114  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements  (continued)

 

     Year Ended
12/31/22
    Year Ended
12/31/21
 
LifePath Index Fund Name / Share Class (continued)   Shares     Amounts     Shares     Amounts  

LifePath Index 2045 Fund (continued)

       

Investor A

       

Shares sold

    1,442,972     $ 25,997,776       1,641,743     $ 32,791,396  

Shares issued in reinvestment of distributions

    104,093       1,748,465       128,467       2,643,449  

Shares redeemed

    (1,276,785     (22,802,370     (3,039,874     (61,817,335
 

 

 

   

 

 

   

 

 

   

 

 

 
    270,280     $ 4,943,871       (1,269,664   $ (26,382,490
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor P

       

Shares sold

    332,033     $ 5,964,077       200,755     $ 3,984,750  

Shares issued in reinvestment of distributions

    12,925       216,147       11,882       244,726  

Shares redeemed

    (95,012     (1,689,100     (53,022     (1,055,025
 

 

 

   

 

 

   

 

 

   

 

 

 
    249,946     $ 4,491,124       159,615     $ 3,174,451  
 

 

 

   

 

 

   

 

 

   

 

 

 

Class K

       

Shares sold

    75,212,536     $   1,362,339,830       71,955,684     $   1,449,065,948  

Shares issued in reinvestment of distributions

    6,009,379       101,367,050       6,014,683       124,109,443  

Shares redeemed

    (35,353,975     (635,082,318     (33,609,340     (681,384,304
 

 

 

   

 

 

   

 

 

   

 

 

 
    45,867,940     $ 828,624,562       44,361,027     $ 891,791,087  
 

 

 

   

 

 

   

 

 

   

 

 

 
    47,467,701     $ 856,813,921       43,598,689     $ 876,051,772  
 

 

 

   

 

 

   

 

 

   

 

 

 
       
     Year Ended
12/31/22
    Year Ended
12/31/21
 
LifePath Index Fund Name / Share Class   Shares     Amounts     Shares     Amounts  

LifePath Index 2050 Fund

       

Institutional

       

Shares sold

    2,549,671     $ 47,196,152       2,103,979     $ 43,339,523  

Shares issued in reinvestment of distributions

    142,969       2,472,803       158,110       3,355,283  

Shares redeemed

    (2,483,297     (49,523,550     (1,910,826     (38,813,495
 

 

 

   

 

 

   

 

 

   

 

 

 
    209,343     $ 145,405       351,263     $ 7,881,311  
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor A

       

Shares sold

    1,642,174     $ 30,560,874       1,717,133     $ 35,062,088  

Shares issued in reinvestment of distributions

    101,874       1,755,763       112,836       2,389,213  

Shares redeemed

    (1,378,442     (25,187,158     (2,321,226     (48,704,036
 

 

 

   

 

 

   

 

 

   

 

 

 
    365,606     $ 7,129,479       (491,257   $ (11,252,735
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor P

       

Shares sold

    1,976,270     $ 36,586,198       2,049,756     $ 42,144,734  

Shares issued in reinvestment of distributions

    480,520       8,268,056       533,333       11,296,633  

Shares redeemed

    (2,665,469     (49,477,023     (3,206,097     (65,467,384
 

 

 

   

 

 

   

 

 

   

 

 

 
    (208,679   $ (4,622,769     (623,008   $ (12,026,017
 

 

 

   

 

 

   

 

 

   

 

 

 

Class K

       

Shares sold

    77,649,004     $   1,444,251,749       63,867,577     $   1,318,753,038  

Shares issued in reinvestment of distributions

    5,528,115       95,596,203       4,996,672       106,010,358  

Shares redeemed

    (31,260,519     (575,870,895     (29,867,183     (621,128,143
 

 

 

   

 

 

   

 

 

   

 

 

 
    51,916,600     $ 963,977,057       38,997,066     $ 803,635,253  
 

 

 

   

 

 

   

 

 

   

 

 

 
    52,282,870     $ 966,629,172       38,234,064     $ 788,237,812  
 

 

 

   

 

 

   

 

 

   

 

 

 
       
     Year Ended
12/31/22
    Year Ended
12/31/21
 
LifePath Index Fund Name / Share Class   Shares     Amounts     Shares     Amounts  

LifePath Index 2055 Fund

       

Institutional

       

Shares sold

    2,009,247     $ 38,207,124       1,482,520     $ 31,197,391  

Shares issued in reinvestment of distributions

    113,929       2,021,394       104,120       2,261,929  

Shares redeemed

    (1,019,871     (19,744,592     (1,097,199     (23,014,442
 

 

 

   

 

 

   

 

 

   

 

 

 
    1,103,305     $ 20,483,926       489,441     $ 10,444,878  
 

 

 

   

 

 

   

 

 

   

 

 

 

 

 

N O T E S   T O   F I N A N C I A L   S T A T E M E N T S

  115


Notes to Financial Statements  (continued)

 

     Year Ended
12/31/22
    Year Ended
12/31/21
 
LifePath Index Fund Name / Share Class (continued)   Shares     Amounts     Shares     Amounts  

LifePath Index 2055 Fund (continued)

       

Investor A

       

Shares sold

    1,291,592     $ 24,562,840       1,497,344     $ 31,505,420  

Shares issued in reinvestment of distributions

    67,032       1,184,678       72,213       1,566,891  

Shares redeemed

    (1,086,906     (20,502,064     (1,835,688     (39,338,925
 

 

 

   

 

 

   

 

 

   

 

 

 
    271,718     $ 5,245,454       (266,131   $ (6,266,614
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor P

       

Shares sold

    182,330     $ 3,471,328       113,419     $ 2,399,786  

Shares issued in reinvestment of distributions

    6,154       108,363       4,717       102,543  

Shares redeemed

    (58,828     (1,144,957     (29,875     (643,323
 

 

 

   

 

 

   

 

 

   

 

 

 
    129,656     $ 2,434,734       88,261     $ 1,859,006  
 

 

 

   

 

 

   

 

 

   

 

 

 

Class K

       

Shares sold

    56,009,618     $   1,063,826,989       45,561,411     $ 964,096,968  

Shares issued in reinvestment of distributions

    3,334,326       59,140,706       2,853,130       62,027,536  

Shares redeemed

    (21,483,115     (407,089,730     (18,897,485       (401,956,984
 

 

 

   

 

 

   

 

 

   

 

 

 
    37,860,829     $ 715,877,965       29,517,056     $ 624,167,520  
 

 

 

   

 

 

   

 

 

   

 

 

 
    39,365,508     $ 744,042,079       29,828,627     $ 630,204,790  
 

 

 

   

 

 

   

 

 

   

 

 

 
       
     Year Ended
12/31/22
    Year Ended
12/31/21
 
LifePath Index Fund Name / Share Class   Shares     Amounts     Shares     Amounts  

LifePath Index 2060 Fund

       

Institutional

       

Shares sold

    1,165,233     $ 19,757,610       1,031,864     $ 19,316,851  

Shares issued in reinvestment of distributions

    37,260       589,744       36,600       709,121  

Shares redeemed

    (821,676     (14,856,646     (429,706     (8,087,217
 

 

 

   

 

 

   

 

 

   

 

 

 
    380,817     $ 5,490,708       638,758     $ 11,938,755  
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor A

       

Shares sold

    611,741     $ 10,432,997       628,940     $ 11,671,091  

Shares issued in reinvestment of distributions

    16,739       264,515       18,250       352,818  

Shares redeemed

    (481,250     (8,096,533     (490,783     (9,371,287
 

 

 

   

 

 

   

 

 

   

 

 

 
    147,230     $ 2,600,979       156,407     $ 2,652,622  
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor P

       

Shares sold

    242,109     $ 4,067,449       179,361     $ 3,356,099  

Shares issued in reinvestment of distributions

    8,303       130,624       6,398       123,945  

Shares redeemed

    (44,815     (760,572     (56,585     (1,061,959
 

 

 

   

 

 

   

 

 

   

 

 

 
    205,597     $ 3,437,501       129,174     $ 2,418,085  
 

 

 

   

 

 

   

 

 

   

 

 

 

Class K

       

Shares sold

    42,004,196     $ 708,721,150       28,994,517     $ 546,224,454  

Shares issued in reinvestment of distributions

    1,586,196       25,099,571       1,248,079       24,174,378  

Shares redeemed

    (12,378,777     (207,392,538     (10,686,119     (203,088,909
 

 

 

   

 

 

   

 

 

   

 

 

 
    31,211,615     $ 526,428,183       19,556,477     $ 367,309,923  
 

 

 

   

 

 

   

 

 

   

 

 

 
    31,945,259     $ 537,957,371       20,480,816     $ 384,319,385  
 

 

 

   

 

 

   

 

 

   

 

 

 
       
     Year Ended
12/31/22
    Year Ended
12/31/21
 
LifePath Index Fund Name / Share Class   Shares     Amounts     Shares     Amounts  

LifePath Index 2065 Fund

       

Institutional

       

Shares sold

    625,634     $ 7,469,198       406,790     $ 5,358,025  

Shares issued in reinvestment of distributions

    13,729       152,414       6,972       95,113  

Shares redeemed

    (170,329     (2,015,415     (57,121     (766,522
 

 

 

   

 

 

   

 

 

   

 

 

 
    469,034     $ 5,606,197       356,641     $ 4,686,616  
 

 

 

   

 

 

   

 

 

   

 

 

 

 

 

116  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements  (continued)

 

     Year Ended
12/31/22
    Year Ended
12/31/21
 
LifePath Index Fund Name / Share Class (continued)   Shares     Amounts     Shares     Amounts  

LifePath Index 2065 Fund (continued)

       

Investor A

       

Shares sold

    65,917     $ 775,993       47,080     $ 626,809  

Shares issued in reinvestment of distributions

    1,006       11,133       419       5,736  

Shares redeemed

    (8,793     (104,679     (20,262     (273,274
 

 

 

   

 

 

   

 

 

   

 

 

 
    58,130     $ 682,447       27,237     $ 359,271  
 

 

 

   

 

 

   

 

 

   

 

 

 

Investor P

       

Shares sold

    206,328     $ 2,453,467       181,793     $ 2,433,004  

Shares issued in reinvestment of distributions

    4,901       54,187       2,616       35,855  

Shares redeemed

    (44,565     (532,125     (11,511     (147,778
 

 

 

   

 

 

   

 

 

   

 

 

 
    166,664     $ 1,975,529       172,898     $ 2,321,081  
 

 

 

   

 

 

   

 

 

   

 

 

 

Class K

       

Shares sold

    14,667,722     $   173,015,046       8,743,994     $   116,589,057  

Shares issued in reinvestment of distributions

    296,267       3,285,680       126,418       1,728,646  

Shares redeemed

    (2,892,871     (33,746,649     (1,902,794     (25,481,943
 

 

 

   

 

 

   

 

 

   

 

 

 
    12,071,118     $ 142,554,077       6,967,618     $ 92,835,760  
 

 

 

   

 

 

   

 

 

   

 

 

 
    12,764,946     $ 150,818,250       7,524,394     $ 100,202,728  
 

 

 

   

 

 

   

 

 

   

 

 

 

As of December 31, 2022, shares owned by BlackRock Financial Management, Inc., an affiliate of the Funds, were as follows:

 

Fund Name   Institutional      Investor A      Investor P      Class K  

LifePath Index Retirement Fund

                  32,483         

LifePath Index 2025 Fund

                  14,948         

LifePath Index 2030 Fund

                  14,524         

LifePath Index 2035 Fund

                  14,025         

LifePath Index 2040 Fund

                  13,661         

LifePath Index 2045 Fund

                  13,289         

LifePath Index 2050 Fund

                  13,072         

LifePath Index 2055 Fund

                  12,821         

LifePath Index 2060 Fund

                  14,482         

LifePath Index 2065 Fund

    5,000        5,000        5,000        85,000  

 

11.

SUBSEQUENT EVENTS

Management has evaluated the impact of all subsequent events on the Funds through the date the financial statements were issued and has determined that there were no subsequent events requiring adjustment or additional disclosure in the financial statements.

 

 

N O T E S   T O   F I N A N C I A L   S T A T E M E N T S

  117


Report of Independent Registered Public Accounting Firm

 

To the Board of Trustees of BlackRock Funds III and Shareholders of each of the ten funds listed in the table below

Opinions on the Financial Statements

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of each of the funds listed in the table below (ten of the series constituting BlackRock Funds III, hereafter collectively referred to as the “Funds”) as of December 31, 2022, the related statements of operations for the year ended December 31, 2022, the statements of changes in net assets for each of the two years in the period ended December 31, 2022, including the related notes, and the financial highlights for each of the periods indicated therein (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Funds as of December 31, 2022, the results of each of their operations for the year then ended, the changes in each of their net assets for each of the two years in the period ended December 31, 2022, and each of the financial highlights for each of the periods indicated therein in conformity with accounting principles generally accepted in the United States of America.

 

BlackRock LifePath® Index Retirement Fund

BlackRock LifePath® Index 2025 Fund

BlackRock LifePath® Index 2030 Fund

BlackRock LifePath® Index 2035 Fund

BlackRock LifePath® Index 2040 Fund

BlackRock LifePath® Index 2045 Fund

BlackRock LifePath® Index 2050 Fund

BlackRock LifePath® Index 2055 Fund

BlackRock LifePath® Index 2060 Fund

BlackRock LifePath® Index 2065 Fund

Basis for Opinions

These financial statements are the responsibility of the Funds’ management. Our responsibility is to express an opinion on the Funds’ financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Funds in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of December 31, 2022 by correspondence with the custodian, accounting agent of the Underlying Master Portfolios, transfer agents and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinions.

/s/PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania

February 23, 2023

We have served as the auditor of one or more BlackRock investment companies since 2000.

 

 

118  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Important Tax Information  (unaudited)

 

The following amounts, or maximum amounts allowable by law, are hereby designated as qualified dividend income for individuals for the fiscal year ended December 31, 2022:

 

LifePath Index Fund Name   Qualified Dividend
Income
 

LifePath Index Retirement Fund

  $ 47,350,772  

LifePath Index 2025 Fund

    45,030,900  

LifePath Index 2030 Fund

    94,999,185  

LifePath Index 2035 Fund

    73,794,026  

LifePath Index 2040 Fund

    112,104,631  

LifePath Index 2045 Fund

    75,973,726  

LifePath Index 2050 Fund

    83,330,858  

LifePath Index 2055 Fund

    49,437,736  

LifePath Index 2060 Fund

    21,834,363  

LifePath Index 2065 Fund

    2,897,555  

The following amounts, or maximum amounts allowable by law, are hereby designated as qualified business income for individuals for the fiscal year ended December 31, 2022:

 

LifePath Index Fund Name   Qualified Business
Income
 

LifePath Index Retirement Fund

  $ 3,474,025  

LifePath Index 2025 Fund

    2,869,209  

LifePath Index 2030 Fund

    5,609,751  

LifePath Index 2035 Fund

    4,280,035  

LifePath Index 2040 Fund

    6,369,310  

LifePath Index 2045 Fund

    4,165,821  

LifePath Index 2050 Fund

    4,410,242  

LifePath Index 2055 Fund

    2,544,240  

LifePath Index 2060 Fund

    1,047,730  

LifePath Index 2065 Fund

    101,255  

The Funds hereby designate the following amounts, or maximum amounts allowable by law, as capital gain dividends, subject to a long-term capital gains tax rate as noted below, for the fiscal year ended December 31, 2022:

 

LifePath Index Fund Name   20% Rate Long-Term
Capital Gain Dividends
 

LifePath Index Retirement Fund

  $ 11,551,127  

LifePath Index 2025 Fund

    2,152,536  

LifePath Index 2030 Fund

    12,590,478  

LifePath Index 2035 Fund

    6,492,265  

LifePath Index 2040 Fund

    6,492,265  

LifePath Index 2045 Fund

    6,492,265  

LifePath Index 2050 Fund

    5,135,862  

LifePath Index 2055 Fund

    2,358,195  

LifePath Index 2060 Fund

     

LifePath Index 2065 Fund

     

The Funds hereby designate the following amounts, or maximum amounts allowable by law, of distributions from direct federal obligation interest for the fiscal year ended December 31, 2022:

 

LifePath Index Fund Name   Federal Obligation
Interest
 

LifePath Index Retirement Fund

  $ 60,067,163  

LifePath Index 2025 Fund

    44,245,643  

LifePath Index 2030 Fund

    59,423,956  

LifePath Index 2035 Fund

    27,812,452  

LifePath Index 2040 Fund

    26,196,079  

LifePath Index 2045 Fund

    8,536,777  

LifePath Index 2050 Fund

    2,314,546  

LifePath Index 2055 Fund

    517,176  

LifePath Index 2060 Fund

    111,743  

LifePath Index 2065 Fund

    40,636  

The law varies in each state as to whether and what percent of ordinary income dividends attributable to federal obligations is exempt from state income tax. Shareholders are advised to check with their tax advisers to determine if any portion of the dividends received is exempt from state income tax.

 

 

I M P O R T A N T   T A X   I N F O R M A T I O N

  119


Important Tax Information  (unaudited) (continued)

 

The following percentages, or maximum percentages allowable by law, of ordinary income distributions paid during the fiscal year ended December 31, 2022 qualified for the dividends-received deduction for corporate shareholders:

 

LifePath Index Fund Name   Dividends-Received
Deduction
 

LifePath Index Retirement Fund

    12.09

LifePath Index 2025 Fund

    13.88  

LifePath Index 2030 Fund

    18.24  

LifePath Index 2035 Fund

    22.11  

LifePath Index 2040 Fund

    27.38  

LifePath Index 2045 Fund

    31.75  

LifePath Index 2050 Fund

    35.39  

LifePath Index 2055 Fund

    35.98  

LifePath Index 2060 Fund

    36.54  

LifePath Index 2065 Fund

    35.90  

The Funds hereby designate the following amounts, or maximum amounts allowable by law, as interest income eligible to be treated as a Section 163(j) interest dividend for the fiscal year ended December 31, 2022:

 

LifePath Index Fund Name   Interest
Dividends
 

LifePath Index Retirement Fund

  $     129,503,734  

LifePath Index 2025 Fund

    96,403,133  

LifePath Index 2030 Fund

    126,054,588  

LifePath Index 2035 Fund

    63,901,798  

LifePath Index 2040 Fund

    54,613,508  

LifePath Index 2045 Fund

    18,192,728  

LifePath Index 2050 Fund

    6,360,158  

LifePath Index 2055 Fund

    1,735,991  

LifePath Index 2060 Fund

    643,853  

LifePath Index 2065 Fund

    208,538  

The Funds hereby designate the following amounts, or maximum amounts allowable by law, as interest-related dividends eligible for exemption from U.S. withholding tax for nonresident aliens and foreign corporations for the fiscal year ended December 31, 2022:

 

LifePath Index Fund Name   Interest
Related
Dividends
 

LifePath Index Retirement Fund

  $ 126,560,893  

LifePath Index 2025 Fund

    94,359,506  

LifePath Index 2030 Fund

    123,520,750  

LifePath Index 2035 Fund

    62,667,055  

LifePath Index 2040 Fund

    53,578,207  

LifePath Index 2045 Fund

    17,751,185  

LifePath Index 2050 Fund

    6,094,122  

LifePath Index 2055 Fund

    1,588,916  

LifePath Index 2060 Fund

    576,706  

LifePath Index 2065 Fund

    185,161  

 

 

120  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Statement Regarding Liquidity Risk Management Program

 

In compliance with Rule 22e-4 under the Investment Company Act of 1940, as amended (the “Liquidity Rule”), BlackRock Funds III (the “Trust”) has adopted and implemented a liquidity risk management program (the “Program”) for BlackRock LifePath® Index Retirement Fund, BlackRock LifePath® Index 2025 Fund, BlackRock LifePath® Index 2030 Fund, BlackRock LifePath® Index 2035 Fund, BlackRock LifePath® Index 2040 Fund, BlackRock LifePath® Index 2045 Fund, BlackRock LifePath® Index 2050 Fund, BlackRock LifePath® Index 2055 Fund, BlackRock LifePath® Index 2060 Fund and BlackRock LifePath® Index 2065 Fund (each, a “Fund” and collectively, the “Funds”), each a series of the Trust, which is reasonably designed to assess and manage each Fund’s liquidity risk.

The Board of Trustees (the “Board”) of the Trust, on behalf of the Funds, met on November 8-9, 2022 (the “Meeting”) to review the Program. The Board previously appointed BlackRock Advisors, LLC or BlackRock Fund Advisors (“BlackRock”), each an investment adviser to certain BlackRock funds, as the program administrator for each Fund’s Program, as applicable. BlackRock also previously delegated oversight of the Program to the 40 Act Liquidity Risk Management Committee (the “Committee”). At the Meeting, the Committee, on behalf of BlackRock, provided the Board with a report that addressed the operation of the Program and assessed its adequacy and effectiveness of implementation, including the management of each Fund’s Highly Liquid Investment Minimum (“HLIM”) where applicable, and any material changes to the Program (the “Report”). The Report covered the period from October 1, 2021 through September 30, 2022 (the “Program Reporting Period”).

The Report described the Program’s liquidity classification methodology for categorizing each Fund’s investments (including derivative transactions) into one of four liquidity buckets. It also referenced the methodology used by BlackRock to establish each Fund’s HLIM and noted that the Committee reviews and ratifies the HLIM assigned to each Fund no less frequently than annually. The Report also discussed notable events affecting liquidity over the Program Reporting Period, including the imposition of capital controls in certain countries.

The Report noted that the Program complied with the key factors for consideration under the Liquidity Rule for assessing, managing and periodically reviewing each Fund’s liquidity risk, as follows:

 

  a)

The Fund’s investment strategy and liquidity of portfolio investments during both normal and reasonably foreseeable stressed conditions. During the Program Reporting Period, the Committee reviewed whether each Fund’s strategy is appropriate for an open-end fund structure with a focus on funds withmore significant and consistent holdings of less liquid and illiquid assets. The Committee also factored a fund’s concentration in an issuer into the liquidity classification methodology by taking issuer position sizes into account. Where a fund participated in borrowings for investment purposes (such as tender option bonds or reverse repurchase agreements), such borrowings were factored into the Program’s calculation of a fund’s liquidity bucketing. A fund’s derivative exposure was also considered in such calculation.

 

  b)

Short-term and long-term cash flow projections during both normal and reasonably foreseeable stressed conditions. During the Program Reporting Period, the Committee reviewed historical redemption activity and used this information as a component to establish each Fund’s reasonably anticipated trading size utilized for liquidity classifications. Each Fund has adopted an in-kind redemption policy which may be utilized to meet larger redemption requests. The Committee may also take into consideration a fund’s shareholder ownership concentration (which, depending on product type and distribution channel, may or may not be available), a fund’s distribution channels, and the degree of certainty associated with a fund’s short-term and long-term cash flow projections.

 

  c)

Holdings of cash and cash equivalents, as well as borrowing arrangements. The Committee considered the terms of the credit facility committed to each Fund, the financial health of the institution providing the facility and the fact that the credit facility is shared among multiple funds (including that a portion of the aggregate commitment amount is specifically designated for BlackRock Floating Rate Income Portfolio, a series of BlackRock Funds V, and BlackRock Floating Rate Loan ETF, a series of BlackRock ETF Trust II). The Committee also considered other types of borrowing available to the Funds, such as the ability to use reverse repurchase agreements and interfund lending, as applicable.

There were no material changes to the Program during the Program Reporting Period other than the enhancement of certain model components in the Program’s classification methodology. The Report provided to the Board stated that the Committee concluded that based on the operation of the functions, as described in the Report, the Program is operating as intended and is effective in implementing the requirements of the Liquidity Rule.

 

 

S T A T E M E N T   R E G A R D I N G   L I Q U I D I T Y   R I S K   M A N A G E M E N T   P R O G R A M

  121


Trustee and Officer Information

 

Independent Trustees(a)
         

Name

Year of Birth(b)

   Position(s) Held
(Length of Service)(c)
   Principal Occupation(s) During Past 5 Years    Number of BlackRock-Advised
Registered Investment Companies
(“RICs”) Consisting of
Investment Portfolios
(“Portfolios”) Overseen
   Public Company
and Other
Investment
Company
Directorships Held
During
Past 5 Years

Mark Stalnecker

1951

   Chair of the Board (Since 2019) and Trustee (Since 2015)    Chief Investment Officer, University of Delaware from 1999 to 2013; Trustee and Chair of the Finance and Investment Committees, Winterthur Museum and Country Estate from 2005 to 2016; Member of the Investment Committee, Delaware Public Employees’ Retirement System since 2002; Member of the Investment Committee, Christiana Care Health System from 2009 to 2017; Member of the Investment Committee, Delaware Community Foundation from 2013 to 2014; Director and Chair of the Audit Committee, SEI Private Trust Co. from 2001 to 2014.    28 RICs consisting of 164 Portfolios    None

Susan J. Carter

1956

   Trustee
(Since 2016)
   Trustee, Financial Accounting Foundation from 2017 to 2021; Advisory Board Member, Center for Private Equity and Entrepreneurship at Tuck School of Business from 1997 to 2021; Director, Pacific Pension Institute from 2014 to 2018; Senior Advisor, Commonfund Capital, Inc. (“CCI”) (investment adviser) in 2015; Chief Executive Officer, CCI from 2013 to 2014; President & Chief Executive Officer, CCI from 1997 to 2013; Advisory Board Member, Girls Who Invest from 2015 to 2018 and Board Member thereof since 2018; Advisory Board Member, Bridges Fund Management since 2016; Practitioner Advisory Board Member, Private Capital Research Institute (“PCRI”) since 2017; Lecturer in the Practice of Management, Yale School of Management since 2019; Advisor to Finance Committee, Altman Foundation since 2020; Investment Committee Member, Tostan since 2021.    28 RICs consisting of 164 Portfolios    None

Collette Chilton

1958

   Trustee
(Since 2015)
   Chief Investment Officer, Williams College since 2006; Chief Investment Officer, Lucent Asset Management Corporation from 1998 to 2006; Director, Boys and Girls Club of Boston since 2017; Director, B1 Capital since 2018; Director, David and Lucile Packard Foundation since 2020.    28 RICs consisting of 164 Portfolios    None

Neil A. Cotty

1954

   Trustee
(Since 2016)
   Bank of America Corporation from 1996 to 2015, serving in various senior finance leadership roles, including Chief Accounting Officer from 2009 to 2015, Chief Financial Officer of Global Banking, Markets and Wealth Management from 2008 to 2009, Chief Accounting Officer from 2004 to 2008, Chief Financial Officer of Consumer Bank from 2003 to 2004, Chief Financial Officer of Global Corporate Investment Bank from 1999 to 2002.    28 RICs consisting of 164 Portfolios    None

Lena G. Goldberg

1949

   Trustee
(Since 2019)
   Director, Charles Stark Draper Laboratory, Inc. from 2013 to 2021; Senior Lecturer, Harvard Business School from 2008 to 2021; FMR LLC/Fidelity Investments (financial services) from 1996 to 2008, serving in various senior roles including Executive Vice President - Strategic Corporate Initiatives and Executive Vice President and General Counsel; Partner, Sullivan & Worcester LLP from 1985 to 1996 and Associate thereof from 1979 to 1985.    28 RICs consisting of 164 Portfolios    None

 

 

122  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Trustee and Officer Information  (continued)

 

Independent Trustees(a) (continued)
         

Name

Year of Birth(b)

   Position(s) Held
(Length of Service)(c)
   Principal Occupation(s) During Past 5 Years    Number of BlackRock-Advised
Registered Investment Companies
(“RICs”) Consisting of
Investment Portfolios
(“Portfolios”) Overseen
   Public Company
and Other
Investment
Company
Directorships Held
During
Past 5 Years

Henry R. Keizer

1956

   Trustee
(Since 2019)
   Director, Park Indemnity Ltd. (captive insurer) since 2010; Director, MUFG Americas Holdings Corporation and MUFG Union Bank, N.A. (financial and bank holding company) from 2014 to 2016; Director, American Institute of Certified Public Accountants from 2009 to 2011; Director, KPMG LLP (audit, tax and advisory services) from 2004 to 2005 and 2010 to 2012; Director, KPMG International in 2012, Deputy Chairman and Chief Operating Officer thereof from 2010 to 2012 and U.S. Vice Chairman of Audit thereof from 2005 to 2010; Global Head of Audit, KPMGI (consortium of KPMG firms) from 2006 to 2010; Director, YMCA of Greater New York from 2006 to 2010.    28 RICs consisting of 164 Portfolios    Hertz Global Holdings (car rental) from 2015 to 2021; GrafTech International Ltd. (materials manufacturing); WABCO (commercial vehicle safety systems) from 2015 to 2020; Sealed Air Corp. (packaging) from 2015 to 2021

Cynthia A. Montgomery

1952

   Trustee
(Since 2009)
   Professor, Harvard Business School since 1989.    28 RICs consisting of 164 Portfolios    None
Donald C. Opatrny 1952    Trustee
(Since 2019)
   Director, Athena Capital Advisors LLC (investment management firm) from 2013 to 2020; Trustee, Vice Chair, Member of the Executive Committee and Chair of the Investment Committee, Cornell University from 2004 to 2019; President and Trustee, the Center for the Arts, Jackson Hole from 2011 to 2018; Member of the Board and Investment Committee, University School from 2007 to 2018; Trustee, Artstor (a Mellon Foundation affiliate) from 2010 to 2015; Member of the Investment Committee, Mellon Foundation from 2009 to 2015; President, Trustee and Member of the Investment Committee, The Aldrich Contemporary Art Museum from 2007 to 2014; Trustee and Chair of the Investment Committee, Community Foundation of Jackson Hole since 2014; Member of Affordable Housing Supply Board of Jackson, Wyoming since 2017; Member, Investment Funds Committee, State of Wyoming since 2017; Trustee, Phoenix Art Museum since 2018; Trustee, Arizona Community Foundation and Member of Investment Committee since 2020.    28 RICs consisting of 164 Portfolios    None

Joseph P. Platt

1947

   Trustee
(Since 2009)
   General Partner, Thorn Partners, LP (private investments) since 1998; Director, WQED Multi-Media (public broadcasting not-for-profit) since 2001; Chair, Basic Health International (non-profit) since 2015.    28 RICs consisting of 164 Portfolios    Greenlight Capital Re, Ltd. (reinsurance company); Consol Energy Inc.

Kenneth L. Urish

1951

   Trustee
(Since 2009)
   Managing Partner, Urish Popeck & Co., LLC (certified public accountants and consultants) since 1976; Past- Chairman of the Professional Ethics Committee of the Pennsylvania Institute of Certified Public Accountants and Committee Member thereof since 2007; Member of External Advisory Board, The Pennsylvania State University Accounting Department since founding in 2001; Principal, UP Strategic Wealth Investment Advisors, LLC since 2013; Trustee, The Holy Family Institute from 2001 to 2010; President and Trustee, Pittsburgh Catholic Publishing Associates from 2003 to 2008; Director, Inter- Tel from 2006 to 2007; Member, Advisory Board, ESG Competent Boards since 2020.    28 RICs consisting of 164 Portfolios    None

 

 

T R U S T E E   A N D   O F F I C E R   I N F O R M A T I O N

  123


Trustee and Officer Information  (continued)

 

Independent Trustees(a) (continued)
         
Name
Year of Birth(b)
   Position(s) Held
(Length of Service)(c)
   Principal Occupation(s) During Past 5 Years    Number of BlackRock-Advised
Registered Investment Companies
(“RICs”) Consisting of
Investment Portfolios
(“Portfolios”) Overseen
   Public Company
and Other
Investment
Company
Directorships Held
During
Past 5 Years

Claire A. Walton

1957

   Trustee
(Since 2016)
   Chief Operating Officer and Chief Financial Officer of Liberty Square Asset Management, LP from 1998 to 2015; General Partner of Neon Liberty Capital Management, LLC since 2003; Director, Boston Hedge Fund Group from 2009 to 2018; Director, Woodstock Ski Runners since 2013; Director, Massachusetts Council on Economic Education from 2013 to 2015.    28 RICs consisting of 164 Portfolios    None

 

Interested Trustees(a)(d)
         
Name
Year of Birth(b)
   Position(s) Held
(Length of Service)(c)
   Principal Occupation(s) During Past 5 Years    Number of BlackRock-Advised
Registered Investment Companies
(“RICs”) Consisting of
Investment Portfolios
(“Portfolios”) Overseen
   Public Company
and Other
Investment
Company
Directorships Held
During
Past 5 Years

Robert Fairbairn

1965

   Trustee
(Since 2018)
   Vice Chairman of BlackRock, Inc. since 2019; Member of BlackRock’s Global Executive and Global Operating Committees; Co-Chair of BlackRock’s Human Capital Committee; Senior Managing Director of BlackRock, Inc. from 2010 to 2019; oversaw BlackRock’s Strategic Partner Program and Strategic Product Management Group from 2012 to 2019; Member of the Board of Managers of BlackRock Investments, LLC from 2011 to 2018; Global Head of BlackRock’s Retail and iShares® businesses from 2012 to 2016.    98 RICs consisting of 266 Portfolios    None

John M. Perlowski(e)

1964

   Trustee
(Since 2015)
President and Chief Executive Officer
(Since 2010)
   Managing Director of BlackRock, Inc. since 2009; Head of BlackRock Global Accounting and Product Services since 2009; Advisory Director of Family Resource Network (charitable foundation) since 2009.    100 RICs consisting of 268 Portfolios    None

(a) The address of each Trustee is c/o BlackRock, Inc., 55 East 52nd Street, New York, New York 10055.

(b) Independent Trustees serve until their resignation, retirement, removal or death, or until December 31 of the year in which they turn 75. The Board may determine to extend the terms of Independent Trustees on a case-by-case basis, as appropriate.

(c) In connection with the acquisition of Barclays Global Investors by BlackRock, Inc. in December 2009, certain Independent Trustees were elected to the Board. Furthermore, effective January 1, 2019, three BlackRock Fund Complexes were realigned and consolidated into two BlackRock Fund Complexes. As a result, although the chart shows the year that each Independent Trustee joined the Board, certain Independent Trustees first became members of the boards of other BlackRock-advised Funds or legacy BlackRock funds as follows: Cynthia A. Montgomery, 1994; Joseph P. Platt, 1999; Kenneth L. Urish, 1999; Lena G. Goldberg, 2016; Henry R. Keizer, 2016; Donald C. Opatrny, 2015.

(d) Mr. Fairbairn and Mr. Perlowski are both “interested persons,” as defined in the 1940 Act, of the Trust based on their positions with BlackRock, Inc. and its affiliates. Mr. Fairbairn and Mr. Perlowski are also board members of the BlackRock Fixed-Income Complex.

(e) Mr. Perlowski is also a trustee of the BlackRock Credit Strategies Fund and BlackRock Private Investments Fund.

 

 

124  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Trustee and Officer Information  (continued)

 

Officers Who Are Not Trustees(a)
     
Name
Year of Birth(b)
   Position(s) Held
(Length of Service)
   Principal Occupation(s) During Past 5 Years

Roland Villacorta

1971

   Vice President (Since 2022)    Managing Director of BlackRock, Inc. since 2022; Head of Global Cash Management and Head of Securities Lending within BlackRock’s Portfolio Management Group since 2022; Member of BlackRock’s Global Operating Committee since 2022; Head of Portfolio Management in BlackRock’s Financial Markets Advisory Group within BlackRock Solutions from 2008 to 2015; Co-Head of BlackRock Solutions’ Portfolio Analytics Group; previously Mr. Villacorta was Co-Head of Fixed Income within BlackRock’s Risk & Quantitative Analysis Group.

Jennifer McGovern

1977

   Vice President
(Since 2014)
   Managing Director of BlackRock, Inc. since 2016; Director of BlackRock, Inc. from 2011 to 2015; Head of Americas Product Development and Governance for BlackRock’s Global Product Group since 2019; Head of Product Structure and Oversight for BlackRock’s U.S. Wealth Advisory Group from 2013 to 2019.

Trent Walker

1974

   Chief Financial Officer (Since 2021)    Managing Director of BlackRock, Inc. since September 2019; Executive Vice President of PIMCO from 2016 to 2019; Senior Vice President of PIMCO from 2008 to 2015; Treasurer from 2013 to 2019 and Assistant Treasurer from 2007 to 2017 of PIMCO Funds, PIMCO Variable Insurance Trust, PIMCO ETF Trust, PIMCO Equity Series, PIMCO Equity Series VIT, PIMCO Managed Accounts Trust, 2 PIMCO-sponsored interval funds and 21 PIMCO-sponsored closed-end funds.

Jay M. Fife

1970

   Treasurer
(Since 2009)
   Managing Director of BlackRock, Inc. since 2007.

Charles Park

1967

   Chief Compliance Officer (Since 2014)    Anti-Money Laundering Compliance Officer for certain BlackRock-advised Funds from 2014 to 2015; Chief Compliance Officer of BlackRock Advisors, LLC and the BlackRock-advised Funds in the BlackRock Multi-Asset Complex and the BlackRock Fixed-Income Complex since 2014; Principal of and Chief Compliance Officer for iShares® Delaware Trust Sponsor LLC since 2012 and BlackRock Fund Advisors (“BFA”) since 2006; Chief Compliance Officer for the BFA-advised iShares® exchange traded funds since 2006; Chief Compliance Officer for BlackRock Asset Management International Inc. since 2012.

Lisa Belle

1968

  

Anti-Money Laundering

Compliance Officer (Since 2019)

  

Managing Director of BlackRock, Inc. since 2019; Global Financial Crime Head for Asset and Wealth Management of JP Morgan from 2013 to 2019; Managing Director of RBS Securities from 2012 to 2013; Head of Financial Crimes for Barclays Wealth Americas from 2010 to 2012.

Janey Ahn

1975

   Secretary
(Since 2019)
   Managing Director of BlackRock, Inc. since 2018; Director of BlackRock, Inc. from 2009 to 2017.

(a) The address of each Officer is c/o BlackRock, Inc., 55 East 52nd Street, New York, New York 10055.

(b) Officers of the Trust serve at the pleasure of the Board.

Further information about the Trust’s Trustees and Officers is available in the Trust’s Statement of Additional Information, which can be obtained without charge by calling (800) 441-7762.

 

Effective March 31, 2022, Thomas Callahan resigned as a Vice President of the Trust and effective May 10, 2022, Roland Villacorta was appointed as a Vice President of the Trust.

Effective December 31, 2022, Joseph P. Platt retired as a Trustee of the Trust.

 

 

T R U S T E E   A N D   O F F I C E R   I N F O R M A T I O N

  125


Additional Information

 

General Information

Quarterly performance, semi-annual and annual reports, current net asset value and other information regarding the Funds may be found on BlackRock’s website, which can be accessed at blackrock.com. Any reference to BlackRock’s website in this report is intended to allow investors public access to information regarding the Funds and does not, and is not intended to, incorporate BlackRock’s website in this report.

Householding

The Funds will mail only one copy of shareholder documents, including prospectuses, annual and semi-annual reports, Rule 30e-3 notices and proxy statements, to shareholders with multiple accounts at the same address. This practice is commonly called “householding” and is intended to reduce expenses and eliminate duplicate mailings of shareholder documents. Mailings of your shareholder documents may be householded indefinitely unless you instruct us otherwise. If you do not want the mailing of these documents to be combined with those for other members of your household, please call the Funds at (800) 441-7762.

Availability of Quarterly Schedule of Investments

The Funds file their complete schedules of portfolio holdings with the SEC for the first and third quarters of each fiscal year as an exhibit to their reports on Form N-PORT. The Funds’ Forms N-PORT are available on the SEC’s website at sec.gov. Additionally, each Fund makes its portfolio holdings for the first and third quarters of each fiscal year available at blackrock.com/fundreports.

Availability of Proxy Voting Policies, Procedures and Voting Records

A description of the policies and procedures that the Funds use to determine how to vote proxies relating to portfolio securities and information about how the Funds voted proxies relating to securities held in the Funds’ portfolios during the most recent 12-month period ended June 30 is available without charge, upon request (1) by calling (800) 441-7762; (2) on the BlackRock website at blackrock.com; and (3) on the SEC’s website at sec.gov.

BlackRock’s Mutual Fund Family

BlackRock offers a diverse lineup of open-end mutual funds crossing all investment styles and managed by experts in equity, fixed-income and tax-exempt investing. Visit blackrock.com for more information.

Shareholder Privileges

Account Information

Call us at (800) 441-7762 from 8:00AM to 6:00PM ET on any business day to get information about your account balances, recent transactions and share prices. You can also visit blackrock.com for more information.

Automatic Investment Plans

Investor class shareholders who want to invest regularly can arrange to have $50 or more automatically deducted from their checking or savings account and invested in any of the BlackRock funds.

Systematic Withdrawal Plans

Investor class shareholders can establish a systematic withdrawal plan and receive periodic payments of $50 or more from their BlackRock funds, as long as their account balance is at least $10,000.

Retirement Plans

Shareholders may make investments in conjunction with Traditional, Rollover, Roth, Coverdell, Simple IRAs, SEP IRAs and 403(b) Plans.

BlackRock Privacy Principles

BlackRock is committed to maintaining the privacy of its current and former fund investors and individual clients (collectively, “Clients”) and to safeguarding their non-public personal information. The following information is provided to help you understand what personal information BlackRock collects, how we protect that information and why in certain cases we share such information with select parties.

If you are located in a jurisdiction where specific laws, rules or regulations require BlackRock to provide you with additional or different privacy-related rights beyond what is set forth below, then BlackRock will comply with those specific laws, rules or regulations.

BlackRock obtains or verifies personal non-public information from and about you from different sources, including the following: (i) information we receive from you or, if applicable, your financial intermediary, on applications, forms or other documents; (ii) information about your transactions with us, our affiliates, or others; (iii) information we receive from a consumer reporting agency; and (iv) from visits to our websites.

 

 

126  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Additional Information  (continued)

 

BlackRock Privacy Principles (continued)

BlackRock does not sell or disclose to non-affiliated third parties any non-public personal information about its Clients, except as permitted by law or as is necessary to respond to regulatory requests or to service Client accounts. These non-affiliated third parties are required to protect the confidentiality and security of this information and to use it only for its intended purpose.

We may share information with our affiliates to service your account or to provide you with information about other BlackRock products or services that may be of interest to you. In addition, BlackRock restricts access to non-public personal information about its Clients to those BlackRock employees with a legitimate business need for the information. BlackRock maintains physical, electronic and procedural safeguards that are designed to protect the non-public personal information of its Clients, including procedures relating to the proper storage and disposal of such information.

LifePath Index Fund and Service Providers

 

Investment Adviser

BlackRock Fund Advisors

San Francisco, CA 94105

Administrator

BlackRock Advisors, LLC

Wilmington, DE 19809

Accounting Agent and Custodian

State Street Bank and Trust Company

Boston, MA 02111

Transfer Agent

BNY Mellon Investment Servicing (US) Inc.

Wilmington, DE 19809

Distributor

BlackRock Investments, LLC

New York, NY 10022

Independent Registered Public Accounting Firm

PricewaterhouseCoopers LLP

Philadelphia, PA 19103

Legal Counsel

Sidley Austin LLP

New York, NY 10019

Address of the Funds

400 Howard Street

San Francisco, CA 94105

 

 

 

A D D I T I O N A L   I N F O R M A T I O N

  127


Glossary of Terms Used in this Report

 

Portfolio Abbreviation
ETF    Exchange-Traded Fund
MSCI    Morgan Stanley Capital International

 

 

128  

2 0 2 2   B L A C K R O C K   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


 

 

 

 

Want to know more?

blackrock.com    |    800-441-7762

This report is intended for current holders. It is not authorized for use as an offer of sale or a solicitation of an offer to buy shares of the Funds unless preceded or accompanied by the Funds’ current prospectus. Past performance results shown in this report should not be considered a representation of future performance. Investment returns and principal value of shares will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Statements and other information herein are as dated and are subject to change.

LPindex-12/22-AR

 

 

LOGO

   LOGO


(b) Not Applicable

 

Item 2 –

Code of Ethics – The registrant (or the “Fund”) has adopted a code of ethics, as of the end of the period covered by this report, applicable to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. During the period covered by this report, the code of ethics was amended to update certain information and to make other non-material changes. During the period covered by this report, there have been no waivers granted under the code of ethics. The registrant undertakes to provide a copy of the code of ethics to any person upon request, without charge, who calls 1-800-441-7762.

 

Item 3 –

Audit Committee Financial Expert – The registrant’s board of directors (the “board of directors”), has determined that (i) the registrant has the following audit committee financial experts serving on its audit committee and (ii) each audit committee financial expert is independent:

Neil A. Cotty

Henry R. Keizer

Kenneth L. Urish

Under applicable securities laws, a person determined to be an audit committee financial expert will not be deemed an “expert” for any purpose, including without limitation for the purposes of Section 11 of the Securities Act of 1933, as a result of being designated or identified as an audit committee financial expert. The designation or identification of a person as an audit committee financial expert does not impose on such person any duties, obligations, or liabilities greater than the duties, obligations, and liabilities imposed on such person as a member of the audit committee and board of directors in the absence of such designation or identification. The designation or identification of a person as an audit committee financial expert does not affect the duties, obligations, or liability of any other member of the audit committee or board of directors.

 

Item 4 –

Principal Accountant Fees and Services

The following table presents fees billed by PricewaterhouseCoopers LLP (“PwC”) in each of the last two fiscal years for the services rendered to the Fund:

 

     (a) Audit Fees   (b) Audit-Related Fees1   (c) Tax Fees2   (d) All Other Fees

Entity Name

 

Current

Fiscal Year

End

 

Previous

Fiscal Year

End

 

Current

Fiscal Year

End

 

Previous

Fiscal Year

End

 

Current

Fiscal Year

End

 

Previous

Fiscal Year

End

 

Current

Fiscal Year

End

 

Previous

Fiscal Year

End

BlackRock LifePath Index 2025 Fund   $22,000   $22,000   $0   $323   $10,750   $9,600   $0   $0
BlackRock LifePath Index 2030 Fund   $22,000   $22,000   $0   $323   $10,750   $9,600   $0   $0
BlackRock LifePath Index 2035 Fund   $22,000   $22,000   $0   $323   $10,750   $9,600   $0   $0
BlackRock LifePath Index 2040 Fund   $22,000   $22,000   $0   $323   $10,750   $9,600   $0   $0
BlackRock LifePath Index 2045 Fund   $22,000   $22,000   $0   $323   $10,750   $9,600   $0   $0
BlackRock LifePath Index 2050 Fund   $22,000   $22,000   $0   $323   $10,750   $9,600   $0   $0


BlackRock LifePath Index 2055 Fund   $22,000   $22,000   $0   $323   $10,750   $9,600   $0   $0
BlackRock LifePath Index 2060 Fund   $22,000   $22,000   $0   $323   $10,750   $9,600   $0   $0
BlackRock LifePath Index 2065 Fund   $22,000   $22,000   $0   $323   $10,750   $9,600   $0   $0
                 
    $22,000   $22,000   $0   $323   $10,750   $9,600   $0   $0
BlackRock LifePath Index Retirement Fund   $22,000   $22,000   $0   $323   $10,750   $9,600   $0   $0

The following table presents fees billed by PwC that were required to be approved by the registrant’s audit committee (the “Committee”) for services that relate directly to the operations or financial reporting of the Fund and that are rendered on behalf of BlackRock Advisors, LLC (the “Investment Adviser” or “BlackRock”) and entities controlling, controlled by, or under common control with BlackRock (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser) that provide ongoing services to the Fund (“Affiliated Service Providers”):

 

     Current Fiscal Year End   Previous Fiscal Year End

(b) Audit-Related Fees1

  $0   $0

(c) Tax Fees2

  $0   $0

(d) All Other Fees3

  $0   $0

1 The nature of the services includes assurance and related services reasonably related to the performance of the audit or review of financial statements not included in Audit Fees, including accounting consultations, agreed-upon procedure reports, attestation reports, comfort letters, out-of-pocket expenses and internal control reviews not required by regulators.

2 The nature of the services includes tax compliance and/or tax preparation, including services relating to the filing or amendment of federal, state or local income tax returns, regulated investment company qualification reviews, taxable income and tax distribution calculations.

3 Aggregate fees borne by BlackRock in connection with the review of compliance procedures and attestation thereto performed by PwC with respect to all of the registered closed-end funds and some of the registered open-end funds advised by BlackRock.

(e)(1) Audit Committee Pre-Approval Policies and Procedures:

 

        The Committee has adopted policies and procedures with regard to the pre-approval of services. Audit, audit-related and tax compliance services provided to the registrant on an annual basis require specific pre-approval by the Committee. The Committee also must approve other non-audit services provided to the registrant and those non-audit services provided to the Investment Adviser and Affiliated Service Providers that relate directly to the operations and the financial reporting of the registrant. Certain of these non-audit services that the Committee believes are (a) consistent with the SEC’s auditor independence rules and (b) routine and recurring services that will not impair the independence of the independent accountants may be approved by the Committee without consideration on a specific case-by-case basis (“general pre-approval”). The term of any general pre-approval is 12 months from the date of the pre-approval, unless the Committee provides for a different period. Tax or other non-audit services provided to the registrant which have a direct impact on the operations or financial reporting of the registrant will only be deemed pre-approved provided that any individual project does not exceed $10,000 attributable to the registrant or $50,000 per project. For this purpose, multiple projects will be aggregated to determine if they exceed the previously mentioned cost levels.

        Any proposed services exceeding the pre-approved cost levels will require specific pre-approval by the registrant’s Committee, as will any other services not subject to general pre-approval (e.g., unanticipated but permissible services). The Committee is informed of each service approved subject to general pre-approval at the next regularly scheduled in-person board meeting. At this meeting, an analysis of such services is presented to the Committee for ratification. The Committee may delegate to the


Committee Chairman the authority to approve the provision of and fees for any specific engagement of permitted non-audit services, including services exceeding pre-approved cost levels.

(e)(2) None of the services described in each of Items 4(b) through (d) were approved by the Committee pursuant to the de minimis exception in paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.

(f) Not Applicable

(g) The aggregate non-audit fees, defined as the sum of the fees shown under “Audit-Related Fees,” “Tax Fees” and “All Other Fees,” paid to the accountant for services rendered by the accountant to the registrant, the Investment Adviser and the Affiliated Service Providers were:

 

Entity Name

 

Current Fiscal Year

End

 

Previous Fiscal Year

End

    
BlackRock LifePath Index 2025 Fund   $10,750   $9,923
BlackRock LifePath Index 2030 Fund   $10,750   $9,923  
BlackRock LifePath Index 2035 Fund   $10,750   $9,923  
BlackRock LifePath Index 2040 Fund   $10,750   $9,923  
BlackRock LifePath Index 2045 Fund   $10,750   $9,923  
BlackRock LifePath Index 2050 Fund   $10,750   $9,923  
BlackRock LifePath Index 2055 Fund   $10,750   $9,923  
BlackRock LlifePath Index 2060 Fund   $10,750   $9,923  
BlackRock LifePath Index 2065 Fund   $10,750   $9,923  
BlackRock LifePath Index Retirement Fund   $10,750   $9,923  

(h) The Committee has considered and determined that the provision of non-audit services that were rendered to the Investment Adviser and the Affiliated Service Providers that were not pre-approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X is compatible with maintaining the principal accountant’s independence.

(i) – Not Applicable

(j) – Not Applicable

 

Item 5 –

Audit Committee of Listed Registrant – Not Applicable

 

Item 6 –

Investments

(a) The registrant’s Schedule of Investments is included as part of the Report to Stockholders filed under Item 1(a) of this Form.

(b) Not Applicable due to no such divestments during the semi-annual period covered since the previous Form N-CSR filing.


Item 7 –

Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies – Not Applicable

 

Item 8 –

Portfolio Managers of Closed-End Management Investment Companies – Not Applicable

 

Item 9 –

Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers – Not Applicable

 

Item 10 –

Submission of Matters to a Vote of Security Holders – There have been no material changes to these procedures.

 

Item 11 –

Controls and Procedures

(a) The registrant’s principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”)) are effective as of a date within 90 days of the filing of this report based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act and Rule 15d-15(b) under the Securities Exchange Act of 1934, as amended.

(b) There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

Item 12 –

Disclosure of Securities Lending Activities for Closed-End Management Investment Companies – Not Applicable

 

Item 13 –

Exhibits attached hereto

(a)(1) Code of Ethics – See Item 2

(a)(2) Section 302 Certifications are attached

(a)(3) Any written solicitation to purchase securities under Rule 23c-1 – Not Applicable

(a)(4) Change in Registrant’s independent public accountant – Not Applicable

(b) Section 906 Certifications are attached


Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BlackRock Funds III

 

 

By:

    

/s/ John M. Perlowski                            

      

John M. Perlowski

      

Chief Executive Officer (principal executive officer) of

      

BlackRock Funds III

Date: February 23, 2023

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

 

By:

    

/s/ John M. Perlowski                            

      

John M. Perlowski

      

Chief Executive Officer (principal executive officer) of

      

BlackRock Funds III

Date: February 23, 2023

 

 

By:

    

/s/ Trent Walker                            

      

Trent Walker

      

Chief Financial Officer (principal financial officer) of

      

BlackRock Funds III

Date: February 23, 2023